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RESUME 
Chaque division cellulaire requiert une duplication précise du génome. Des 
dizaines de milliers de sites d’initiation de la réplication d’ADN (origines de 
réplication) sont impliqués dans la réplication complète du génome humain. 
L’activation des origines de réplication est régulée précisément et des 
études génomiques extensives ont démontré la présence de 
caractéristiques génomiques associées à l’activation des origines de 
réplication. Le complexe de pré-réplication (pre-RC) est la base de 
l’initiation de la réplication et consiste en deux sous-complexes majeurs : l’ 
« origin recognition complex » (ORC) qui interagit directement avec l'ADN 
et est nécessaire pour recruter le second sous-complexe, les hélicases 
Mcm2-7, qui sont responsables de l'initiation de la réplication. La régulation 
de l’assemblage du pre-RC est bien étudiée, mais les caractéristiques de la 
chromatine qui déterminent le positionnement du pre-RC sur le génome 
restent peu connues. Les études génomiques par immuno-précipitation de 
la chromatine et séquençage à haut débit (ChIP-seq) des pre-RCs sont rares 
et jusqu’à aujourd’hui seulement disponibles pour ORC. Du fait que Mcm2-7 
migre de son site de chargement initial, il est crucial d'obtenir des 
informations sur le positionnement des Mcm2-7 pour la compréhension 
complète de la régulation de la réplication.        
Ce travail présente la première analyse génomique par méthode ChIP-seq 
des deux sous-unités majeures du pre-RC, ORC et Mcm2-7, dans la lignée 
cellulaire de lymphome de Burkitt Raji infectée par le virus d’Epstein-Barr 
(EBV). La présence du génome d’EBV permet d'avoir un contrôle interne de 
la qualité de nos expériences, en comparant les positions de pre-RC 
déterminées avec des positions du pre-RC précédemment publiées. Sur le 
génome humain, les résultats de séquençage du pre-RC corrèlent bien avec 
des zones de réplication active. De façon intéressante, les zones de 
terminaison de la réplication étaient spécifiquement bas en pre-RC, 
spécialement en Mcm2-7. La localisation des sites d'initiation de la 
réplication identifiés est généralement bien corrélée avec les sites de 
transcription active. En effet, des sites d’assemblage du pre-RC de haute 
affinité sont localisés préférentiellement en voisinage de sites de 
transcription active, ce qui est possiblement dû à l’accessibilité de la 
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chromatine dans ces régions. La fixation de Mcm2-7 fluctuait de façon 
dépendante du cycle cellulaire, ce qui suggère des translocations de 
Mcm2-7 en G1, probablement dépendantes de la machinerie active de la 
transcription. Ces résultats indiquent que les positions de ORC et Mcm2-7 
sont principalement dépendantes de l’accessibilité de la chromatine avec un 
accès privilégié dans la chromatine active et Mcm2-7 étant le déterminant 
majeur de l’initiation de la réplication.         
Au sein de l'hétérochromatine, ORC était enrichi dans des zones associées 
avec l'histone modifié H4K20me3. Cependant, cet enrichissement était 
moins important pour les Mcm2-7. En utilisant un système de réplication 
basé sur des plasmides, nous avons démontré que l’association d'ORC et 
H4K20me3 favorise l’assemblage du pre-RC et l’initiation de la réplication. 
Cette observation suggère que l’interaction ORC-chromatine est le 
déterminant majeur de la régulation de la réplication d’ADN au sein de 
l’hétérochromatine. En conclusion, cette étude propose deux mécanismes 
différents de la régulation de l'assemblage du pre-RC dépendants de 
l’environnement de la chromatine. 
 
Mots clés : Réplication d’ADN, pre-RC, chromatine, PR-Set7, 
Suv4-20h1/h2, H4K20 méthylation 
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ZUSAMMENFASSUNG 
Mit jeder Zellteilung muss das Genom exakt dupliziert werden. 
Zehntausende Replikationsinitiationsstellen sind bei der Replikation des 
gesamten humanen Genoms beteiligt. Die Aktivierung der Initiationsstellen 
ist präzise reguliert und umfassende Genom-weite Studien haben 
verschiedene genomische Faktoren identifiziert, die die Aktivierung der 
Replikationsinitiationsstellen beeinflussen. Der Prä-Replikationskomplex 
(pre-RC) bildet die Grundlage der Replikationsinitiation und besteht aus 
zwei Hauptuntereinheiten: der „origin recognition complex“ (ORC) bindet 
DNS und wird zum Laden der zweiten Untereinheit, den Mcm2-7 Helikasen 
benötigt, die die eigentliche Replikationsinitiation veranlassen. Während die 
Regulation des pre-RC Aufbaus vielfach untersucht wurde und mittlerweile 
gut verstanden wird, sind die Chromatinkomponenten, welche die 
Positionierung der pre-RCs regulieren, weitgehend unbekannt. Die wenigen 
Genom-weiten pre-RC Chromatin Immunopräzipitations- und 
Sequenzierungsstudien (ChIP-seq), behandeln bis heute nur ORC. Da sich 
Mcm2-7 allerdings von seiner initialen Ladeposition fortbewegen kann, 
werden vor allem die Genom-weiten Positionen von Mcm2-7 benötigt, um 
die Regulation der DNS Replikation vollständig zu verstehen.         
Diese Arbeit umfasst die erste Genom-weite pre-RC ChIP-seq Analyse der 
zwei pre-RC Hauptkomponenten ORC und Mcm2-7 in der Epstein-Barr Virus 
(EBV) infizierten Burkitt-Lymphom Zelllinie Raji. Als Qualitätskontrolle für 
erfolgreiche ChIPs wurden die aus den vorliegenden Experimenten 
bestimmten pre-RC Positionen auf dem EBV-Genom mit bereits bekannten 
pre-RC Positionen verglichen. Auf dem humanen Genom korrelierten die 
pre-RC ChIP Ergebnisse mit aktiven Replikationszonen, während 
Replikationsterminationszonen eine spezifische Abnahme der pre-RC 
Komponenten, besonders von Mcm2-7, aufzeigten. Es ist bereits bekannt, 
dass aktive Replikation mit aktiver Transkription korreliert. Starke pre-RC 
Bindung war in der Tat hauptsächlich an Regulationsstellen der aktiven 
Transkription zu finden, was vermutlich durch die Zugänglichkeit des 
Chromatins determiniert wird. Starke Mcm2-7 Bindung variierte dabei in 
Abhängigkeit des Zellzyklus, was für Mcm2-7 Translokationen während der 
G1 Phase spricht, die vermutlich von der aktiven Transkriptionsmaschinerie 
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beeinflusst werden. Diese Ergebnisse deuten darauf hin, dass ORC und 
Mcm2-7 Positionen in der aktiven Chromatinumgebung hauptsächlich von 
der Zugänglichkeit des Chromatins abhängen und Mcm2-7 die 
Hauptkomponente der Bestimmung der Replikationsinitiationsstellen 
darstellt.        
In Heterochromatin assoziierte vorwiegend ORC mit der 
heterochromatischen Histonmodifikation H4K20me3, während Mcm2-7 
weniger Anreicherung zeigte. Unter Verwendung eines Plasmid-basierten 
Replikationssystems wurde bestätigt, dass diese ORC-Chromatin 
Assoziation einen essentiellen Einfluss auf die Regulation der pre-RC 
Positionierung und Aktivierung ausübt. Dieses Ergebnis zeigt, dass ORC-
Chromatin Interaktionen einen entscheidenden Faktor für die Regulation 
der Replikation in Heterochromatin darstellen. Zusammenfassed schlägt 
diese Studie zwei verschiedene Modi der pre-RC Positionierung vor, welche 
jeweils vom Chromatinkontext abhängen.    
 
Schlagwörter : DNA Replikation, pre-RC, Chromatin, PR-Set7, 
Suv4-20h1/h2, H4K20 Methylierung 
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ABSTRACT 
With every cell division, the genome needs to be faithfully duplicated. Tens 
of thousands of DNA replication initiation sites (origins of replication) are 
involved in replicating the human genome. Origin activation is precisely 
regulated and extensive genome-wide studies found association of origin 
activation to several different genomic features. The pre-replication 
complex (pre-RC) is the basis for replication initiation and consists of two 
major subcomponents: the origin recognition complex (ORC) binds DNA and 
is required for loading of the second component, Mcm2-7 helicases, which 
initiate DNA replication. Regulation of pre-RC assembly is well studied, 
however, chromatin features driving pre-RC positioning on the human 
genome remain largely unknown. Genome-wide pre-RC chromatin 
immunoprecipitation experiments followed by sequencing (ChIP-seq) 
studies are rare and so far only performed for ORC. As Mcm2-7 can 
translocate from their initial loading site, information about Mcm2-7 
positioning are required for full understanding of DNA replication regulation. 
This work presents the first genome-wide ChIP-seq analysis of the two 
major pre-RC subcomponents ORC and Mcm2-7 in the Epstein-Barr virus 
(EBV) infected Burkitt’s lymphoma cell line Raji. Successful ChIPs were 
validated on the EBV genome by comparing obtained pre-RC positions with 
already existing pre-RC ChIP-on chip data. On the human genome, pre-RC 
sequencing results nicely correlated with zones of active replication. 
Interestingly, zones of replication termination were specifically depleted 
from pre-RC components, especially from Mcm2-7. Active DNA replication 
is known to correlate with active transcription. Indeed, strong pre-RC 
assembly preferentially occurred at sites of active transcriptional regulation, 
presumably determined by chromatin accessibility. Strong Mcm2-7 binding 
thereby fluctuated cell cycle-dependently, arguing for Mcm2-7 
translocations during G1, possibly depending on the active transcriptional 
machinery. These results indicate ORC and Mcm2-7 positions being mainly 
dependent on chromatin accessibility in active chromatin, with Mcm2-7 
being the major determinant of replication initiation.     
In heterochromatin, ORC was enriched at H4K20me3 sites, while Mcm2-7 
enrichment was less prominent. Employing a plasmid-based replication 
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system, ORC association to H4K20me3 was proven to promote successful 
pre-RC assembly and replication initiation, situating direct ORC-chromatin 
interactions being the major determinant for DNA replication regulation in 
heterochromatin. Taken together, this study proposes two different modes 
of pre-RC assembly regulation depending on chromatin environment. 
 
Keywords: DNA replication, origin licensing, pre-RC, chromatin, PR-Set7, 
Suv4-20h1/h2, H4K20methylation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE OF CONTENTS 
8 | 
 
 
 
 
 
 
 
TABLE OF CONTENTS 
RESUME ___________________________________________________ 2 
ZUSAMMENFASSUNG_________________________________________ 4 
ABSTRACT _________________________________________________ 6 
TABLE OF CONTENTS ________________________________________ 8 
1. INTRODUCTION _________________________________________ 11 
 DNA REPLICATION IS TIGHTLY REGULATED – AND STOCHASTIC 11 
1.1.1 ASSEMBLY OF THE PRE-REPLICATION COMPLEX IN LATE MITOSIS/ EARLY G1 
  12 
1.1.2 REPLICATION ACTIVATION IN S-PHASE: FROM PRE-REPLICATION COMPLEX TO 
PRE-INITIATION COMPLEX 13 
1.1.3 TERMINATING DNA REPLICATION 13 
1.1.4 CELL CYCLE REGULATION OF DNA REPLICATION: PREVENTING RE-
REPLICATION AND INCOMPLETE REPLICATION 13 
1.1.5 METAZOAN ORIGIN LICENSING AND ACTIVATION IS MAINLY STOCHASTIC 15 
 DNA REPLICATION REGULATION THROUGH CHROMATIN 17 
1.2.1 HISTONE MODIFICATIONS REGULATING DNA REPLICATION 18 
1.2.2 HISTONE 4 LYSINE 20 METHYLATION AFFECTS DNA REPLICATION 18 
 DNA REPLICATION DEPENDS ON NUCLEAR CHROMATIN ORGANIZATION 19 
 MAPPING OF DNA REPLICATION INITIATION EVENTS 21 
1.4.1 SINGLE MOLECULE DNA COMBING 21 
1.4.2 BUBBLE-SEQUENCING AND SHORT NASCENT STRAND SEQUENCING 21 
1.4.3 OKAZAKI-FRAGMENT SEQUENCING 22 
1.4.4 CHIP-SEQUENCING OF PRE-RC COMPONENTS 23 
1.4.5 EPSTEIN-BARR VIRUS GENOME AS MODEL OF HUMAN DNA REPLICATION 24 
2. AIM OF THE THESIS ______________________________________ 25 
3. MATERIAL AND METHODS _________________________________ 26 
 MEDIA, MATERIAL, DEVICES, CHEMICALS AND AGENTS 26 
 BIOLOGICAL METHODS 29 
3.2.1 CELL CULTURE 29 
3.2.2 CELL CYCLE FRACTIONATION BY CENTRIFUGAL ELUTRIATION 31 
TABLE OF CONTENTS 
9 | 
 
3.2.3 FLUORESCENCE ACTIVATED CELL SORTING (FACS) 32 
3.2.4 IMMUNOBLOT 32 
3.2.5 PLASMID ABUNDANCE ASSAY 34 
3.2.6 CROSS-LINK 35 
3.2.7 CHROMATIN IMMUNOPRECIPITATION (CHIP) 35 
3.2.8 QUANTITATIVE PCR (QPCR) 38 
3.2.9 SEQUENCING 39 
 BIOINFORMATICS 39 
3.3.1 BOWTIE MAPPING OF SEQUENCING READS AGAINST THE GENOME 40 
3.3.2 GENERATION OF PILEUP PROFILES 40 
3.3.3 MACS2, HOMER, AND T-PIC PEAK-CALLING 40 
3.3.4 DEFINITION OF ORC, MCM2-7, AND PRE-RC 41 
3.3.5 PEAK COMPARISONS: JACCARD INDEX AND OVERLAPS 41 
3.3.6 CALCULATING GENOMIC DISTRIBUTIONS WITH CEAS 41 
4. RESULTS AND DISCUSSION ________________________________ 42 
 SETTING UP CHIP-SEQ EXPERIMENTS IN HUMAN CELLS 42 
4.1.1 CONSIDERATIONS TO OPTIMIZE PRE-RC CHIP-SEQ EXPERIMENTS 42 
4.1.2 PERFORMING CHIP-SEQ EXPERIMENTS IN RAJI CELLS 44 
4.1.3 PERFORMING CHIP-SEQ EXPERIMENTS IN HUMAN EMBRYONIC STEM (HES) 
CELLS 56 
 PRE-RC COMPONENTS ARE ENRICHED WITHIN REPLICATION UNITS 60 
4.2.1 COMPARING T-PIC VS. HOMER PEAK-CALLING ALGORITHMS AND DEFINING 
ORC, MCM2-7, AND PRE-RC ON THE HUMAN GENOME 60 
4.2.2 PRE-RCS CORRELATE WITH ACTIVE REPLICATION UNITS 65 
 STABLE ORIGIN LICENSING IS ASSOCIATED TO REGULATION OF ACTIVE 
TRANSCRIPTION 72 
4.3.1 PRE-RC COVERAGE WAS INCREASED AT ACTIVE TRANSCRIPTION START SITES 
  72 
4.3.2 STRONG HOMER-DEFINED ORC, MCM2-7 AND PRE-RC ASSOCIATED WITH 
ACTIVE TRANSCRIPTION START SITES 74 
4.3.3 PRE-RC COVERAGE WAS ENHANCED AT H3K4ME3 PEAKS 76 
4.3.4 STRONG HOMER-DEFINED MCM2-7 AND PRE-RC ENTIRELY ASSOCIATE WITH 
H3K4ME3 78 
 MCM2-7 HELICASES APPROXIMATE ORC IN S/G2 82 
4.4.1 COMPLEX NUMBER AND SIZES DO NOT CHANGE IN S/G2 82 
4.4.2 MCM2-7 COVERAGE AT AS AND DEPLETION FROM DS ARE LESS PRONOUNCED 
  85 
4.4.3 PRE-RC COVERAGE AT TSS AND H3K4ME3 WAS INCREASED IN S/G2 87 
4.4.4 MCM2-7 HELICASES APPROXIMATE ORC POSITIONS IN S/G2 90 
 ORC ASSOCIATES WITH H4K20ME3 IN HETEROCHROMATIN 94 
4.5.1 H4K20ME1 IS PRESENT IN ACTIVE CHROMATIN WHILE H4K20ME3 
LOCALIZES TO HETEROCHROMATIN REGIONS 94 
4.5.2 ORC PREFERENTIALLY ASSOCIATES WITH H4K20ME3 95 
4.5.3 NO DISTRIBUTIONAL CHANGE WAS OBSERVED IN S/G2 99 
 H4K20ME3 IS NECESSARY FOR ORIGIN LICENSING AND ACTIVATION IN 
HETEROCHROMATIN 100 
4.6.1 SUV4-20H1 TARGETING UNSPECIFICALLY INDUCES H4K20ME3 102 
4.6.2 PR-SET7 TARGETING LEADS TO INDUCTION OF H4K20ME1, CONVERSION 
INTO H4K20ME3 AND PRE-RC FORMATION 103 
4.6.3 PR-SET7 TARGETING ENHANCES PLASMID REPLICATION EFFICIENCIES 105 
TABLE OF CONTENTS 
10 | 
 
4.6.4 PR-SET7 TARGETING INDUCES PLASMID REPLICATION 106 
4.6.5 REPLICATION LICENSING AND ACTIVATION DEPEND ON H4K20ME3 107 
5. CONCLUSION __________________________________________ 114 
 CHROMATIN ACCESSIBILITY IS THE MAIN DETERMINANT OF PRE-RC 
POSITIONING IN ACTIVE CHROMATIN 114 
 DIRECT ORC-CHROMATIN INTERACTIONS REGULATE PRE-RC POSITIONING IN 
HETEROCHROMATIN 117 
APPENDIX _______________________________________________ 119 
BIBLIOGRAPHY ___________________________________________ 149 
TABLE OF FIGURES ________________________________________ 159 
TABLE OF TABLES _________________________________________ 163 
ABBREVIATIONS __________________________________________ 164 
RESUME SUBSTANTIEL _____________________________________ 166 
ACKNOWLEDGEMENTS _____________________________________ 174 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  1. INTRODUCTION 
11 | 
 
 
 
 
 
 
 
1. INTRODUCTION 
DNA replication is the process of precisely copying the complete genetic 
information, which assures faithful inheritance of the genome during each 
cell division. Thereby, DNA replication initiates only once per cell cycle. 
Misregulation during this process leads to genetic instability, which might 
have fatal consequences on organs and tissues and can cause cancer or 
other genetic disorders in humans (Abbas, Keaton, and Dutta 2013). Sites 
of DNA replication initiation are called origins of replication. While bacteria 
initiate genome replication at one specific origin (Mott and Berger 2007), 
replication regulation in Saccharomyces cerevisiae is already more complex. 
In S. cerevisiae, DNA replication origins were initially identified as 
autonomous replication sequences (ARS), which contain an 11-17 bp AT-
rich consensus sequence. However, only a small part of all ARS consensus 
sequences are used as replication origins, suggesting that other features 
also contribute to origin recognition and activation (Fragkos et al. 2015). In 
higher eukaryotes, origins do not exhibit sequence specificities and DNA 
replication can initiate at any DNA sequence (Vashee et al. 2003). In 
humans, 30000-50000 origins are activated in each cell at each cell cycle. 
Numerous studies during the recent years revealed that origins exhibit a 
preference for specific features, although none of these features alone are 
predictive for replication origins (Méchali 2010).  In the following, I will 
detail the regulation of DNA replication in higher eukaryotes and the impact 
of chromatin, histone modifications, and structural arrangements within the 
nucleus. 
 DNA REPLICATION IS TIGHTLY REGULATED – AND 
STOCHASTIC 
DNA replication is spatio-temporally separated to ensure correct duplication 
of the genome. During each S-phase of the cell cycle, 30000-50000 origins 
are activated per cell. These origins are chosen from an exceeding pool of 
possible origins. For an origin to be activated, proper loading of the pre-
replication complex (pre-RC) during preceding G1 is required.  
  1. INTRODUCTION 
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1.1.1 ASSEMBLY OF THE PRE-REPLICATION COMPLEX IN LATE MITOSIS/ EARLY 
G1 
The process of pre-RC assembly is called origin licensing and is restricted 
from late mitosis to the restriction point in G1-phase of the cell cycle. All 
possible origins need to be properly licensed, while only a subset is activated 
during S-phase. Origin licensing consists of the sequential loading of pre-
RC proteins and starts with the binding of the origin recognition complex 
(ORC, Figure 1.1).  
 
FIGURE 1.1: SCHEMATIC REPRESENTATION OF SEQUENTIAL PRE-RC ASSEMBLY. Licensing consists of 
the sequential loading of pre-RC components and is restricted to G1-phase. First ORC binds DNA as 
hexameric complex. Cdc6 recruitment traps DNA in the center of the circle and initiates Cdt1-
dependent Mcm2-7 helicase loading. Cdt1 dissociates from Mcm2-7 after loading. Another Mcm2-7 
hexamer is subsequently loaded in head-to-head conformation (Model template from Bleichert, 
Botchan, and Berger 2015).  
ORC is a hexameric complex with ATPase activity and ATP-dependent DNA 
contact (Bleichert, Botchan, and Berger 2015). After ORC binding, the 
ATPase Cdc6 is recruited and DNA-bound ORC-Cdc6 initiates Cdt1 
association. Cdt1 chaperones Mcm2-7 (for Minichromosome Maintenance) 
loading, the ring-structured core of the replicative helicase (Remus et al. 
2009; Bell and Kaguni 2013). Cdc6 hydrolyses ATP only when bound to ORC 
and is required for proper Mcm2-7 loading. Mcm2-7 helicases are 
sequentially loaded as head-to-head double-hexamer (Remus et al. 2009). 
Interestingly, once Mcm2-7 double-hexamers are loaded, ORC, Cdc6, and 
Cdt1 are no longer required for replication initiation (Hua and Newport 
1998; Yeeles et al. 2015). Pre-RC assembly is restricted to G1-phase when 
cyclin-dependent kinase (CDK) activity is low. Licensed origins are then 
competent for replication activation.  
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1.1.2 REPLICATION ACTIVATION IN S-PHASE: FROM PRE-REPLICATION 
COMPLEX TO PRE-INITIATION COMPLEX 
With the onset of DBF4-dependent kinase (DDK) and CDK activity during 
the G1/S-phase transition (for kinase activities, see also Figure 1.2, chapter 
1.1.4, p. 124), pre-RCs are converted into the pre-initiation complexes 
(pre-ICs). Pre-IC formation involves the binding of further proteins, such as 
Mcm10, Cdc45, Dbp11 and the GINS (Sld5, Psf1, Psf2, Psf3) complex 
(Gambus et al. 2006). During origin activation, several pre-IC proteins, 
including Mcm2-7, are phosphorylated by CDK and DDK to initiate 
replication (Francis et al. 2009). Cdc45-Mcm2-7-GINS (CMG) represent the 
active replicative helicase, which unwinds the DNA and DNA polymerase 
loads on single-stranded DNA (Ilves et al. 2010). Replication activation 
involves the dissociation of the Mcm2-7 double-hexamer into two active 
hexamers that originate the two replisomes consisting of about 150 proteins 
replicating DNA bidirectionally (Herrera et al. 2015).  
Bidirectional DNA replication involves one strand to be replicated 
continuously (leading strand), while the other strand is synthesized in 
discontinuous fragments (Okazaki fragments), which are subsequently 
ligated (lagging strand). RNA primase de novo generates RNA primers, 
which are extended by DNA polymerases in 5’ to 3’ direction and removed 
during a maturation process (see also Figure 1.6, p. 22). DNA polymerases 
duplicate several hundreds of kb before replication forks collapse (Fragkos 
et al. 2015; Petryk et al. 2016). Replication termination happens e.g. when 
two replisomes converge.      
1.1.3 TERMINATING DNA REPLICATION  
Although initiation of DNA replication is well characterized, replication 
termination remains poorly understood. Replication termination mainly 
occurs when two opposite replication forks (from two adjacent origins of 
replication) collide. Also, termination needs to be tightly regulated to 
prevent premature termination without completing replication. The process 
involves the disassembly of converging replisomes and resolution of 
replication-induced DNA catenated intertwines by topoisomerases 
(Fachinetti et al. 2010). Recent work has shown that the polyubiquitination 
of the Mcm2-7 subunit Mcm7 at the end of S-phase leads to CMG 
disassembly (Moreno et al. 2014; Maric et al. 2014). However, this 
ubiquitination is necessary but not sufficient, suggesting additional factors 
being involved in replication termination (Lengronne and Pasero 2014).  
1.1.4 CELL CYCLE REGULATION OF DNA REPLICATION: PREVENTING RE-
REPLICATION AND INCOMPLETE REPLICATION 
It is crucial for genetic stability, that the genome is completely replicated 
only once per cell cycle. The proteins that regulate cell cycle progression 
(amongst others cyclins, CDKs, and ubiquitin ligases) are also tightly linked 
with the control of DNA replication (DePamphilis et al. 2006). Origin 
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licensing only happens in absence of DDK and CDKs (Figure 1.2). Existing 
pre-RCs are inactivated during S, G2 and M, preventing repeated licensing 
and activation (Blow and Dutta 2005; DePamphilis 2005). As already 
mentioned in chapter 1.1.2, DDK and CDK phosphorylate several members 
of pre-RC and pre-IC, which leads to replication activation, but also inhibits 
re-licensing of replication origins.   
 
FIGURE 1.2: CELL CYCLE KINASE ACTIVITIES DETERMINE PRE-RC FORMATION AND ACTIVATION. Pre-
RC assembly happens in absence of kinase activities. With onset of CDKs (red, blue) and DDK 
(green), replication is activated and re-licensing prevented (Adapted from PINES 1999). The dashed 
grey line represents expression H4K20 monomethyltransferase PR-Set7 (introduced in chapter 1.2.2, 
p. 18.)  
In metazoans, Cyclin A-Cdk2 phosphorylates Cdt1 and Orc1 (Depamphilis 
et al. 2012). Phosphorylation of the Mcm2-7 chaperone Cdt1 in S-phase, 
leads to its ubiquitination, export to the cytoplasm, and subsequent 
degradation. This process ensures Cdt1 protein levels only being present in 
the nucleus in late mitosis/early G1. Additionally, Cdt1 activity is also 
repressed by Geminin, a specific Cdt1 inhibitor exclusively existing in 
metazoans. Geminin is active from S-phase on and degraded with the onset 
of mitosis. Interestingly, Cdt1 recruits Geminin to DNA and their binding 
stabilizes Cdt1, probably securing the availability of Cdt1 for the next G1-
phase (Ballabeni et al. 2004).  
In metazoan cells, ORC subunits are phosphorylated to prevent re-licensing 
during and after S phase (DePamphilis 2005; DePamphilis et al. 2006). Orc1 
phosphorylation reduces binding affinities to chromatin is followed by 
ubiquitination and degradation (Méndez et al. 2002). Orc2 phosphorylation 
also dissociates ORC subunits 2-5 from DNA (Lee et al. 2012). Orc1 re-
associates to chromatin during mitosis to G1 transition, followed by origin 
licensing (DePamphilis 2005).   
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Replication forks encountering obstacles (such as DNA secondary structures 
or lesions), or reduced deoxyribonucleotide triphosphate (dNTP) pools 
within the cell can lead to replication stress and induce replication fork 
stalling (Yekezare, Gómez-González, and Diffley 2013).  For the cell to 
complete DNA replication, it is crucial to activate another licensed origin 
that has not been activated so far (dormant origin). Consequently, 
activation of additional origins decreases inter-origin distances and S-phase 
length remains constant (Blow, Ge, and Jackson 2011). Existence of 
dormant origins requires an excess of origin licensing during G1. Only a 
small proportion of licensed origins is actually activated during S-phase, 
while the vast majority remains dormant (Musiałek and Rybaczek 2015) and 
are evicted during passive replication (Kuipers et al. 2011). The choice of 
which origin to activate is thereby mainly stochastic.  
 
FIGURE 1.3: ORIGIN USAGE FREQUENCY DEFINES ORIGIN EFFICIENCY. Pre-RCs are assembled in G1. 
Only a subset is stochastically activated during S-phase, with each cell using a different cohort. The 
frequency of origin usage defines origin efficiency. Origin efficiency is represented schematically as 
result of SNS-seq (explained in chapter 1.4.2).  
 
1.1.5 METAZOAN ORIGIN LICENSING AND ACTIVATION IS MAINLY STOCHASTIC 
Only a subset of licensed origins is activated with the onset of S-phase and 
each cell uses a different cohort of replication origins. This observation led 
to the definition of origin efficiency as the frequency of a specific origin to 
be activated in a given cell during a given cell cycle (Méchali 2010) (Figure 
1.3).   
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There are many features identified so far that influence origin licensing and 
efficiency (Figure 1.4). While AT-richness defines ARS elements in yeasts, 
there is a clear preference for CG-rich regions in mammals (Cayrou et al. 
2015). Interestingly, not only CG-content, but also potentially resulting 
three-dimensional G-quadruplex structures (G4) impact on origin efficiency 
(Besnard et al. 2012; Valton et al. 2014; Langley et al. 2016). Thereby it 
remains controversial whether G4s actually positively or negatively 
influence DNA replication (Valton and Prioleau 2016). DNA accessibility, as 
well as specific histone modifications have been linked to active replication 
(introduced in detail in chapter 1.2, p. 17), as well as transcriptional activity 
and enhancer functions. Origins are often more concentrated and active in 
promoter regions, most probably due to open chromatin configurations, as 
direct interactions of transcription factors and replication factors have not 
been found so far (Fragkos et al. 2015). However, while all these different 
features contribute to origin licensing and activation on different levels, 
none of them is sufficient on its own and it is most likely a random 
combination of these different features that defines an origin (Méchali 
2010).  
 
FIGURE 1.4: DIFFERENT FEATURES INFLUENCE REPLICATION ORIGINS. From DNA sequence to 
structure over chromatin to functional organization, all features have been linked to regulation of 
replication, while none of these features alone define an origin. DNA: AT-rich sequences might 
facilitate replication activation due to lower melting temperatures. Replication and GC-richness seems 
to be mainly linked on the structural level, as G4-structures are enriched at active initiation sites. 
Whether G4-structures facilitate pre-RC binding or replication initiation remains unclear so far. 
Structure: Bent DNA or loop formation might also facilitate pre-RC loading; MAR: matrix attachment 
regions. Local chromatin: nucleosome positioning/ nucleosome-free regions promote pre-RC binding, 
specific histone modification might directly interact with pre-RC components, targeting factors 
(EBNA1, HMGA1a) interact with ORC and direct replication. Functional organization: Active 
transcription/transcriptional regulation through enhancers/promoters have been described to 
influence DNA replication. Direct interactions between replication origin factors and transcription 
factors have not been reported.  (Modified from Méchali 2010). 
Recent work on the sequencing of Okazaki fragments led to the 
identification of broad (10-100 kb) initiation zones (Petryk et al. 2016, 
introduced in detail in chapter 1.4, p21). The authors claim that broad 
initiation zones represent replication units, within which replication 
preferentially initiates from multiple inefficient origins but only one single 
origin stochastically fires per cell. This observation also implies the necessity 
of broadly distributed licensed replication origins within such replication 
units.  
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It has been demonstrated, that the number of chromatin-bound Mcm2-7 
helicases exceeds the number of active origins of ORC by a factor of 10 to 
50 (Donovan et al. 1997; Powell et al .2015; Hyrien 2016). This can be 
achieved by either i) ORC loading several Mcm2-7 double-hexamers which 
spread from their binding site (Powell et al. 2015, Drosophila) or ii) ORC 
loading only one Mcm2-7 double-hexamer at a time, associating and 
dissociating quickly from DNA (Sonneville et al. 2012, C. elegans). There is 
evidence for either mechanism and further investigations will be required 
to conclusively resolve this question.  
Finally, these recent findings evoked the model of the Mcm2-7 
double-hexamer excess influencing organization of replication timing (Das 
and Rhind 2016; Hyrien 2016). Replication timing describes the time-point 
of origin activation during S-phase (early, middle, or late). Given that 
Mcm2-7 helicase activation can occur without the presence of ORC, higher 
densities of Mcm2-7 proteins could define early replicating regions, as the 
probability of early origin firing is simply higher than in late replicating 
domains containing less Mcm2-7 double-hexamers loaded on DNA. The 
organization of replication timing domains is described in chapter 1.3.  
 DNA REPLICATION REGULATION THROUGH CHROMATIN 
Chromatin is a combination of DNA and proteins and ensures DNA 
compaction in the cell. The core unit of chromatin is the nucleosome – 147 
bp DNA wrapped 1.7 times around a histone octamer consisting of two 
copies of H2A, H2B, H3 and H4.  The most accessible chromatin level is the 
10 nm fiber, often also referred to as “beads on a string” while higher order 
compacted structures constitute condensed chromatin (Soshnev, 
Josefowicz, and Allis 2016). Two main chromatin states exist: i) the 
compact and transcriptionally inactive state of chromatin is called 
heterochromatin, while ii) euchromatin represents accessible, 
transcriptionally active chromatin. Specific modifications of histone tails 
regulate chromatin states. Activating histone marks often involve 
acetylation, methylation (e.g. H3K4me1/2/3), and ubiquitination 
(Kouzarides 2007). Main repressing histone modifications associated to 
gene silencing are H3K9me3 and H3K27me3. Histone modifications are 
recognized by specific chromatin readers, which recruit other chromatin 
modifiers or remodelers, establishing chromatin as a very dynamic 
structure, being able to rapidly respond to environmental cues and 
requirements. However, not only histone modifications regulate chromatin 
structure, also nucleosome positioning impacts on chromatin and gene 
expression. Promoters and enhancers frequently exhibit accessible 
chromatin conformations, to allow binding of transcriptional regulators 
(Kouzarides 2007). Chromatin accessibility is not only a feature of 
transcriptional regulations, also pre-RC proteins preferentially bind 
accessible DNA regions (Méchali 2010; Miotto, Ji, and Struhl 2016), 
rendering chromatin conformation also important for regulation of DNA 
replication.  
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1.2.1 HISTONE MODIFICATIONS REGULATING DNA REPLICATION 
Nucleosome depleted regions (NDRs) mark origins of replication in yeast 
(Field et al. 2008), Drosophila (Ding and MacAlpine 2011), Epstein-Barr-
Virus (Papior et al. 2012) and humans (Miotto, Ji, and Struhl 2016). 
Nucleosome depletion might also be the link between DNA replication and 
G4 structures, as G4s exclude nucleosomes, thereby eventually favoring 
pre-RC formation (Fenouil et al. 2012; Valton and Prioleau 2016).   
Transcriptionally active chromatin is marked by active histone 
modifications, typically acetylations of lysine residues of histone H3 and H4 
(H3ac, H4ac), and H3K4me1/2/3.  Genome-wide studies often correlate 
active chromatin modifications with DNA replication (Cadoret et al. 2008; 
Sequeira-Mendes et al. 2009; Valenzuela et al. 2011; Martin et al. 2011; 
Picard et al. 2014; Smith et al. 2016; Miotto, Ji, and Struhl 2016). However, 
most of these correlations result from the general association of replication 
with accessible chromatin. The only evidence of direct interactions between 
pre-RC components and chromatin regulators is the histone 
acetyltransferase HBO1 (histone acetyltransferase binding to Orc1, (Iizuka 
et al. 2009; Miotto and Struhl 2010). HBO1 interacts with Orc1 and Cdt1, 
and acetylates H4K5 and H4K12 in G1, which leads to chromatin 
decondensation and is necessary for Mcm2-7 loading.  
In silent chromatin, origin licensing seems to be differently organized. 
Compacted chromatin has no accessible regions for pre-RCs to bind. 
Peptide-binding assays reported H3K9me3 and H3K27me3 peptides to 
interact with ORC components (Vermeulen et al. 2010). It has been shown 
very recently that pre-RC proteins directly interact with H3K9me3 
demethylase Kdm4d, which presumably removes H3K9me3 to prepare 
favorable chromatin environment for origin firing (R. Wu et al. 2016). 
However, the question remains of how pre-RC assembly occurs in 
heterochromatin in the first place. One candidate is H4K20me3, which also 
localizes in silent chromatin and has been shown to directly interact with 
ORC (Vermeulen et al. 2010; Kuo et al. 2012; Beck et al. 2012). 
1.2.2 HISTONE 4 LYSINE 20 METHYLATION AFFECTS DNA REPLICATION  
Histone 4 lysine 20 methylation (H4K20me) is for several reasons the most 
promising histone methylation to be directly involved in regulation of DNA 
replication. First, the H4K20 monomethyltransferase PR-Set7 (also known 
as Set8, SetD8 or KMT5A) is cell cycle-dependently regulated, with low 
protein levels in G1 and complete absence in S-phase, while expression 
increases in G2 and peaks in mitosis (Figure 1.2, grey dashed line; S. Wu 
et al. 2010; S. Wu and Rice 2011). Second, both stabilization of PR-Set7 
expression and depletion of PR-Set7 have severe effects on DNA replication 
and S-phase progression.  Cell cycle regulation of PR-Set7 occurs mainly 
through the CRL4Cdt2 E3 ubiquitin ligase complex that uses PR-Set7 as direct 
substrate and targets it for proteasomal degradation during S-phase (Abbas 
et al. 2010; Centore et al. 2010; Oda et al. 2010). Expression of a non-
degradable mutant (PR-Set7PIPmut) leads to DNA re-replication, suggesting 
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repeated origin licensing and activation (Tardat et al. 2010; Beck et al. 
2012). Additional mutation of the SET-domain of PR-Set7, responsible for 
methylation activity, rescues this re-replication phenotype. Complete 
absence of PR-Set7 impairs cell cycle progression and is embryonic lethal 
at early stages of mouse development (Oda et al. 2010; S. Wu and Rice 
2011; Beck et al. 2012). PR-Set7 is the only enzyme known to catalyze 
H4K20me1, whereas Suv4-20h1 and –h2 further convert H4K20me1 to 
H4K20me2 and –me3 (Schotta et al. 2004; Schotta et al. 2008; Brustel et 
al. 2011). Interestingly, loss of Suv4-20h1/h2 and H4K20me2/3 results in 
a less severe phenotype than PR-Set7 knock-out (Schotta et al. 2008), 
strengthening the importance for H4K20 methylation states during cell cycle 
regulation.   
Artificial targeting of PR-Set7 to an integrated targeting site in the 
genome leads to induction of H4K20me1, conversion to H4K20me2/3 by 
endogenous Suv4-20h1/2 enzymes and to pre-RC assembly at the targeting 
site (Tardat et al. 2010). However, while Beck et al. claim necessity of 
conversion to H4K20me2/3 for efficient origin licensing (Beck et al. 2012), 
half of all detected active origins are found associated to H4K20me1 (Picard 
et al. 2014). Consequently, the exact role of PR-Set7/H4K20 methylation in 
origin licensing and/or activation remains to be uncovered. 
 DNA REPLICATION DEPENDS ON NUCLEAR CHROMATIN 
ORGANIZATION  
DNA replication is organized on three different spatial levels. The first 
organizational level was described in detail in the chapter 1.1, consisting in 
pre-RC formation and single origin activation. The second level is composed 
in replication units (50-120 kb in size), which contain several origins from 
which only one is flexibly activated per cell. The third level consists of 
synchronously firing clusters of active replication units, the replication 
domains (400 kb – 1 Mb), which depend on nuclear compartmentalization 
(Fragkos et al. 2015).  
Replication domains are mainly characterized by their replication timing 
program. Replication timing is established at one precise point during G1 
(timing decision point), which coincides with chromatin anchorage after 
mitosis (Pope and Gilbert 2013). Concordantly, replication domains accord 
with topologically associating domains (TADs) (Pope et al. 2014). TADs 
were described by recent Hi-C (evolution of 3C: chromosome confirmation 
capture technique) experiments and are units of chromatin in spatial 
proximity, which are separated by distinct conserved boundaries. These 
boundaries are defined at the molecular level by CCCTC-binding factor 
(CTCF) and cohesins (Ciabrelli and Cavalli 2015). Interestingly, TADs are 
inherited to daughter cells after cell division. Furthermore, they are often 
conserved across cell types and species (Gonzalez-Sandoval and Gasser 
2016) and are only reorganized during lineage specification in embryonic 
stem cells (Wilson et al. 2016). TADs contacting the nuclear lamina are also 
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called LADs (lamin associated domains). LADs represent repressive 
chromatin with low transcriptional activities (Guelen et al. 2008). In 
general, LADs and also TADs with low gene densities and heterochromatin 
marks are replicated late in S-phase, while early replicating TADs are gene-
rich, transcriptionally active with active histone modifications (Fragkos et 
al. 2015) (Figure 1.5). With the compartmentalization of the genome into 
replication domains, which are further subdivided into replication units, cells 
reduce the complexity of replication origin distribution. Also, replication fork 
stalling can be resolved at a local level and avoids involving the whole 
cellular organization (Rivera-Mulia and Gilbert 2016b).  
In conclusion, replication timing is largely imposed by the nuclear 
compartmentalization of chromatin in TADs and their transcriptional 
activity. Thus, chromatin state within these TADs also defines origin 
activities. Boundaries of these domains are precisely defined by insulators 
(CTCF, cohesins) and are also hypersensitive to DNaseI, indicating a 
nucleosome- and protein-free chromatin environment.  
 
FIGURE 1.5: REPLICATION DOMAIN MODEL. Upper panel: Active chromatin TADs replicate early in S-
phase and locate towards nuclear interior, while heterochromatin TADs replicate late during S-phase 
and locate towards the nuclear periphery (these lamin-associated TADs are also called LADs). Lower 
panel: Replication domains correspond to TADs. TADs are generally identified using Hi-C techniques 
and interactions between regions are plotted as Hi-C interaction heatmaps with dark-red regions 
strongly interacting and light-red regions only showing weak interaction (from Rivera-Mulia and 
Gilbert 2016a). 
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 MAPPING OF DNA REPLICATION INITIATION EVENTS 
Several different approaches have been developed to detect active 
replication initiation events in metazoans. Strategies vary from detection of 
single, defined replication origins to revelation of whole replication units.  
1.4.1 SINGLE MOLECULE DNA COMBING 
Single molecule DNA combing consists in pulse-labeling replicating DNA 
with the thymidine analogues CldU and IdU and detecting progress of 
replication forks by fluorescent microscopy. This technique requires uniform 
spreading of DNA molecules on a cover-slip and allows obtaining precise 
information about replication fork speed, fork asymmetry and inter-origin 
distances within the same DNA molecule during the same S-phase. 
Combining this technique with fluorescence in situ hybridization (FISH) 
allows to map precise loci of interest (Urban et al. 2015). However, technical 
limitations permit only detecting a defined set of single origins and efforts 
are currently made to establish high-throughput origin detection by 
molecular combing (De Carli et al. 2016).    
1.4.2 BUBBLE-SEQUENCING AND SHORT NASCENT STRAND SEQUENCING 
Alternative methods taking advantage of high-throughput sequencing are 
bubble trap or the purification of short nascent strands (SNS) followed by 
sequencing. Bubble trap uses the circular nature of replication bubbles to 
trap restriction fragments containing replication forks in gelling agarose. 
Purification and subsequent sequencing revealed 35000 to 40000 bubble-
containing fragments per experiment (Mesner et al. 2013). However, 
although bubble trap was shown to contain few false positives (Mesner, 
Crawford, and Hamlin 2006), use of single restriction fragments does not 
allow to recover all possible genomic origins and resolution is limited (Urban 
et al. 2015).  
For SNS-seq, short DNA fragments originating from leading strands of 
active replication forks are isolated and sequenced. Application of elevated 
sequencing depth revealed more than 200000 activated origins from bulk 
cells, representing different cohorts of potential origins being used per cell 
(Besnard et al. 2012). In short, this method relies on isolation of 500 - 2500 
bp fragments by size fractionation on a sucrose gradient. Exploiting the 
RNA-primer used to initiate DNA replication, λ-exonuclease selectively 
digests all contaminating DNA fragments which are not protected by an 
RNA-primer from the 5’ end. The resulting DNA population represents 
nascent leading strands adjacent to replication origins (Figure 1.6). As λ-
exonuclease digest remains debated in the field for possible biases (favoring 
detection of GC-rich/G4 DNA), nascent DNA can be alternatively labeled 
with the thymidine analogue BrdU and precipitated by immunoprecipitation 
(Fu et al. 2014). However, both methods have been shown to be highly 
concordant (Smith et al. 2016) and the detection of G4-structures at origins 
has been recently confirmed by an independent approach (Langley et al. 
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2016). Isolation of SNS followed by sequencing has been performed on 
several different organisms, including mouse (Cayrou et al. 2015) and 
human (Besnard et al. 2012; Picard et al. 2014; Cayrou et al. 2015; Smith 
et al. 2016). Thereby, origin efficiency can be deduced from the 
accumulation of sequencing reads per origin (schematically represented in 
Figure 1.3).  
 
FIGURE 1.6: BIDERECTIONAL DNA REPLICATION REQUIRES LEADING AND LAGGING STRAND 
SYNTHESIS.  RNA primer allow DNA polymerase to start synthesis.  DNA polymerase only synthesizes 
in 5‘ à 3‘ direction, which leads to the continuously synthesized leading strand and the discontinuous 
Okazaki fragments. 
1.4.3 OKAZAKI-FRAGMENT SEQUENCING 
Isolation and sequencing of Okazaki fragments (OK-seq) not only 
represents an alternative method to detect replication origins, it also allows 
determining replication fork directionality (Petryk et al. 2016). Principal of 
OK-seq is pulse-labeling of Okazaki-fragments with the Thymidine analogue 
EdU and subsequent size fractionation of these fragments (< 200 bp). After 
biotinylation, adapter ligation, and precipitation, Okazaki fragments are 
sequenced and specific adapters allow to distinguish between Watson 
(leftward moving fork) and Crick (rightward moving fork) Okazaki 
fragments. Calculation of replication fork directionality (RFD = (!"#$%&')*+,-.
(!"#$%/')*+,-.
) 
results in ascending (AS), descending (DS), and flat segments of different 
sizes and slopes (see also Figure 4.17 A). AS represent zones of preferential 
replication initiation, while DS are zones of preferential replication 
termination. The amplitude thereby reflects initiation efficiency. A broad 
initiation zone represents a zone of preferential replication initiation with 
multiple inefficient initiation sites but only one single origin firing per cell, 
corresponding to replication units (chapter 1.1.5, p. 15). 
Interestingly, these different methods of replication origin detection show 
little concordance. SNS-seq studies already show poor overlap between 
each other, which might result from insufficient sequencing saturation 
(Urban et al. 2015). Also comparison of bubble-seq and SNS-seq only 
results in little agreement on the local level of single origins (Mesner et al. 
2013). By contrast, initiation zones detected by OK-seq better align to 
bubbles than to SNS (Petryk et al. 2016). These little concordances between 
different approaches might originate from divergent replication events 
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considered. SNS-seq focuses on narrow sites of defined active replication 
events, while bubble-seq and OK-seq both detect broader regions which 
might contain several origins, but only one origin firing per cell. Especially 
OK-seq reveals zones of preferential origin activation within initiation zones 
and preferential replication termination in termination zones. However, this 
does not limit origins to initiation zones, as inefficient origins might also be 
present (and detected by SNS-seq) in termination zones.  
Information about pre-RC sites would help in this context, to bridge the 
discrepancies of the different detection methods. To date, two attempts 
have been made to perform ChIP against ORC components in human cells 
and will be introduced in the following.      
1.4.4 CHIP-SEQUENCING OF PRE-RC COMPONENTS 
Little is known about genome-wide pre-RC positioning in humans. Major 
difficulty is thereby the low enrichment over background that hampers 
precise pre-RC detection (Schepers and Papior 2010). Due to the low 
sequence specificity and potentially high on-and-off rates, chromatin 
association of metazoan ORC is dispersed, especially in comparison to other 
nuclear factors (such as transcription factors). To date, only two genome-
wide studies are available that target either Orc1 (Dellino et al. 2013) or 
Orc2 (Miotto, Ji, and Struhl 2016) in human cells. Dellino et al. overcame 
the high background problem by performing Orc1 ChIP from low-density 
chromatin. Thereby, they detected a prominent association of ORC to 
transcriptional start sites (TSS). However, chromatin selection prior to ChIP 
also introduced a bias towards Orc1 sites belonging to early replication 
origins (Dellino et al. 2013). Furthermore, 44% of all Orc1 sites overlap with 
replication origins identified by SNS-seq (Picard et al. 2014) and Orc1 was 
rather found at borders of replication initiation zones determined by OK-seq 
(Petryk et al. 2016). Miotto et al. performed Orc2 ChIP-seq experiments in 
unfractionated chromatin. Orc2 peaks showed moderate concordance with 
replication origins detected from SNS-seq (13% of all SNS sites located 
within 1 kb distance of Orc2 binding sites, 41% within 10 kb distance, 
Miotto, Ji, and Struhl 2016). Comparing Orc2 positions with several 
chromatin features, the authors concluded that ORC positioning majorly 
depends on chromatin accessibility.   
Taken together, these results reveal that while ORC ChIP-seq already shows 
a certain level of concordance with active replication data, the overall 
picture remains incomplete. As ORC does not bind any consensus sequence 
in humans, but seems to solely depend on chromatin accessibility, ORC 
positions likely vary from cell to cell, resulting in a scattered ChIP-seq 
profile. This phenomenon might be even more pronounced for Mcm2-7, as 
there is evidence for multiple Mcm2-7 helicases at individual origins, which 
might even translocate from their original loading site (Das and Rhind 2016; 
Hyrien 2016). Consequently, Mcm2-7 ChIP-seq would result in a broad 
Mcm2-7 distribution, mostly lacking clear peaks. This is presumably the 
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reason why human Mcm2-7 positions have not been assessed so far. 
However, as Mcm2-7 helicases can activate replication without spatial 
proximity to ORC, Mcm2-7 positions might be the missing link to 
conclusively connect replication initiation SNS-seq and ORC ChIP-seq 
results.  
1.4.5 EPSTEIN-BARR VIRUS GENOME AS MODEL OF HUMAN DNA 
REPLICATION 
Until now, genome-wide pre-RC ChIP experiments in humans have been 
unsuccessful. My laboratory used Epstein-Barr virus (EBV) as model system 
to study the relation between pre-RC formation and origin activation. EBV 
infects human B-cells and establishes a persistent latent infection. During 
latency, the EBV genome is maintained autonomously in proliferating cells 
and is thereby replicated in synchrony with the host cell genome by the 
cellular replication machinery (J. L. Yates and Guan 1991). For autonomous 
maintenance of the EBV episome, the cis-acting element oriP is required. 
OriP consists of two distinct elements: the family of repeats (FR-element) 
and the dyad symmetry (DS) element. Both elements contain binding 
arrays for the viral transactivator EBNA1 (Epstein-Barr virus nuclear antigen 
1). By binding of EBNA1 to the FR-element, the EBV genome is tethered to 
the host chromatin during chromosome segregation (Marechal et al. 1999; 
Sears et al. 2003; Sears et al. 2004). EBNA1 binding to DS targets ORC to 
oriP, designating oriP as exceptional origin, since origin licensing depends 
on direct interaction between DNA, a targeting factor and ORC (Schepers et 
al. 2001; Ritzi et al. 2003). Thus, oriP represents a very strong origin 
licensing site, however, this is not necessarily accompanied by efficient 
origin activation (Papior et al. 2012). My laboratory took advantage of full 
chromatinization of the EBV genome (166 kbp in size), and high EBV copy-
numbers in the Burkitt’s lymphoma cell line Raji. Performing ChIP against 
the pre-RC components Orc2 and Mcm3, SNS isolation and micrococcal 
nuclease (MNase) digest in Raji cells, followed by hybridization against a 
designated microarray, allowed extensive analysis of the relation between 
origin licensing, activation and nucleosome positioning in a cell cycle 
resolved manner. They found 64 pre-RC sites, which also highly correlated 
with origin activation and S-phase-specific MNase sensitivities. Origin 
activation efficiencies were moderately influenced by AT-richness, however 
pre-RC sites themselves were independent of any specific primary motifs 
(Papior et al. 2012).  
EBV employs cellular replication machinery to duplicate its genome and 
correlation of pre-RC and replication initiation sites provided insights in our 
understanding of replication origin organization in mammalian cells. It also 
showed that ChIP of human pre-RC components is technically feasible and 
sensibilized for need of careful controls. The next step will be to perform 
similar analysis on the human genome to answer the question of similar 
pre-RC organization genome-wide.        
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2. AIM OF THE THESIS 
While the regulation of replication initiation in humans is already extensively 
studied and led to the identification of several contributing features, full 
understanding of the regulation of DNA replication can only be provided by 
combining replication initiation with the regulation of pre-RC positioning. 
Especially Mcm2-7 positioning – which has not been assessed so far – is 
expected to bridge the discrepancies between current ORC ChIP-seq and 
replication initiation data. In my laboratory, human pre-RC ChIP has been 
technically established using the EBV genome as model system. Intent of 
my thesis was to adopt this pre-RC ChIP technique for genome-wide ChIP-
seq in Raji cells, by targeting the two major pre-RC subunits ORC and 
Mcm2-7. Containing the EBV genome as internal reference, Raji cells 
present the perfect control for ChIP-seq result quality. Once established, 
ChIP-seq will be also performed on embryonic stem (hES) cells, in 
collaboration with my co-supervisor Dr. Jean-Marc Lemaitre (Genome and 
Stem Cell Plasticity in Development and Ageing, IRMB, Montpellier, France). 
When compared to replication initiation, information about pre-RC positions 
and features that drive this positioning will contribute to the fundamental 
understanding of the relation between origin licensing and activation. 
Furthermore, pre-RC positions will be attributed to chromatin features, such 
as histone modifications. There is functional evidence for H4K20 
methylation to be involved in DNA replication, however, we lack molecular 
understanding. Thus, ChIP-seq will also be performed for H4K20me1 and –
me3, in order to directly conclude for possible implications between either 
H4K20 methylation and origin licensing. Possible candidates will be 
validated using an EBV-based plasmid system established in our laboratory, 
to functionally confirm the relation between H4K20 methylation and 
replication.  
Consequently, I aim to combine genome-wide pre-RC positioning with the 
regulation of replication initiation. Simultaneously, I will evaluate the 
implication of H4K20 methylation as a promising histone modification 
candidate for regulation of DNA replication licensing and activation both by 
genome-wide correlation studies and by functional approaches. 
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3. MATERIAL AND METHODS 
 MEDIA, MATERIAL, DEVICES, CHEMICALS AND AGENTS 
In the following, cell culture media and supplements (Table 3.1), chemicals 
and agents (Table 3.2), Enzymes (Table 3.3), Kits (Table 3.4), Material 
(Table 3.5), and devices (Table 3.6) used in this work are listed.   
Table 3.1 lists all media, supplements, antibiotics, and other substances 
that were used for cell culture.  
TABLE 3.1: CELL CULTURE MEDIA, SUPPLEMENTS, ANTIBIOTICS AND AGENTS. 
Cell culture media and 
supplements 
Distributor 
BD Matrigel BD Biosciences 
CryoStor CS10  STEMCELL, Canada 
Dimethylsulfoxide (DMSO) Carl Roth GmbH, Germany 
DMEM, high glucose, L-Glutamine Gibco, Thermo Fisher, USA 
Essential 8 Basal Medium + 
supplement 
Gibco, Thermo Fisher, USA 
Fetal calf serum (FCS) Lot BS225160.5, Bio&SELL, 
Germany 
G418 Carl Roth GmbH, Germany 
L-Glutamin Gibco, Thermo Fisher, USA 
Lipofectamine 2000 Invitrogen, Germany 
MEM non-essential amino acids Gibco, Thermo Fisher, USA 
PBS Dulbecco, pH 7.2 Biochrom AG, Berlin 
Penicillin Streptomycin Gibco, Thermo Fisher, USA 
RPMI 1640 Gibco, Thermo Fisher, USA 
Sodium pyruvate Gibco, Thermo Fisher, USA 
TripLE Select  Life technologies, USA 
Trypsin-EDTA Gibco, Thermo Fisher, USA 
Versene solution Gibco, Thermo Fisher, USA 
Zeocine Invitrogen, Germany 
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In the following Table 3.2, all chemicals and agents used during this work 
are specified.  
TABLE 3.2: CHEMICALS AND AGENTS. 
Chemicals and agents Distributor 
Ampicillin sodium salt Carl Roth GmbH, Germany 
ATX Ponceau S red staining 
solution 
Fluka Analytical, Germany 
Bovine serum albumin Sigma-Aldrich, Germany 
Bradford reagent, Bio-Rad protein 
assay 
Bio-Rad, Germany 
Chloroform Merck-Eurolab GmbH, Germany 
Deoxycholic acid (DOC) Sigma-Aldrich, Germany 
Dithiothreitol (DTT) Sigma-Aldrich, Germany 
EGTA, Titriplex® Merck Millipore, Germany 
Ethanol Merck-Eurolab GmbH, Germany 
Ethylenediaminetetraacetic acid 
(EDTA) 
Carl Roth GmbH, Germany 
Formaldehyde, MeOH-free Thermo Scientific, USA 
Glycerol AppliChem GmbH, Germany 
Glycine Carl Roth GmbH, Germany 
HEPES Sigma-Aldrich, Germany 
Isoamyl alcohol Merck-Eurolab GmbH, Germany 
Methanol Merck-Eurolab GmbH, Germany 
NP-40 (Igepal CA-630) Sigma-Aldrich, Germany 
Phenol Carl Roth GmbH, Germany 
Polyacrylamide Carl Roth GmbH, Germany 
Propidium iodide Sigma-Aldrich, Germany 
Salmon sperm  Invitrogen, Germany 
Sodium chloride Merck-Eurolab GmbH, Germany 
Sodium dodecylsulfate (SDS) Serva Electrophoresis GmbH, 
Germany 
Sodium lauroyl sarcosinate 
(Sarkosyl) 
Sigma-Aldrich, Germany 
Tris AppliChem GmbH, Germany 
Triton-X-100 Sigma-Aldrich, Germany 
Tween-20 AppliChem GmbH, Germany 
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Table 3.3 shows all enzymes employed during the study. 
TABLE 3.3: ENZYMES.  
Enzymes Distributor 
Benzonase Sigma-Aldrich, Germany 
DNase Roche, Germany 
DpnI New England Biolabs, USA  
Protease inhibitor complete Roche, Germany 
Proteinase K Roche, Germany 
RNase, DNase-free Roche, Germany 
 
Kits used during this work are listed in Table 3.4.  
TABLE 3.4: KITS. 
Kits Distributor 
BD StemflowTM Human and Mouse 
Pluripotent Stem Cell Analysis Kit 
BD Biosciences, Germany 
NTB buffer Macherey-Nagel, Germany 
NucleoSpin Extract II Kit Macherey-Nagel, Germany 
Qubit HS dsDNA Invitrogen, Germany 
SYBR Green I Master Roche, Germany 
 
In Table 3.5, all material needed for the experiments are specified.  
TABLE 3.5: MATERIAL. 
Material Distributor 
AFA Fiber & Cap tubes (12x12 mm) Covaris Inc., UK 
Amersham Hybond ECL GE Healthcare, Germany 
CEA Blue Sensitive X-ray films Agfa Healthcare, Germany 
Cell culture dishes and 6-well 
plates 
Nunc GmbH, Germany 
Cell strainer, 40 µm, 100 µm Corning Inc., USA 
CoolCell LX Freezing Container Sigma-Aldrich, Germany 
Cryotubes Nunc GmbH, Germany 
Nalgen Nunc Cryo 1°C freezing 
container 
Nunc GmbH, Germany 
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Table 3.6 names the devices used during this work.  
TABLE 3.6: DEVICES. 
Devices Distributor 
Beckman JE-5.0 rotor with a large 
separation chamber 
Beckman-Coulter, Germany 
Cole-Parmer Masterflex pump Cole-Parmer, USA 
FACSCaliburTM BD Biosciences, Germany 
semiDry blotting system Hoefer Scientific Instruments, USA 
Covaris S220 Covaris Inc., Germany 
NanoDrop ND-1000 Spectrometer ThermoScientific, USA 
Qubit fluorometer Invitrogen, Germany 
Roche LightCycler 480 System Roche, Germany 
Optimax X-ray film processor Rotec GmbH, Germany 
Electroporation system Gene-
Pulser II 
Bio-Rad Laboratories, USA 
 
 BIOLOGICAL METHODS 
3.2.1 CELL CULTURE 
Cells with corresponding AGV-internal identification number, a short 
description and the respective media are listed in Table 3.7. More detailed 
cultivation information is given in the following. 
RAJI CELLS 
Raji cells (ATCC) were cultivated at 37°C and 5% CO2 in RPMI 1640 (Gibco, 
Thermo Fisher, USA) supplemented with 8% FCS (Lot BS225160.5, 
Bio&SELL, Germany), 100 Units/ml Penicillin/ 100 µg/ml Streptomycin 
(Gibco, Thermo Fisher, USA), 1x MEM non-essential amino acids (Gibco, 
Thermo Fisher, USA), 2 mM L-Glutamin (Gibco, Thermo Fisher, USA), and 
1 mM Sodium pyruvate (Gibco, Thermo Fisher, USA). Cells were routinely 
diluted to 2x105 cells/ml and maximally grown to a density of 5x105.  
ADHERENT HEK293 CELLS 
HEK293 EBNA1+ cells were cultivated at 37°C and 5% CO2 in DMEM (Gibco, 
Thermo Fisher, USA) supplemented with 8% FCS (Lot BS225160.5, 
Bio&SELL, Germany), 100 Units/ml Penicillin/ 100 µg/ml Streptomycin 
(Gibco, Thermo Fisher, USA), and 220 µg/ml G418 (Carl Roth GmbH, 
Germany). Cells were grown to 80% confluence and routinely split 1:4. 
Therefore, cells were washed with PBS, treated with 0.25% Trypsin-EDTA 
(Thermo Fisher, USA) for 2 min at 37°C, carefully resuspended in new 
medium and seeded on a new culture dish.   
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GENERATING STABLE HEK293 CELL LINES 
Cells were seeded in a 6-well (Nunc GmbH, Germany) to a density of 2x105 
and transfected with 3 µg linearized expression plasmid (see also Table 3.7) 
using Lipofectamine2000 according manufacturer’s instructions 
(Invitrogen, Germany). Transfected cells from one 6-well were plated in 
medium with 20 µg/ml Zeocine (Invitrogen, Germany) on three 150 mm 
culture dishes (Nunc GmbH, Germany) the next day. After two to three 
weeks, single colonies were selected and expanded in 6-well plates. 
Expression of the protein of interest was verified by immunoblot. Positive 
clones were expanded and frozen.       
HES CELLS H9 
HES cells were cultivated in standard conditions (Ludwig et al. 2006) at 
37°C, 5% CO2. The hES cell line H9 was cultivated on BD Matrigel 
(Basement membrane matrix, BD Biosciences) covered dishes. From BD 
Matrigel stocks, 72 µl aliquots were routinely prepared in chilled 2 ml 
Eppendorf tubes and stored at -20°C. For BD Matrigel preparation, one 
aliquot was thawed, resuspended in 1.5 ml Essential 8 Basal Medium (Gibco, 
Thermo Fisher, USA) and mixed with 4.5 ml medium (6 ml total). Of this 
mixture, 1 ml was distributed per 35 mm dish and incubated for at least 30 
min at 37°C. For larger plates, surfaces and volumes were upscaled 
accordingly.   
For passaging, cells were washed twice with PBS, 1 ml of Versene solution 
(Gibco, Thermo Fisher, USA) was added per 35 mm dish. Before cells 
detached, Versene solution was removed, new medium added and cells 
were gently detached from the dish. Cells were routinely diluted 1:6 once 
per week. Medium was changed every day.         
CRYOPRESERVATION 
HEK293 and Raji cells were concentrated by centrifugation (200g, 7 min, 
room temperature) and the cell pellet was resuspended in FCS 10% DMSO 
to a concentration of ~ 5x107 cells/ml (HEK293) and 5x106 cells/ml (Raji 
cells). 1 ml cell suspension was aliquoted in 2 ml cryotubes (Nunc GmbH, 
Germany) and slowly cooled at a rate of -1°C/ min in a Nalgen Nunc Cryo 
1°C freezing container (Nunc GmbH, Germany) at -80°C. After few days, 
cells were transferred in liquid nitrogen for long term storage. For thawing, 
cells were incubated at 37°C in water bath, washed with 30 ml fresh pre-
warmed medium and plated accordingly. 
HES cells were detached as previously described and concentrated by 
centrifugation (300g, 5 min, room temperature). 106 cells were 
resuspended in 1 ml CryoStor CS10 (STEMCELL, Canada), transferred to 2 
ml cryotubes, placed in CoolCell LX Freezing Container (Sigma, Germany) 
at -80°C. After few days, cells were transferred in liquid nitrogen. 
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TABLE 3.7: ESSENTIAL CELL LINE INFORMATION. 
Cell lines (AGV 
identification) 
Description Medium 
Raji (#1577) EBV-containing 
Burkitt’s lymphoma cell 
line 
RPMI 1640, 8% FCS, 
1% Penicillin/ 
Streptomycin, 2 mM 
Glutamin, 1% MEM 
Non-essential amino 
acids, 1 mM Sodium 
Pyruvate   
HEK293 
EBNA1+(#1803) 
Human embryonic 
kidney cells, stably 
expressing EBNA1 
DMEM, 8% FCS, 1% 
Penicillin/ 
Streptomycin, 220 
µg/ml G418 
HEK293 EBNA1+ Gal4 
(#2116) 
Generated from cell 
line #1803 by 
integrating expression 
plasmid p5237 
DMEM, 8% FCS, 1% 
Penicillin/ 
Streptomycin, 220 
µg/ml G418, 20 µg/ml 
Zeocine 
HEK293 EBNA1+ Gal4-
Suv4-20h1 (#2680) 
Generated from cell 
line #1803 by 
integrating expression 
plasmid p5572 
DMEM, 8% FCS, 1% 
Penicillin/ 
Streptomycin, 220 
µg/ml G418, 20 µg/ml 
Zeocine 
HEK293 EBNA1+ Gal4-
PR-Set7 (#2113) 
Generated from cell 
line #1803 by 
integrating expression 
plasmid p5235 
DMEM, 8% FCS, 1% 
Penicillin/ 
Streptomycin, 220 
µg/ml G418, 20 µg/ml 
Zeocine 
HEK293 EBNA1+ Gal4-
PR-Set7SETmut (#2188) 
Generated from cell 
line #1803 by 
integrating expression 
plasmid p5236 
DMEM, 8% FCS, 1% 
Penicillin/ 
Streptomycin, 220 
µg/ml G418, 20 µg/ml 
Zeocine 
hES cells H9 
(cultivated at the 
IRMB, Montpellier) 
Human embryonic 
stem cell line, 
cultivated from 
passage 15 to 24 
Essential 8 Basal 
Medium + Essential 8 
Supplement 
3.2.2 CELL CYCLE FRACTIONATION BY CENTRIFUGAL ELUTRIATION 
For centrifugal elutriation, 5x109 exponentially growing Raji cells were 
harvested, washed with PBS and resuspended in 50 ml RPMI 1640/ 8% 
FCS/ 1mM EDTA/ 0.25 U/ml DNaseI (Roche, Germany). Concentrated cell 
suspension was passed through 40 µm cell strainer and injected in a 
Beckman JE-5.0 rotor with a large separation chamber turning at 1500 rpm 
and a flow rate of 30 ml/min controlled by a Cole-Parmer Masterflex pump. 
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While rotor speed was kept constant, 400 ml fractions were collected at 
increasing flow rates (40, 45, 50, 60, 80, 100ml/min). Individual fractions 
were quantified, 5x106 cells taken for propidium iodide stain and 
subsequent FACS analysis, while the remaining cells were subjected to 
cross-link (chapter 3.2.6, p. 35).   
3.2.3 FLUORESCENCE ACTIVATED CELL SORTING (FACS) 
CELL CYCLE DETERMINATION BY FACS 
Cells from elutriation fractions (5x106 cells) were washed with PBS, 
resuspended in 3 ml PBS (4°C) and fixed by addition of 7 ml ice-cold 100% 
EtOH for at least 30 min at -20°C. After centrifugation at 400g for 5 min at 
4°C, the pellet was washed with PBS 4°C and resuspended in 500 µl PBS 
4°C. After 5 min of RNase (200 µg/ml final) treatment, propidium iodide 
(0.5 mg/ml in PBS) was added to a final concentration of 50 µg/ml and cells 
were subjected to FACSCaliburTM (BD Biosciences, Germany) detection by 
the FL2 channel. 
DETECTION OF PLURIPOTENCY MARKERS BY FACS 
hES cells were stained and assessed for pluripotency markers with the BD 
StemflowTM Human and Mouse Pluripotent Stem Cell Analysis Kit (BD 
Biosciences) according to manufacturers’ instructions. 
3.2.4 IMMUNOBLOT 
VERIFICATION OF STABLE CELL LINES  
Cell extracts were prepared using NP-40 lysation. Cells were washed with 
ice-cold PBS and 400µl NP-40 extract buffer (4°C) were added to 15 cm 
culture dish. Cells were scraped off the plate and transferred to 1.5 ml 
Eppendorf tube. After 30 s vortex and 15 min on ice, cell lysate was 
centrifuged (16.100 g, 10 min, 4°C) and supernatant was kept for 
experiments or long term storage at -20°C. 
Protein concentration was determined using Bradford reagent (BioRad, 
USA) and 50 µg protein extract with 1X Laemmli was loaded on the gel.   
Proteins were separated on a 10% SDS-polyacrylamide gel and blotted on 
Amersham Hybond ECL (GE Healthcare, Germany) membrane using 
semiDry blotting system (Hoefer Scientific Innstruments, USA). Successful 
protein separation was verified by ponceau stain (ATX Ponceau S red 
staining solution; Fluka Analytical, Germany) and the membrane was 
blocked for at least 30 min in PBS, 1% Tween-20 (AppliChem GmbH, 
Germany), 5% milk. Incubation with primary anti-Gal4 (DBD) (sc-577, 
Santa Cruz Biotechnology) antibody (1:400 in PBS 1% Tween-20) was 
performed for 16h at 4°C, membrane was washed 3x 10 min with PBS 1% 
Tween-20 and incubated with anti-rabbit-HRP (Jackson ImmunoResearch 
Inc., USA) 1:10000 secondary antibody in PBS 1% Tween-20, 2.5% milk 
for 1 h at room temperature. After repeated washing steps, revelation was 
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done using ECL on CEA Blue Sensitive X-ray films (Agfa Healthcare, 
Germany).  
NP-40 extract buffer: 150 mM NaCl, 50 mM HEPES, 5 mM EDTA, 0.1% 
(v/v) NP-40, freshly add 1x protease inhibitor complete (EDTA-free, Roche, 
Germany) 
5X Laemmli buffer: 250 mM Tris pH 6.8 (2M), 10% SDS, 500 mM DTT, 
25% Glycerol, 0.5% Bromphenolblue 
10% polyacrylamide running gel: 10% polyacrylamide (Carl Roth 
GmbH, Germany), 3.4 mM SDS, 375 mM Tris pH 8.8 
Stacking gel: 4% polyacrylamide (Carl Roth GmbH, Germany), 3.4 mM 
SDS, 125 mM Tris pH 6.8  
1X running buffer: 192 mM Glycine, 24 mM Tris pH 7.4, 3.4 mM SDS 
Blotting buffer: 1X running buffer, 20% MeOH 
ECL solution: 1 ml solution A, 3 µl solution B 
 Solution A: 100mM Tris pH 8.8, 200 mM p-cumaric acid, 1.25 mM  
  Luminol 
 Solution B: 3% (v/v) H2O2 
HISTONE IMMUNOBLOT 
RIPA protein extraction was performed by trypsinizing HEK293 cells, 
washing with ice-cold PBS, adding two pellet volumes RIPA extract buffer 
(+ 1X complete protease inhibitor, Roche) and incubation for 20 minutes 
on ice. After 30 seconds vortex, 50 U Benzonase (Sigma, Germany) were 
added for 15 minutes at room temperature. Extract was centrifuged (16100 
g, 15 min, 4°C), supernatant transferred to a new tube and subjected to 
immunoblot or stored at 20°C for long term storage.  
Extract (50 µg) was loaded on a 15% layered with 12.5% polyacrylamide 
gel and treated as described above. Antibody dilutions were applied as listed 
in Table 3.8. 
RIPA extract buffer: 50 mM Tris-HCl pH 7.9, 150 mM NaCl, 1% NP-40, 
0.5% DOC, 0.1% SDS 
15% polyacrylamide gel: 15% polyacrylamide (Carl Roth GmbH, 
Germany), 3.4 mM SDS, 375 mM Tris pH 8.8 
12.5% polyacrylamide gel: 12.5% polyacrylamide (Carl Roth GmbH, 
Germany), 3.4 mM SDS, 375 mM Tris pH 8.8 
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TABLE 3.8: HISTONE ANTIBODIES AND RESPECTIVE DILUTIONS FOR IMMUNOBLOT. 
Target protein Antibody Dilution in PBS 1% 
Tween 
H4K20me1 Cell Signaling 9724S 1:1000 
H4K20me2 Cell Signaling 9759S 1:1000 
H4K20me3 Cell signaling 5737S 1:1000 
H3K4me3 Abcam 8580 1:1000 
H3K9me3 Active Motif 39161 1:1000 
H3K27me2/3 Active Motif 39536 (use 
anti-mouse-HRP 
secondary antibody) 
1:1000 
H4 Abcam 31830 (use 
anti-mouse-HRP 
secondary antibody) 
1:1000 
3.2.5 PLASMID ABUNDANCE ASSAY 
GFP-positive reporter plasmids (1µg, Table 3.9) were transfected into 
HEK293 EBNA1+ cell line stably expressing the respective GAL4-fusion 
protein using Lipofectamine2000 (Invitrogen, Germany) according to 
manufacturer’s instructions. Transfections with comparable efficiencies 
were verified by visualizing GFP-positive cells. Six days post-transfection, 
cells were harvested according to the HIRT protocol (Hirt 1966). After 
washing with PBS, cells were equilibrated in 5ml TEN buffer. TEN was 
removed and cells were collected in 1,5 ml TEN buffer and an equal volume 
of 2X HIRT buffer. The lysate was then incubated at 4°C for 16h, in the 
presence of 1.25 M NaCl. After centrifugation at maximal speed, 4°C for 1h, 
DNA was purified by phenol-chloroform extraction (with Phenol/ Phenol-
Chloroform/ Chloroform-Isoamyl alcohol steps). After precipitation, DNA 
was digested with 40 U DpnI (NEB, USA) in presence of 200µg/ml RNase 
(Roche, Germany). Digested DNA (300 ng) was electroporated into 
Electromax DH10B competent cells (Invitrogen, Germany) and ampicillin-
resistant colonies, representing the number of recovered plasmids, were 
counted. The FR-DS plasmid was always transfected in parallel and the 
number of resulting colonies was used for normalization. 
The Suv4-20h1/2 inhibitor A-196 (kind gift of Structural Genomics 
Consortium (SGC)) was added to a final concentration of 5 µM immediately 
after transfection to the cell culture medium and the cells were kept under 
5% O2 during A-196 treatment. Medium was exchanged every second day. 
TEN buffer: 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl 
2x HIRT buffer: 1.2% SDS, 20 mM Tris-HCl pH 7.5, 20 mM EDTA 
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TABLE 3.9: REPORTER PLASMIDS USED FOR PLASMID ABUNDANCE ASSAYS AND PLASMID CHIPS. 
Plasmid (AGV identification) Plasmid name 
p3230 FR-DS 
p5233 FR-UAS-DS 
p5234 FR-UAS 
p3244.2 FR-oriRDH 
p5588 FR-UAS-oriRDH 
3.2.6 CROSS-LINK  
RAJI CELLS (STANDARD PROTOCOL)  
Cells were washed twice with PBS, resuspend in PBS to a concentration of 
2x107 cells/ml and passed through 100 µm cell strainer (Corning Inc., USA). 
An equal volume of PBS 2% methanol-free formaldehyde (Thermo 
Scientific, USA) was added and cells were fixed for 5 minutes on a roller at 
room temperature. The cross-linking reaction was then quenched with 
glycine (125 mM final concentration) and incubated for another minute on 
the roller. After washing once with PBS and once with PBS 0.5% NP-40, 
cells were resuspended in PBS containing 10% glycerol, pelleted and snap 
frozen in liquid nitrogen. 
HES CELLS 
HES cells are more fragile and need to be resuspended with care. Cells were 
covered with 10 ml TripLE Select (Life technologies, USA) on a 15 cm dish 
and incubated until cells detach. Cells were dissociated by carefully 
resuspending once, transferred to centrifugation tube and washed once with 
PBS. Cell concentration was adjusted to 2x107 cells/ml in PBS, passed 
through 100 µm cell strainer and cross-link was performed according to the 
standard protocol.   
HEK293 
Transfected HEK293 EBNA1+ cell lines were trypsinized, washed twice in 
PBS and standard cross-link protocol was performed.   
3.2.7 CHROMATIN IMMUNOPRECIPITATION (CHIP) 
SONICATION 
Cross-linked cell pellets were thawed on ice for 15 min and resuspended for 
lysis in LB3+ buffer to a final concentration of 2x107 cells/ml. Sonication 
was performed in AFA Fiber & Cap tubes (12x12 mm, Covaris, Great Britain) 
at an average temperature of 5°C according the settings established for 
each cell line (Table 3.10) using the Covaris S220 (Covaris Inc., Great 
Britain). 
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TABLE 3.10: SONICATION SETTINGS ESTABLISHED FOR EACH CELL LINE. 
Cell line Sonication settings 
Raji 100W, 150 cycles/burst, 10% duty 
cycle, 20 min (S-phase: 17 min) 
hES 100W, 150 cycles/burst, 10% duty 
cycle, 14 min 
HEK293 EBNA1+ Gal4-fusion 150W, 200 cycles/burst, 20% duty 
cycle, 20 min 
 
IMMUNOPRECIPITATION 
After sonication, sheared chromatin was pre-cleared with 50 µl protein A 
beads (protein A Sepharose 4 Fast Flow, GE Healthcare, Germany; washed 
3x in PBS, 50% bead slurry prepared) per 500 µg chromatin for 2h. 
Chromatin concentration was measured by NanoDrop ND-1000 
Spectrometer (ThermoScientific, USA). An appropriate amount of chromatin 
was incubated with the respective antibody (for plasmid ChIPs see Table 
3.11, for ChIP-seq see Table 3.12) for 16h at 4°C. BSA-blocked protein A 
beads (incubated for 2h on roller in blocking solution at 4°C; protein G 
beads (protein G Sepharose 4 Fast Flow, GE Healthcare, Germany) were 
used for antibodies raised in mouse) were then added (50 µl/ 500 µg 
chromatin) and incubated for at least 4h on orbital shaker at 4°C. 
Sequential washing steps with RIPA-150 mM NaCl, RIPA-300 mM NaCl, LiCl 
buffer and finally twice in TE (pH 8.0) buffer were performed. 
Immunoprecipitated chromatin fragments were eluted from the beads by 
shaking twice at 1200 rpm for 10 min at 65°C with 100µl of TE and 1% 
SDS. The elution was treated with 80 µg RNAse A (Roche, Germany) for 2h 
at 37°C and with 8 µg proteinase K (Roche, Germany) at 65°C for 16h. DNA 
was purified using the NucleoSpin Extract II Kit (and NTB binding buffer for 
SDS containing samples) according to manufacturer’s instructions. 
Quantitative PCR analysis was performed as described in 3.2.8, p. 38 and 
quantitative PCR values were represented as fold enrichment relative to 
isotype IgG control. Chromatin sizes were verified by loading 1-2 µg 
chromatin on an 1.5% agarose gel. Samples intended for ChIP-seq were 
quantified using Qubit HS dsDNA (Invitrogen, Germany).  
LB3+ buffer: 25 mM HEPES (pH 7.5), 140 mM NaCl, 1 mM EDTA, 0.5 mM  
EGTA, 0.5% Sarcosyl, 0.1% DOC, 0.5% Triton-X-100, 1X protease  
inhibitor complete (Roche, Germany) 
Blocking solution: 0.5 mg/ml BSA, 30 µg/ml salmon sperm (Invitrogen, 
Germany), 1X protease inhibitor complete, 0.1% Triton-X-100 in LB3(-) 
buffer (without detergents) 
RIPA-150 mM NaCl: 150 mM NaCl, 0.1% SDS, 0.5% DOC, 1% NP-40, 
50 mM Tris (pH 8.0), 1 mM EDTA 
RIPA-300 mM NaCl: 300 mM NaCl, 0.1% SDS, 0.5% DOC, 1% NP-40, 
50 mM Tris (pH 8.0), 1 mM EDTA 
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LiCl: 250 mM LiCl, 0.1% SDS, 0.5% DOC, 1% NP-40, 50 mM Tris (pH 8.0), 
1 mM EDTA 
1X TE: Tris-EDTA pH 8.0 (Carl Roth GmbH, Germany) 
 
TABLE 3.11: ANTIBODIES FOR PLASMID CHIPS IN HEK293 EBNA1+ GAL4-FUSION CELL LINES.  
ChIP target Antibody Amount Chromatin 
Gal4 anti-Gal4 (Santa 
Cruz 
Biotechnologies, 
sc-577) 
2.5 µg 
250 µg 
H4K20me1 anti-H4K20me1 
(Diagenode, 
MAb-147-100) 
2.5 µg 
H4K20me3 anti-H4K20me3 
(Diagenode, 
pAB-057-050) 
2.5 µg 
Mcm3 anti-Mcm3 
SA8413 
15 µl 
IgG Rabbit IgG 
(Sigma, R2004) 
2.5 µg 
 
TABLE 3.12: ANTIBODIES FOR CHIP-SEQUENCING. 
ChIP target Antibody Amount Chromatin 
Orc2 anti-Orc2 SA93 15 µl 500 µg 
Orc3 anti-Orc3 
SA7976 
15 µl 500 µg 
Mcm3 anti-Mcm3 
SA8413 
15 µl 500 µg 
Mcm7 anti-Mcm7 
SA8496 
15 µl 500 µg 
H4K20me1 anti-H4K20me1 
(Diagenode, 
MAb-147-100) 
2.5 µg 250 µg 
H4K20me3 anti-H4K20me3 
(Diagenode, 
pAB-057-050) 
2.5 µg 250 µg 
H4 anti-H4 
(Millipore, 05-
838, clone 62-
141-13 
5 µl 250 µg 
IgG Rabbit IgG 
(Sigma, R2004) 
10 µg/ 2.5 µg 500 µg/ 250 µg 
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3.2.8 QUANTITATIVE PCR (QPCR) 
Quantitative PCR was performed Roche LightCycler 480 System and the 
SYBR Green I Master (Roche). 2 µl of ChIP elution were mixed with [5 µl 
2xSYBR, 2.5 µl H2O, 0.5 µl 5 µM primer mix]. Amplification was performed 
using the Roche SYBR standard program Table 3.13. QPCR primers are 
listed in Table 3.14. 
TABLE 3.13: ROCHE SYBR QPCR STANDARD PROGRAM.  
 Temperature 
[°C] 
Duration 
[s] 
Cycles Detection 
Pre-
incubation 
95 300 1  
Amplification 
95 1 
45 
 
60 10  
72 10  
75 3 single 
Melting 
curve 
97 1 
1 
 
67 10, then 
heat to 
97°C 
 
97 continuous 
Cooling 37 15   
 
TABLE 3.14: QPCR PRIMERS. 
Primer (Schepers group 
internal numeration) 
Sequence [5’ à 3’]  
DS_for (575) AGTTCACTGCCCGCTCCT 
DS_rev (576) CAGGATTCCACGAGGGTAGT 
FR_for (276) CGTGCTCTCAGCGACCTCG 
FR_rev (277) TCAAACCACTTGCCCACAAAAC 
UAS_for (270) TTACAGTCCAAAACCGCAGGG 
UAS_rev (271) TTGTCGCTCCGTAGACGAAGC 
oriRDH_for (414) CTGTCTTGGTCCCTGCC 
oriRDH_rev (415) TGCCTTCTCCTTCTCATCC 
Mcm4+_for (776) CTGAAAGAAGCGGCACTGTC 
Mcm4+_rev (777) CTCACCAATCACAGCGGC 
Mcm4-_for (778) CCACCCAGGCATTGCTAAAG 
Mcm4-_rev (779) CCCCTCTATTTGCCGTTCCT 
BANF1+_for (772) CCTCCCTTGTCCGTCTTCTA 
BANF1+_rev (773) GACCCGGAACTCAAGGACTTA 
H4K20me1+_GAPDH_for (629) ATGCCTTCTTGCCTCTTGTC 
H4K20me1+_GAPDH_rev (630) AGTTAAAAGCAGCCCTGGTG 
H4K20me3+_ZNF180_for (621) TCTGAGCAGGGTTGCAAGTAC 
H4K20me3+_ZNF180_rev (622) AAGGAAATGATGCCCAGCTG 
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3.2.9 SEQUENCING 
The Genomics unit of LAFUGA (headed by Helmut Blum, LMU Munich) 
performed ChIP sample library preparations from > 4 ng of ChIP-DNA using 
Accel-NGS® 1S Plus DNA Library Kit for Illumina (Swift Biosciences). 50 bp 
single-end sequencing was done with the Illumina HiSEQ 1500 sequencer 
to a sequencing depth of ~ 70 million reads (for pre-RC) and 35 million 
reads (for histone modifications).  
 
 BIOINFORMATICS 
Programs used for bioinformatics analyses are listed in tTable 3.15. 
TABLE 3.15: PROGRAMS USED DURING BIOINFORMATIC ANALYSIS. Program sources are indicated. 
[Typo] marks terminal commands.  
Program Source 
Bowtie1 (1.1.1) https://sourceforge.net/projects/bowtie-
bio/files/bowtie/1.1.1/ 
R (3.2.3) https://cran.rstudio.com/ 
R package 
GenomicRanges 
(1.22.4) 
In R: install.packages(“package”) 
library(package) 
R package IRanges 
(2.4.8) 
R package 
S4Vectors (0.8.11) 
R package 
BiocGenerics 
(0.16.1) 
R package 
RColorBrewer (1.1-
2) 
R package gplots 
(3.0.1) 
MACS2 (8.1.2) pip install macs2 
HOMER (v4.8) http://homer.salk.edu/homer/ 
T-PIC Download scripts from 
http://www.math.miami.edu/~vhower/tpic.html 
Bedtools (2.25.0) https://github.com/arq5x/bedtools2/releases 
CEAS (1.0.2) http://liulab.dfci.harvard.edu/CEAS/download.html 
Venn Diagram 
Plotter 
https://omics.pnl.gov/software/venn-diagram-
plotter 
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3.3.1 BOWTIE MAPPING OF SEQUENCING READS AGAINST THE GENOME 
Fastq-files from sequencing were mapped against the human genome 
(hg19, GRCh37, version 2009), extended for the EBV genome (NC007605) 
using the bowtie command:  
bowtie -m 1 index file.fastq 
3.3.2 GENERATION OF PILEUP PROFILES 
Pileup profiles were generated in R by extending 50 bp reads by 150 bp and 
calculating the number of reads per base. The coverage was either saved 
as .wig files for visualization in IGB or as .rda for coverage analyses.  
3.3.3 MACS2, HOMER, AND T-PIC PEAK-CALLING 
PEAK-CALLING ON THE EBV GENOME 
Peak-calling on the EBV genome was performed using the following 
commands. Commands in italics are variable and adapted for each file. 
· MACS2:  
macs2 callpeak -t ChIP.bam -c input.bam -f BAM -g 1.75e5 -n 
output_name -B -q 0.01 –nomodel 
· HOMER:  
1. create tag directory: 
makeTagDirectory tags_name1 input.bam –single 
makeTagDirectory tags_name2 ChIP.bam –single 
2. perform peak calling: 
findPeaks tags_name2 -i tags_name1 -style factor -size 200 -
fragLength 200 -inputFragLength 200 -C 0 > output_name.txt 
3. convert .txt to .bed 
pos2bed.pl output_name.txt > output_name.bed 
· T-PIC:  
T-PIC uses scripts running in perl and R (download scripts from 
http://www.math.miami.edu/~vhower/tpic.html). The scripts need to be 
placed the same folder as ChIP and input .bed files. Scripts have to be 
adapted for each filename and each genome (create_coverage.pl: my 
$bed_filename = "ChIP.bed"; zeta.pl: my $bed_filename = "ChIP.bed", 
my $input_filename = "input.bed"). For T-PIC peak-calling on the EBV 
genome, both scripts also need to be adapted for detecting the EBV 
“chromosome” (my @index_set = ("EBV")).  
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PEAK-CALLING ON THE HUMAN GENOME 
The HOMER peak-calling command for the human genome does not differ 
from EBV. For histone ChIPs, the – style parameter was changed to 
“histone”.  
For T-PIC peak calling, the scripts run with the human and filenames have 
to be modified as described previously. 
MACS2 peak-calling for hES cells samples was performed with the following 
command:  
macs2 callpeak -t ChIP.bed -c input.bed -g hs --broad -B -f BEDPE 
-n output_name 
3.3.4 DEFINITION OF ORC, MCM2-7, AND PRE-RC 
Complexes were calculated by first merging overlapping peaks, counting 
the number of overlapping events and retaining only the positions display 
sufficient overlaps:   
3.3.5 PEAK COMPARISONS: JACCARD INDEX AND OVERLAPS 
JACCARD INDEX 
Jaccard index was calculated using the “bedtools jaccard” function 
applied for every possible ChIP combination. Heatmap representation was 
calculated in R.   
OVERLAPS 
Overlaps of peak/ complex positions were calculated using the “bedtools 
intersect” function. Thereby, overlaps of the query files were calculated 
in both directions, merged, and the unique positions of every file were also 
retained. The results were used for Venn Diagram generation using 
VennDiagramPlotter.  
3.3.6 CALCULATING GENOMIC DISTRIBUTIONS WITH CEAS 
The genomic distribution of peaks or complexes were calculated using the 
command  
ceas --name=output_name -g hg19.refGene -b ChIP/COMPLEX.bed 
Thereby, hg19.refGene was downloaded from 
http://liulab.dfci.harvard.edu/CEAS/download.html. The results of interest 
were extracted and used for differential representation in R.  
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4. RESULTS AND DISCUSSION 
To date, little is known about the mechanisms that define pre-RC formation 
and activation in mammals. Because PR-Set7 and consequently H4K20 
methylation clearly impact on DNA replication, I decided to receive a first 
impression of the relationship between replication licensing and H4K20 
methylation by ChIP-seq in human cells. I targeted both H4K20me1 and 
H4K20me3, as well as four different members of the pre-RC complex, 
targeting the two major subunits ORC and Mcm2-7: Orc2, Orc3, Mcm3, and 
Mcm7. In the following chapters, I will refer to the setup of ChIP 
experiments in both human lymphoblastoid Raji cells and hES cells H9. 
Further, I will detail the analysis of sequencing results and resulting 
conclusions in Raji cells, and a functional approach to functionally validate 
the relation between H4K20 methylation and DNA replication.  
 SETTING UP CHIP-SEQ EXPERIMENTS IN HUMAN CELLS 
ChIP is a sensitive technique to study protein-DNA interactions. To fix the 
current chromatin state of the cells, DNA and proteins within a distance of 
~2-3 Å are covalently linked by formaldehyde. After chromatin 
fragmentation, specific antibodies are used to precipitate the target proteins 
together with the associated DNA fragments. These DNA fragments are then 
isolated and quantified either by qPCR at defined loci or by sequencing to 
detect all possible protein binding sites. 
4.1.1 CONSIDERATIONS TO OPTIMIZE PRE-RC CHIP-SEQ EXPERIMENTS 
To date, there are only two ChIP-seq studies of pre-RC proteins in 
mammalian cells, both targeting the pre-RC subcomponent ORC (Dellino et 
al. 2013; Miotto, Ji, and Struhl 2016). Despite much effort, members of the 
Mcm2-7 complex have not been successfully targeted so far. One of the 
major difficulties is the low enrichment over background, challenging 
identification of clear pre-RC binding sites. In contrast to transcription factor 
and histone ChIPs, which are rather easy to perform and very robust to 
methodological differences, I considered several optimization steps for 
pre-RC ChIPs (Figure 4.1): 
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FIGURE 4.1: SCHEMATIC REPRESENTATION OF CRUCIAL CHIP STEPS. A) CELL CYCLE FRACTIONATION 
BY CENTRIFUGAL ELUTRIATION. B) CROSS-LINK AND SONICATION. C) ANTIBODY INCUBATIONS. 
D) IMMUNOPRECIPITATION AND WASHING CONDITIONS. After ChIP, DNA fragments were eluted from 
the beads, the DNA was isolated and quality control was performed by qPCR prior to sequencing. 
a) Performing ChIPs on a G1 cell population 
b) Optimizing cross-linking time and mild sonication to preserve 
complexes 
c) Usage of several antibody targets within the same complex 
d) Increasing antibody specificity (buffer and washing conditions) 
Performing ChIP exclusively in G1 cell cycle stage - the moment where pre-
RC is present on chromatin - is one possibility to increase sensitivity. 
Centrifugal elutriation is a convenient method to do so, as an asynchronous 
cell population is fractionized into the different cell cycle stages by simple 
size selection. This is easily feasible in Raji cells, however impossible in hES 
cells. I decided against chemical synchronization of hES cells and performed 
ChIPs on asynchronous cell populations instead.  
ChIP procedure was optimized experimentally for increased stringency and 
sensitivity. First, cross-linking needs to be strong enough to efficiently 
conserve protein-DNA interactions, but should not impair proper sonication 
or mask any epitopes for antibody recognition. For this reason, I chose a 
very mild cross-link of 5 min with 1% FA at room temperature. Second, 
sonication itself needs to be as mild as possible, to not destroy any protein-
DNA interactions, but should result in chromatin fragments small enough 
for high-throughput sequencing (200-400bp). The focused-ultrasonicator 
S220 from Covaris was used, as energy focusing directly on the sample 
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allows to considerably reduce the applied power. This ensures maximum 
conservation of protein-DNA interactions. Indeed, usage of Covaris S220 in 
comparison to standard sonication methods (Bioruptor or tip sonifier) 
clearly increased protein enrichments compared to mock ChIPs at known 
positive loci (data not shown).  Prior to the actual immunoprecipitation, 
chromatin was treated first with mock IgG antibody, then with protein A 
sepharose beads. This step removes background binding of chromatin 
fragments that stick to IgG and/or protein A sepharose beads.  
To ensure unbiased detection of pre-RC sites, I simultaneously targeted four 
different pre-RC components: Orc2, Orc3 as members of ORC and Mcm3, 
Mcm7 as members of the Mcm2-7 complex. Targeting two different subunits 
decreases possible antibody biases and increases the significance of the 
results. The ChIP-grade of rabbit pre-immune serum antibodies targeting 
Orc2, Orc3, Mcm3, and Mcm7 have been already validated in repeatedly 
(Papior et al. 2012; Ghosh et al. 2006; Ritzi et al. 2003; Schepers et al. 
2001). Furthermore, ChIPs were performed in three independent 
experiments to account for experimental and biological variation. During 
data analysis, usage of rigorous parameters for pre-RC definition from all 
these replicates increased confidence in the results. 
Sonication and immunoprecipitation were performed in detergent 
containing buffer. I decided for a combination of Deoxycholate, Sarkosyl, 
Triton-X-100, and NP-40. After the precipitation, I performed sequential 
stringent washing steps with RIPA buffer containing SDS, NP-40, DOC, while 
increasing salt concentrations decrease low affinity interactions. 
After protein-DNA complex elution from beads, samples were treated with 
RNase, covalent cross-link was reversed by heating to 65°C and proteins 
were digested using Proteinase K. The resulting DNA fragments were 
purified and inserted in control qPCR reactions.   
4.1.2 PERFORMING CHIP-SEQ EXPERIMENTS IN RAJI CELLS 
After careful setup of the ChIP conditions, I performed the ChIPs intended 
for sequencing. To start with, I fractionized asynchronous cell populations 
to obtain G1- and S/G2-phase enriched cells. The S/G2 population thereby 
served as control for pre-RC ChIP-seq, as activated and passively replicated 
pre-RCs disassemble after replication.  
EXPERIMENTAL SETUP: CELL CYCLE FRACTIONATION 
Counterflow centrifugal elutriation is a convenient method for separation of 
mixed cell populations according to size and mass and regularly used in my 
laboratory (Ritzi et al. 2003). Elutriation has the advantage to not disturb 
the cellular metabolism. The principle is based on centrifugation of a 
logarithmically growing asynchronous cell population, with largest cells (late 
cell cycle stages) being sedimented, while a counterflow of medium extracts 
smaller cells (early cell cycle stages) from this population. Regulation of the 
speed of this counterflow thus determines sizes of isolated cells. I routinely 
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used counterflow rates 40, 45, 50, 60, 80, 100ml/min to isolate all different 
cell stages. The respective cell cycle stages were validated by propidium 
iodide (PI) staining of the DNA content and subsequent FACS analysis 
(Figure 4.2). I performed three independent elutriation experiments as 
basis for three ChIP replicates. I chose fractions G1 (counterflow rate 40 
ml/min) - pre-RC formation is supposedly completed - and S/G2 cells (80 
ml/min), directly after replication. The sonication time had to be slightly 
reduced for S/G2-phase cells, as the chromatin of S/G2 cells is fragmented 
more easily. An example for efficient sonication is depicted in Figure 4.3 A. 
 
FIGURE 4.2: EXAMPLE FACS PROFILE OF RAJI CELLS FRACTIONNATED BY CENTRIFUGIAL ELUTRIATION 
REVEALED DISTINCT CELL CYCLE STAGES. Propidium iodide (PI) is an intercalating agent and was 
used to determine DNA content in the cells. The first peak represents the G1 cell population with 2n 
content, the second peak represents G2 population with 4n. The different counterflow rates led to a 
separation into cell populations of different cell cycle stages (indicated on top of each profile). The 
cell populations marked in green were taken for ChIP-seq experiments.  
EXPERIMENTAL SETUP: CHIP VALIDATION 
Like almost all EBV-infected cell lines, the Raji cell line maintains the EBV 
genome as an independent genetic entity, which is autonomously replicated 
during latency by the host cellular replication machinery (John L. Yates 
1996). The latent Epstein-Barr virus origin oriP can serve as a positive 
control for pre-RC ChIP efficiencies. The viral latent protein EBNA1 
specifically targets ORC to the dyad symmetry (DS) element of oriP, 
independent of the cell cycle stage. Consequently, ChIPs showed an 
enrichment of Orc2 and Orc3 at DS in both G1 and S/G2, while Mcm3 and 
Mcm7 binding is cell cycle dependent (Ritzi et al. 2003) and was decreased 
in S/G2 (Figure 4.3 B).     
H4K20 methylation ChIPs were validated at previously identified genomic 
positive loci for either H4K20me1 or –me3 (primer sequences obtained from 
Stanimir Dulev, OICR, Canada). ChIP against canonical histone H4 was also 
included. There were no considerable cell cycle dependent differences 
observed (Figure 4.4). After qPCR validation, the samples were sequenced. 
As a measure for sonication and sequencing biases, “input DNA” (cross-
linked DNA fragmented under same conditions as the ChIPs) was used as 
appropriate control. 
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FIGURE 4.3: PRE-RC CHIP VALIDATION IN RAJI CELLS. A) REPRESENTATIVE EXAMPLE OF SONICATED 
CHROMATIN IN G1 AND S/G2. 1.5% agarose gel, stained with EtBr. B) PRE-RC CHIP VALIDATION BY 
QPCR AT THE DS LOCUS OF ORIP. Cell cycle stages as indicated. Rabbit IgG mock IP served as 
negative control. Mean ± SEM (n=3).  
 
 
 
FIGURE 4.4: H4K20 METHYLATION CHIP VALIDATION BY QPCR AT GAPDH H4K20ME1 POSITIVE AND 
ZNF180 H4K20ME3 POSITIVE LOCI. Cell cycle stages as indicated. Rabbit IgG mock IP served as 
negative control. Mean ± SEM (n=3).  
 
 
 
 
A) B) 
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TREATING SEQUENCING DATA 
The Genomics unit of LAFUGA (headed by Helmut Blum, LMU Munich) 
performed ChIP sample library preparations, as well as final 50bp single-
end sequencing with the Illumina HiSEQ 1500 sequencer. Due to the 
expected variability of pre-RC ChIPs, I chose an elevated sequencing depth 
of around 70 million reads for pre-RC ChIPs and 35 million reads for histone 
modifications.  
Quality of the ChIP-seq reads (or tags) was controlled using FastQC, and 
mapped against the human genome hg19 (GRCh37, version 2009), 
extended for the EBV genome (NC007605) using bowtie1. Choice of 
mapping parameters has an effect on sensitivity and specificity. Usage of 
only uniquely mapping reads excludes some true binding sites, simply 
because they locate in duplicated or repeated regions. However, allowing 
multiple read alignments leads to the detection of false positives. For the 
following analyses, false positives and possible amplification artefacts were 
excluded by blocking the repeated alignment of the identical sequence read.   
An example of either input (input (G1) repl1) or Orc2-ChIP (Orc2 (G1) 
repl1) read sequences aligned on hg19 at the published origin Mcm4/PRKDC 
(Schaarschmidt et al. 2002) is shown in Appendix Figure 1 A. Visualization 
was performed with the Integrated Genome Browser (IGB). In principle, 
protein binding at a specific position leads to an accumulation of reads 
aligning at this locus. A direct comparison of sequencing alignments 
showing single reads and pileup profiles is depicted in Appendix Figure 1 B.  
In general, raw ChIP-seq pileup profiles (without input normalization or any 
filters) turned out to be rather broad with much background, but I also 
observed regions with clear peaks (examples are visualized in Figure 4.14 
(Mcm4/PRKDC locus, broad profile) and Figure 4.15 (chr6: 26516717-
26543982, sharp peaks). Browser visualization is very useful to get an 
impression of the data, but is not quantitative for further analyses. For 
quantitative analysis, significant peaks need to be determined. Peak-calling 
programs compare read distribution of input to the specific ChIP and detect 
significant enrichments by applying dedicated algorithms.  
My Laboratory previously determined positions of active replication and pre-
RC on the EBV genome by SNS- or ChIP-on-chip experiments (Papior et al. 
2012). Thereby, independent ChIP and SNS data sets displayed high 
concordance. To decide for the most appropriate peak-calling program, I 
applied different peak-calling algorithms on EBV ChIP-seq data and selected 
the program whose results matched best to the previously identified pre-
RC and SNS positions on the EBV genome.    
VALIDATION OF PEAK-CALLING ON THE EBV GENOME 
Any peak-calling program’s key task is to reproducibly identify correct 
protein binding positions while avoiding false positives. There are over fifty 
different peak calling programs available and I chose to compare three of 
them: i) the most popular one: MACS2 (Model-based analysis of ChIP-seq; 
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Zhang et al. 2008); ii) a similar stringent peak calling program with many 
downstream applications: HOMER (Hypergeometric optimization of motif 
enrichment; Heinz et al. 2010); and iii) a program that has been shown to 
detect an increased number of biological relevant peaks: T-PIC (Tree-shape 
peak identification for ChIP-seq; Hower, Evans, and Pachter 2011).   
A ChIP-seq profile representation of single replicates and the respective 
peak calling result from EBV is depicted in Figure 4.5 for Orc2 and Orc3 and 
in Figure 4.6 for Mcm3 and Mcm7. While both MACS2 and HOMER peak 
calling programs did not detect any major peaks except for oriP, the T-PIC 
peak calling program also identified significant protein binding outside of 
oriP (Figure 4.5, Figure 4.6). This is consistent with published results, as 
Papior et al. found considerable pre-RC binding as well as active replication 
initiation events all over the EBV genome (dark brown (pre-RC) and light 
brown (SNS) bars in Figure 4.5, Figure 4.6; Papior et al. 2012).   
These very divergent results of different peak-calling programs originate 
from the different underlying algorithms. Despite a lot of work invested, it 
remains difficult to accurately define a peak within the data. MACS2 is 
designated for transcription factor binding detection and histone 
modifications (Feng, Liu, and Zhang 2011). The principle of MACS2 peak-
calling relies on a peak showing a bimodal enrichment pattern, as the 
sequencing reads represent each the end of a ChIP fragment (Figure 4.7). 
Based on the read distribution, MACS2 shifts the reads towards the 3’ends 
to optimize protein binding site location. Thereby, the shift size (d) is often 
unknown. MACS2 either relies on the sonication size (bandwidth parameter 
determined by the user) or calculates shift sizes based on high-quality 
peaks. Careful determination of the shift size is thus crucial for proper peak 
detection. MACS2 performs peak detection by using a dynamic parameter 
defined for each read enriched region (λlocal) and compares this enrichment 
to the peak region and neighboring regions (1 kb, 5 kb, 10 kb from the 
peak) in ChIP and control input sample. Thereby, variations in sequencing 
depth between ChIP and input samples are adjusted by diminishing the 
elevated depth. A p-value is calculated for each enriched region and those 
regions with a p-value smaller that the threshold (default p=10-5) are 
considered significant (Zhang et al. 2008). MACS2 provides two general 
peak-calling functions: “standard” for punctuate enrichments as e.g. 
transcription factors and “broad” to detect enrichments from e.g. histone 
modification patterns that cover broader regions.   
Also the HOMER “findPeaks” function allows choosing two different 
approaches. Either the setting “factor” for defined peaks, and “histone” for 
broader enriched regions can be chosen. To start with, HOMER requires to 
build a “tag directory” from the reads and performs a first quality control 
on data while estimating required parameters for downstream analysis (e.g. 
fragment length). Similar to MACS2, the program also shifts the enriched 
reads in the 3’ direction to center the actual peak depending on the 
fragment size.  
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FIGURE 4.5: VALIDATION OF THE PEAK-CALLING ALGORITHM ON ORC2 AND ORC3 REPLICATES. Significant peaks represented as bars above each pileup 
profile, MACS2 peaks are colored in beige background, HOMER peaks in lightblue background. Input (grey), Orc2 (red), Orc3 (orange). Pre-RC (brown) 
and SNS (light brown) positions identified by Papior et al. 2012. EBV genes represented as black bars, black lines = introns. EBV NC007605 [chrEBV: 
0-171823]. 
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FIGURE 4.6: VALIDATION OF THE PEAK-CALLING ALGORITHM ON MCM3 AND MCM7 REPLICATES. Significant peaks represented as bars above each pileup 
profile, MACS2 peaks are colored in beige background, HOMER peaks in lightblue background. Input (grey), Mcm3 (blue), Mcm7 (turquois). Pre-RC 
(brown) and SNS (light brown) positions identified by Papior et al. 2012. EBV genes represented as black bars, black lines = introns. EBV NC007605 
[chrEBV: 0-171823]. 
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FIGURE 4.7: STRAND-DEPENDENT BIMODALITY IN SEQUENCING READS DISTRIBUTION. The protein of 
interest (blue oval) binds DNA. Wavy lines represent sense (blue) and antisense (red) DNA fragments 
from ChIP enrichments. Sequenced reads are indicated as thicker portion. Alignment to the reference 
genome produces bimodal distribution of a peak that is corrected by peak-calling programs. Distance 
between sense and antisense reads (d) represents optimal shift size. From Wilbanks and Facciotti 
2010.   
It scans the genome for clusters of high-density tags and excludes the 
regions directly adjacent to these clusters. Assuming that the local tag 
densities follow a Poisson distribution, the program estimates the expected 
peak numbers and simultaneously calculates the expected number of false 
positive peaks for each tag threshold. It then uses the threshold that meets 
the specified false discovery rate (default: fdr=0.001). Peaks are filtered 
against the input control experiment using the sequencing-depth 
independent fold-change parameter. This means that a potential peak in 
the target experiment needs 4-fold (default) more normalized tags than the 
control. Similar to MACS2, HOMER also filters peaks based on the local tag 
count. Peak tag densities have to be 4-fold above the surrounding 10 kb 
region (homer.salk.edu/homer/ngs/peaks.html). 
In contrast to MACS2 or HOMER, T-PIC identifies significant peaks from read 
coverage and applies tree-based statistics on the data. The program starts 
by calculating the coverage from the reads of input and target sample 
extended by defined fragment length (set to 200 bp final). Already during 
this calculation, “anomalous” coverage is flagged for being subsequently 
analyzed as putative peaks. In order to detect statistically significant peaks, 
the program first calculates a “null hypothesis” to model regions without 
peak for a given coverage. The actual peak detection is then based on the 
shape of the peak (instead of it’s simple height, also the information from 
the neighborhood is taken into account and used to differentiate from 
random fragment distributions). Potential peaks identified during coverage 
calculation are then reprocessed and the coverage change within the shape 
is represented as a “tree” (Figure 4.8). Sharp peaks consequently 
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correspond to large trees without many branches, while broad peaks lead 
to low, rather bushy trees. A value is attributed to the tree which reflecting 
its shape. The “null hypothesis model” is equally scanned for peaks and 
corresponding trees are calculated to be able to correct for randomly 
occurring read accumulations. By comparing the detected peaks to the 
random peaks from the “null hypothesis model”, significant peaks are 
identified and displayed (Hower, Evans, and Pachter 2011).     
 
 
  
FIGURE 4.8: SCHEMATIC REPRESENTATION OF TRANSFORMATION OF A PEAK SHAPE INTO A TREE. The 
peak starts at a coverage height h and its end is considered at the same height. Every time the 
coverage changes by adding a read, the tree gains in vertices (blue stars, connected by red dotted 
line). The branches originate from “deviations” of the main shape (smaller dotted red lines). Adapted 
from Hower, Evans, and Pachter 2011.  
This diverging mathematical models for peak-calling explain the differences 
of T-PIC to the other two peak-calling algorithms MACS2 and HOMER. 
Furthermore, the authors of the T-PIC algorithm validated their approach 
by re-analyzing already published data of factors with specific binding 
motifs. Indeed, T-PIC identified peaks that specifically contain the 
corresponding motifs, while other peak-calling programs (like MACS) 
missed some of these peaks (Hower, Evans, and Pachter 2011). In 
conclusion, T-PIC is a more sensitive program to detect peaks of biological 
relevance. 
Based on the comparative analysis of the different peak-calling algorithms 
on the EBV pre-RC ChIP-seq results and the published EBV replication 
profile, T-PIC seems to be the most appropriate peak-calling program. I 
investigated the similarities of identified peaks between replicates and the 
different pre-RC proteins by calculating the Jaccard index. This index was 
calculated as explained in Figure 4.9 A. Jaccard index is a direct measure of 
replicate similarities with 1 being exactly redundant and 0 being completely 
different. Jaccard indices can be represented by a heatmap, which allows 
direct visual estimation of ChIP reproducibility. As observed in Figure 4.9 B, 
ChIP peaks clustered principally by experiment. Replicate 1, 2, and 3 cluster 
  4. RESULTS AND DISCUSSION 
53 | 
 
among themselves, but there was also a clustering visible depending on the 
ORC or Mcm2-7 complex. ChIPs from the third experiment (repl3) were 
least similar. 
 
 
FIGURE 4.9: CHIP SIMILARITIES REPRESENTED BY JACCARD INDICES. A) SCHEMATIC EXPLANATION OF 
CALCULATING THE JACCARD INDEX. The peak properties of two ChIPs are directly compared by 
calculating the overlap of both peaks and dividing by the sum of the totality and the overlap. The 
resulting index is a direct measure of similarity and ranges between 0 (no similarity) and 1 (identical). 
B) HEATMAP REPRESENTATION OF JACCARD INDICES OF THE INDIVIDUAL CHIP T-PIC PEAKS ON THE 
EBV GENOME. Dark red represents great similarities while lighter red indicates less redundancies.  
 
A) 
B) 
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These observed differences resulted principally from the biological and 
experimental difference of the samples. Working with three independent 
elutriation fractions, that were cross-linked at different time-points might 
account for experimental differences. Also, Mcm2-7 complexes are not 
necessarily positioned at defined sites but slide away from their ORC-
dependent loading sites (discussed in more detail in chapter 4.3). This 
might explain the increased variance in Mcm2-7 protein ChIPs.   
DEFINING THE PRE-REPLICATION COMPLEX 
The high experimental and biological variances strengthen even more the 
necessity for stringent pre-RC definition. The availability of several 
replicates (two for each Orc-ChIP and three for each Mcm2-7 ChIP) and two 
target proteins within each pre-RC sub-complex, makes robust complex 
definitions possible. Because ORC can also exist without Mcm2-7 helicases 
and the Mcm2-7 helicases might define initiation sites on their own, I 
defined and examined three different complexes: ORC, Mcm2-7, and pre-
RC. A complex is per definition composed of at least 50% overlapping peaks 
within respective target ChIPs and replicates (Figure 4.10 A). Consequently, 
ORC consisted of at least two peaks overlapping from Orc2_repl1, 
Orc2_repl3, Orc3_repl1, Orc3_repl3, Mcm2-7 demanded at least three 
overlapping peaks in Mcm3_repl1, Mcm3_repl2, Mcm3_repl3, Mcm7_repl1, 
Mcm7_repl2, and Mcm7_repl3. Pre-RC was built of at least five overlaps of 
all ChIPs. 
A visualization of the determined T-PIC-defined complex distributions 
together with pre-RC and SNS determined by Papior et al. 2012 is shown in 
Figure 4.10 C. W-repeats and terminal-repeats were excluded from the 
analysis. When calculating overlaps of T-PIC-defined pre-RCs with pre-RC 
determined by Papior et al., 66% of all T-PIC-pre-RCs overlapped. The same 
was true regarding the overlap of T-PIC-pre-RCs with SNS (Figure 4.10 B). 
Interestingly, one particular region from 102000 to 137600 was heavily 
enriched for pre-RCs detected by Papior et al., while T-PIC did not detect 
any enrichments of ORC, Mcm2-7 or pre-RC. Either this region is constantly 
covered by pre-RC components, which impairs T-PIC from detecting 
significant enrichments, or this observation results from differences in 
technique and bioinformatics analysis. 
Jaccard indices of all determined complexes were also calculated and are 
represented in Appendix Figure 2. T-PIC-defined complexes clustered 
together with high similarities and were slightly more similar to SNS 
positions determined by Papior et al. (Jaccard index = 0.32) than to their 
pre-RC positions (Jaccard index = 0.18). 
 
 
 
4
. R
E
S
U
L
T
S
 A
N
D
 D
IS
C
U
S
S
IO
N 
5
5
 | 
  
A) B) 
C) 
FIGURE 4.10: ORC, MCM2-7, AND PRE-RC DIFINITION ON EBV GENOME. A) PRINCIPLE OF COMPLEX DEFINITION. At least 50% overlapping peaks are needed 
to determine a complex. During merging, leftmost start position and rightmost end position are conserved. B) DIRECT COMPARISON OF T-PIC DEFINED 
PRE-RC POSITIONS WITH PRE-RC AND SNS POSITIONS FROM PAPIOR ET AL. Pre-RC (Papior et al. 2012) are represented in brown, SNS (Papior et al. 
2012) in light brown and T-PIC-defined pre-RCs in green. C) IGB VISUALIZATION OF T-PIC-DEFINED ORC, MCM2-7 AND PRE-RC, TOGETHER WITH PRE-RC 
AND SNS DETERMINED BY PAPIOR ET AL. 2012 ON THE EBV GENOME. T-PIC ORC:  orange, T-PIC Mcm2-7: blue, T-PIC pre-RC: green, pre-RC (Papior et 
al. 2012): brown, SNS (Papior et al. 2012): lightbrown; [chrEBV: 0-171823]. 
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In conclusion, the T-PIC peak-calling algorithm is most suitable to detect 
relevant peaks from pre-RC ChIPs. The observed differences of T-PIC-
defined peaks to pre-RC and SNS positions defined by Papior et al. might 
account for completely different technical and bioinformatical approaches. 
Even more, the fact that I also observed considerable similarities (66% 
overlaps) argues for my chosen analysis procedure.   
4.1.3 PERFORMING CHIP-SEQ EXPERIMENTS IN HUMAN EMBRYONIC STEM 
(HES) CELLS  
Setting up pre-RC ChIP-seq experiments in Raji cells had the advantage 
that an internal ChIP quality control was available with oriP on the EBV 
genome. The resulting sequencing data now allowed determination of 
genomic pre-RC positive loci to enable qPCR validation of pre-RC ChIPs in 
other human cells. Together with my partner laboratory of Dr. Jean-Marc 
Lemaitre at the IRMB in Montpellier, we decided to apply pre-RC ChIP-seq 
on the human embryonic stem cell line H9 (hES cells). In these cells, 
SNS-sequencing data is also available, which allows direct comparison of 
pre-RC positions with specific sites of active replication (Besnard et al. 
2012). However, easy G1 synchronization of hES cells is impossible and I 
decided against chemical synchronization to avoid treatment biases, 
performing the ChIPs on asynchronous cell populations.  
EXPERIMENTAL SETUP: CHIP VALIDATION 
ES cells were cultivated to high quantities (up to 2x108 cells). This made 
careful pluripotency controls necessary, as hES cells easily differentiate. 
Besides morphological criteria (Appendix Figure 3 A), I also performed FACS 
staining of known pluripotency markers SSEA4 and Oct4 (Appendix Figure 
3 B). FACS stain revealed a pluripotent population of about 98% of all cells. 
During cross-link using my established protocol, I omitted the second 
washing step prior to cross-linking because cells were more fragile and lysed 
more easily. Sonication time was also reduced and ChIPs were performed 
as described in chapter 3.2.7, p. 35. 
From Raji sequencing data, I chose two positive loci for ChIP validation in 
hES cells by qPCR. The Mcm4/PRKDC locus represents a known origin of 
replication (Schaarschmidt et al. 2002) and primer positions together with 
example ChIP-seq profiles in Raji cells are shown in Appendix Figure 4. 
When screening Raji ChIP-seq data for strong enrichment peaks, I defined 
the BANF1 locus as additional positive control (sequencing profile and 
primer positions are shown in Appendix Figure 5). After validation of 
positive and negative control primers in Raji cells (not shown), I performed 
pre-RC ChIPs according to the established protocol and validated ChIP 
quality by qPCR (Figure 4.11).  
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FIGURE 4.11: PRE-RC CHIP QPCR VALIDATION AT SELECTED BANF1 (BANF1+) AND MCM4/PRKDC 
POSITIVE (MCM4+) AND MCM4/PRKDC NEGATIVE (MCM4-) LOCI. IgG was used as negative control. Mean 
± SEM (n=3). 
Pre-RC ChIP validation on the human genome resulted in low % input 
values, which possibly emerge from the variable binding of pre-RC proteins. 
However, ChIPs remained enriched at positive loci in comparison to the 
Mcm4/PRKDC negative locus and were sequenced at the platform MGX-
Montpellier GenomiX. 
Two complete replicates of Orc2, Orc3, Mcm3, and Mcm7 were sequenced 
by paired-end sequencing of 100 nucleotides from both ends of the ChIP 
fragments. This method improves data set quality because alignment to the 
reference genome is facilitated and also repetitive sequence elements can 
be covered.  
TREATING SEQUENCING DATA 
Anissa Zouaoui, bioinformatician in the laboratory of Dr. Jean-Marc 
Lemaitre, mapped the sequencing data against the human genome hg19 
(GRCh37, version 2009) and performed standard MACS2 broad peak 
calling, as pre-RC binding turned out to be more spread over the genome, 
rather than representing distinct peaks. Currently, we are also adapting the 
T-PIC peak calling algorithm for paired-end sequencing data, as T-PIC is 
originally designed for single-end sequencing results. Nevertheless, to get 
a first impression of the data, I defined ORC, Mcm2-7 and pre-RC as 
previously described and compared their positions to sites of active 
replication (SNS, Besnard et al. 2012). 
First of all, I looked at the total number of defined complexes from replicates 
(Figure 4.12 A). It is evident that many more Mcm2-7 complexes (43846) 
were detected than ORC (12848) or pre-RCs (8651). By extensive deep 
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sequencing, Besnard et al. 2012 detected more than 200000 sites of active 
replication. Although this elevated number of origins has been recently 
questioned by Cayrou et al. 2015 and highly depends on definition and 
detection algorithm, it remained very robust when changing algorithm 
parameters (data not shown). Evidently, the number of defined ORC, 
Mcm2-7 and pre-RCs was smaller and cannot be directly compared to the 
number of active origins. Nevertheless, I analyzed the overlaps of the 
defined complexes with SNS (Figure 4.12 B). While ORC and pre-RC 
overlapped to nearly 80% with SNS sites, only 30% of all Mcm2-7 
complexes were found at SNS sites.  
Given that mainly ORC and pre-RC complexes overlapped with SNS, I 
wondered for the distance of all the complexes towards SNS center. I 
calculated and plotted the distance of the defined complexes towards the 
next SNS center in log10 scale in a bar chart (Figure 4.12 C). Distribution 
of close and more farther located complex populations gives visual 
impression of the behavior towards SNS. 
It becomes evident that majority of ORC (80.5%) and pre-RC (80.3%) 
located within ~1600 bp (log10 = 3.2, marked by red dashed line in Figure 
4.12 C) of SNS center, while only 40.4% of Mcm2-7 located that close. This 
also corresponded to the directly calculated overlaps and shows again, that 
while ORC was located in closer proximity to SNS (mean=4561 bp), Mcm2-
7 complexes were detected further away (22052 bp, p < 2.2x10-16).   
The observed 3.4-fold excess of the total Mcm2-7 numbers of compared to 
ORC is consistent with already reported Mcm2-7 helicase surplus in 
Drosophila, although not to the same extend (Powell et al. 2015 reported 
10 to 50-fold Mcm2-7 helicase excess). The number of detected ORC 
(12848) corresponds to the number of Orc1 sites detected by Dellino et al. 
2013 (~13000) in HeLa cells, but not to ~52000 Orc2 peaks in K562 cells 
(Miotto, Ji, and Struhl 2016) neither to the expected number of total origins 
(30000-50000). Although the numbers and positions of ORC and Mcm2-7 
differ considerably, 67% of all defined ORC coincide with Mcm2-7, which 
resulted in 8651 detected pre-RC positions. Apart from apparent technical 
fluctuations in antibody specificities, this might reflect ORC-dependent 
Mcm2-7 loading (overlapping ORC/Mcm2-7) and subsequent Mcm2-7 
sliding from the loading site (Mcm2-7 without corresponding ORC), as 
suggested previously (Das and Rhind 2016; Hyrien 2016).  
The strong overlap of ORC, but not Mcm2-7 with SNS contradicts the idea 
that Mcm2-7 complexes are solely responsible for replication initiation. In 
that case, mostly Mcm2-7 should overlap with replication initiation sites. 
These results rather indicate, that ORC is indeed important defining active 
origins, and it would be interesting to test, which cohort of origins overlaps 
with ORC (in terms of origin efficiency, links to transcription or histone 
modifications, etc.). However, it would also be interesting to further define 
the Mcm2-7 population not correlating with SNS, to find possible 
explanations.  
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A) 
B) 
C) 
FIGURE 4.12: SNS CORRELATE MORE WITH ORC THAN WITH MCM2-7. A) TOTAL NUMBERS OF DEFINED 
COMPLEXES. B) OVERLAP OF DEFINED COMPLEXES WITH SNS. Percentages in brackets represent the 
% overlap of the complex with SNS. C) SNS SIZE DISTRIBUTION AND DISTANCE TO SNS CENTER 
ANALYSIS OF EACH DEFINED COMPLEX. The frequency of the distance of each complex was calculated 
in respect to the center of the next SNS position and plotted as log10. The red dashed line marks 
log10(3.2) = 1585bp from center. ORC: orange, Mcm2-7: blue, pre-RC: green, SNS: lightbrown. 
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In conclusion, although the data seems promising, it still needs extensive 
further analysis in collaboration with Anissa Zouaoui. First effort will be to 
apply the earlier validated T-PIC peak calling algorithm on the data to gain 
confidence in the peak number and positions detected. This will also 
improve the comparative analysis with SNS positions. Further steps will 
include the correlation of SNS and pre-RC positions with other chromatin 
features, like histone modifications, MNase sensitivity, CG-content, etc. This 
will allow to define features predicting pre-RC correlation with SNS.  
 PRE-RC COMPONENTS ARE ENRICHED WITHIN REPLICATION 
UNITS 
Pre-RC ChIP-seq analysis in hES cells still needs further effort concerning 
data treatment and evaluation. Besides comparison to active replication, 
there is a lot of histone modification ChIP-seq data available in hES cells 
and comparative correlations promise insights into regulation of origin 
licensing and activation.  
For Raji pre-RC ChIP-seq comparisons however, there is less data 
published, and I initiated collaborations with Dr. Olivier Hyrien (IBENS, 
Paris) for active replication data, Prof. Dr. Wolfgang Hammerschmidt 
(HelmholtzZentrum München) for RNA-seq data, and Dr. Jean-Christophe 
Andrau (IGMM, Montpellier) for histone modification data.  
To start data analysis on the human genome, I performed T-PIC and HOMER 
peak-calling on pre-RC ChIP-seq data sets. T-PIC is the peak calling 
algorithm of choice, as validated on the EBV genome. However, I decided 
to also separately focus exclusively on the strongest pre-RC peaks and to 
in parallel use the HOMER algorithm.  
4.2.1 COMPARING T-PIC VS. HOMER PEAK-CALLING ALGORITHMS AND 
DEFINING ORC, MCM2-7, AND PRE-RC ON THE HUMAN GENOME 
As already observed on the EBV genome, T-PIC peak-calling is much more 
sensitive than the HOMER algorithm. This was also true for peak-calling on 
the human genome. As a consequence, peak-calling with T-PIC detected 
around 20-times more peaks than HOMER (Table 4.1). Most HOMER peaks 
resided within the top 10% of T-PIC peaks (representative example for one 
replicate of Orc2 and Mcm3 depicted in Figure 4.13, see Appendix Figure 6 
for Orc3 and Mcm7), confirming that HOMER mostly calls the strongest 
peaks. 
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TABLE 4.1: COMPARISON OF ABSOLUTE NUMBER OF PEAKS WITHIN REPLICATES AND RESULTING 
COMPLEXES. n.a = not assessed 
  PEAK NUMBERS COMPLEX NUMBERS 
  Orc2 Orc3 Mcm3 Mcm7 ORC Mcm2-7 Pre-
RC 
HOMER 
repl1 2309 4503 2203 2584 1936 322 329 
repl2 n.a. n.a. 658 767 
repl3 1391 1997 424 405 
T-PIC 
repl1 52366 63976 76032 50795 57597 25529 23896 
repl2 n.a. n.a. 44400 25060 
repl3 84343 72717 53792 57388 
 
 
 
 
 
Due to its high sensitivity, T-PIC detected peaks at many known origins of 
replication while HOMER did not (for Mcm4/PRKDC locus, see Figure 4.14, 
for LaminB2 (Abdurashidova et al. 2000) and JunB (Fu et al. 2014) origins, 
Appendix Figure 7 and Appendix Figure 8). These observations again 
confirm the T-PIC program detecting peaks of biological relevance. By 
contrast, HOMER mostly detected strong, highly enriched binding sites 
(example in Figure 4.15). 
The number of detected peaks varied considerably between the different 
replicates (Table 4.1), emphasizing even more the necessity for stringent 
complex definition. On the basis of T-PIC and HOMER peaks, I computed 
ORC, Mcm2-7 and pre-RC according to the settings previously defined on 
EBV. The final complex numbers are listed in Table 4.1. For both 
B) A) 
FIGURE 4.13: MOST HOMER PEAKS LOCATE WITHIN THE TOP 10% OF T-PIC PEAKS. REPRESENTATIVE 
EXAMPLE ANALYSIS FOR A) ORC2 AND B) MCM3 IN ONE REPLICATE. Venn diagram of overlap between 
all HOMER-detected peaks with the top 10% of T-PIC-detected peaks. Overall counts are indicated. 
The percentage of overlapping HOMER-detected peaks are specified in brackets. 
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approaches, the total number of ORC was 2 to 6-fold higher than both 
Mcm2-7 and pre-RC. This stands in clear contrast to the 3.4-fold excess of 
Mcm2-7 detected in hES cells and likely depends on the “broad” peak-calling 
performed with MACS2 in hES cells. HOMER-defined complex numbers were 
generally 30 to 80-times lower than T-PIC defined complexes.  
Comparison of complex sizes revealed that HOMER complexes were 
considerably narrower than T-PIC ones (for pre-RC, see Figure 4.16 A, ORC 
an Mcm2-7 in Appendix Figure 9). This is mostly due to the HOMER peak-
calling algorithm settings that produced peaks of around 200 bp. T-PIC peak 
sizes were more variable, also due to the merging process during complex 
computation.  
When looking at the distribution of ORC, Mcm2-7 and pre-RC complexes, it 
became evident that HOMER-defined complexes represent a subpopulation 
of T-PIC-defined complexes (Figure 4.16 B (pre-RC), Appendix Figure 10 
(ORC and Mcm2-7)). This is a logic consequence of HOMER peaks being 
part of the strongest T-PIC peak population but also reflects the fact that 
HOMER-defined complexes (and consequently the ones with very strong 
binding) only built a small sup-population within T-PIC-defined complexes. 
After defining ORC, Mcm2-7 complex and pre-RC, the complexes can now 
be correlated with active replication, transcription and histone 
modifications. 
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FIGURE 4.14: MCM4/PRKDC ORIGIN IS IDENTIFIED BY T-PIC BUT NOT BY HOMER PEAK-CALLING. Input: grey, Orc2: red, Orc3: orange, Mcm3: blue, Mcm7: 
turquois. T-PIC-detected peaks are represented as bars above each pileup profile; HOMER-detected peaks are additionally highlighted by lightblue 
background. Visualization in IGB. [chr8: 48862188-48883250]. 
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A
) 
B
) 
FIGURE 4.15: HOMER PEAK-CALLING IDENTIFIES STRONG PEAKS. Example peak-calling at chr6: 26516717-26543982. Input: grey, Orc2: red, Orc3: 
orange, Mcm3: blue, Mcm7: turquois. T-PIC-detected peaks are represented as bars above each pileup profile; HOMER-detected peaks are additionally 
highlighted by lightblue background. Visualized in IGB. 
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FIGURE 4.16: DIRECT COMPARISON OF HOMER- AND T-PIC-DEFINED PRE-RC. A) PRE-RC SIZES IN [KB]. 
Represented in boxplot: thick line shows the median, the box is the distribution from the first to the 
third quartile, the whiskers indicate the smallest and largest value without being an outlier. B) 
OVERLAPPING PRE-RCS. Venn diagram of overlap between HOMER- and T-PIC-defined pre-RCs. 
Overall counts are indicated. The percentage of HOMER-defined pre-RCs common with T-PIC-defined 
pre-RCs is specified in brackets.    
4.2.2 PRE-RCS CORRELATE WITH ACTIVE REPLICATION UNITS 
As pre-RCs represent sites of licensed origins of replication, I first assessed 
the association of origin licensing and active replication. The group of Dr. 
Olivier Hyrien adopted very recently a method for Okazaki-fragment 
sequencing (OK-seq) on human cells to detect replication initiation (Petryk 
et al. 2016). They also applied this method on Raji cells and kindly provided 
preliminary data on replication initiation and replication termination zones. 
Principal of OK-seq is pulse-labeling of Okazaki-fragments with the 
Thymidine analogue EdU and subsequent purification of these fragments (< 
200 bp). Fragment sequencing allows to distinguish between Watson 
(leftward moving fork) and Crick (rightward moving fork) Okazaki 
fragments. From this differentiation, replication fork directionality (RFD = 
(!"#$%&')*+,-.
(!"#$%/')*+,-.
 ) is calculated resulting in a profile of series of ascending (AS), 
descending (DS), and flat segments of different sizes and slopes (Figure 
4.17 A). AS represent zones of preferential replication initiation, while DS 
are zones of preferential replication termination. The amplitude thereby 
reflects initiation efficiency. A broad initiation zone (AS) represents a zone 
of preferential replication initiation with multiple inefficient initiation sites 
but only one single origin firing per cell, presumably corresponding to 
replication units described in the introduction (chapter 1.1.5, p. 15f). 
Computational wavelet detection of AS and DS in Raji cells (performed by 
Benjamin Audit, ENS Lyon) revealed 4639 AS and 2207 DS, covering 6.6% 
and 8.6% of the genome, respectively. Thereby, AS were smaller (mean = 
37.8 kb, range from 3.9 to 198.0 kb) than DS (mean = 122,2 kb, range 
from 4.7 kb to 339.8 kb) (Figure 4.17 C). 
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VISUAL EXAMINATION OF AS, DS AND T-PIC-DEFINED PRE-RC POSITIONS REVEALS 
A PRE-RC ENRICHMENT IN AS 
First visual examination of the co-occurrence of AS, DS and T-PIC-defined 
pre-RC positions revealed a preferential localization of T-PIC pre-RCs within 
AS, while there were less pre-RCs found in DS (IGB visualized example in 
Figure 4.17 B). To quantify this visual observation, I calculated the density 
of T-PIC pre-RC positions per Mb (Figure 4.17 D). While 8.5 events/Mb were 
observed in AS, only 3.4 events/Mb were detected in DS. Additionally, I also 
considered all genomic regions being neither AS nor DS, termed “remaining 
genome”. With 8 events/Mb, pre-RC density was similar to AS.  
Interestingly, these results do not indicate preferential pre-RC positioning 
within AS zones of active replication initiation, but rather argue for a specific 
depletion of pre-RCs in DS zones of replication termination.  
On average, 8.5 pre-RCs per Mb were detected within an AS, which results 
in one pre-RC every 100 kb. Concordantly, on average, one origin is 
activated every 100 kb (mean size of a replication unit, Fragkos et al. 2015). 
However, one would expect to also detect the excess of licensed origins, 
thus anticipating a higher pre-RC density. This might possibly be a problem 
of peak detection, as every peak-calling algorithm expects protein binding 
at a defined region. This prerequisite is given for ORC but for Mcm2-7 
complexes site specific binding is controversially discussed. Assuming 
Mcm2-7 spreading, Mcm2-7 binding sites might remain undetected. 
Consequently, I chose another approach to unbiasedly detect pre-RC 
omponent binding by calculating the mean read coverage of every pre-RC 
component at AS or DS. 
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A) 
B) 
C) D) 
FIGURE 4.17: CORRELATION OF PRE-RC PEAKS WITH ZONES OF REPLICATION INITIATION (AS) AND 
REPLICATION TERMINATION (DS). A) PRINCIPLE OF AS/DS DETECTION BY OKAZAKI-FRAGMENT 
SEQUENCING. Left: Replication fork directionality (RFD) is calculated by the number of Watson and 
Crick strands. Right: Theoretical RFD profiles for an initiation/ termination site (for one fixed origin) 
or zone (multiple inefficient origins). B) VISUAL COMPARISON OF AS AND DS WITH PRE-RC (T-PIC) 
POSITIONS [chr8: 9033838-9569826]. C) COMPARISON OF AS/DS REGION SIZES. Represented in 
boxplot: thick line shows the median, the box is the distribution from the first to the third quartile, 
the whiskers indicate the smallest and largest value without being an outlier. D) PRE-RC (T-PIC) 
DENSITY WITHIN AS/ DS REGIONS AND THE REMAINING GENOME. Density is represented as events/Mb. 
AS (initiation zones) are colored in red, DS (termination zones) colored in blue, the remaining 
genome is represented in grey. 
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COVERAGE OF PRE-RC COMPONENTS IS ENHANCED AT AS AND DECREASED AT DS 
Examining pre-RC positions already procured an impression of pre-RC 
distribution in relation to AS and DS. Another way of analyzing the data is 
to calculate the sequencing read coverage at the superimposition of either 
AS or DS. This has the advantage of being independent of any peak-calling 
algorithms and obtaining a global impression of the average situation at all 
sites simultaneously.   
Coverage was computed as reads per base within a window of 200 kb 
around AS or DS centers for each replicate. From this, I calculated the mean 
coverage of all three replicates for each pre-RC protein. In Figure 4.18, the 
result of the mean coverage analysis at AS or DS is depicted for A) Orc2, 
B) Orc3, C) Mcm3, and D) Mcm7. All four pre-RC proteins showed an 
enhanced coverage at AS, while coverage was depleted from DS. The input 
is also plotted as a control for intrinsic chromatin composition. As sonication 
does not fragment chromatin uniformly, regions with higher accessibility 
might be underrepresented because of increased destruction during 
sonication, while less accessible regions are slightly overestimated. This is 
possibly the reason for decreasing input coverage at AS and increasing input 
coverage at DS. AS have been shown to reside in rather euchromatic 
environment (Petryk et al. 2016), whereas input coverage implies DS being 
more heterochromatic.  
The coverage increase of target pre-RC proteins of 0.5 to 0.8 reads/base 
seems slight, but accounts for 10% of the mean coverage (assuming a 
mean coverage of 4.5 reads/base). One possible reason is the large AS/DS 
size. Looking at an average of all AS ranging from 3.9 kb to 198 kb, also 
averaged out specific protein binding events. Furthermore, increased 
coverage at AS had an average region width of ~60 kb and decreased 
coverage at DS ~120 kb, which corresponds to the mean AS (37.8 kb) and 
DS sizes (122.2 kb). This observation and the reproducibility of all pre-RC 
components increasingly covering AS together with a specific coverage 
depletion at DS convincingly argues for specificity of these results.  
In conclusion, both T-PIC-defined pre-RC complex distribution and pre-RC 
component coverage analysis revealed an elevated pre-RC binding in 
replication initiation zones (AS), with specific pre-RC depletion in 
termination zones (DS). When looking at the T-PIC-defined pre-RC complex 
distribution, pre-RC density was 2.5-fold higher in initiation zones than in 
termination zones. Analysis of HOMER-defined pre-RC positions by trend 
also resulted in increased density within AS, but the total number of 329 
HOMER-defined pre-RCs was not elevated enough to make a meaningful 
statement (data not shown).  
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AS are broad zones in which replication preferentially initiates from multiple 
inefficient origins (Petryk et al. 2016). Thus, multiple pre-RC sites are 
expected within these zones. However, presence of pre-RCs outside of these 
zones (DS, remaining genome) is not astonishing. These pre-RCs might be 
part of dormant origins, i.e. origins, that are licensed but not activated, 
unless replicative stress (replication fork stalling) makes their activation 
necessary to complete genome replication (Blow, Ge, and Jackson 2011). 
These observations indicate, that while AS is indeed a zone of pre-RC 
occurrences and DS clearly is depleted from pre-RCs, origin licensing also 
efficiently takes place outside of AS. 
AS and DS together make up only 15.2% of the human genome, mostly 
due to low OK-sequencing coverage, which partly impedes confident zone 
detection. But also in HeLa cells, only 61% of the genome contribute to 
zones of replication initiation and termination. Petryk et al. propose AS as 
“master initiation zones”, while the rest of the genome displays disperse, 
stochastically firing origins that cannot be detected by their method. 
Indeed, this is in agreement with AS representing replication units. Other 
methods (bubble trap or SNS-seq) detect many active replication events 
inside and outside AS.  
INTENDED IMPROVEMENTS AND FURTHER ANALYSES 
This analysis of correlating pre-RC components and replication 
initiation/termination represents a first impression of relations between 
origin licensing and activation. Further analyses are anticipated to 
strengthen these results. First of all, the mean pre-RC density was 
calculated for all AS/DS. However, this calculation ignores fluctuations. Pre-
RC density per single AS/DS needs to be calculated and plotted in a boxplot 
to be able to draw any final conclusions. If the mean density is influenced 
by outliers, it will be uncovered. Still, Petryk et al. compared HeLa AS to 
~13000 Orc1 sites detected in the same cell line by Dellino et al. 2013. 
They found Orc1 peak density being 2.4-times higher in AS than DS, 
consistent with my complex densities (pre-RC: 2.5-fold higher in AS than 
DS (Figure 4.17); ORC: 2.4-fold (Appendix Figure 18 B, G1), Mcm2-7: 3.3-
fold (Appendix Figure 18 C, G1)). 
Furthermore, pre-RC components are not necessarily expected in the 
middle of AS, as calculated. On the contrary, HeLa Orc1 sites were mostly 
enriched at AS borders (Petryk et al. 2016). Indeed, the M-shaped pre-RC 
component coverage profiles could result from elevated border distributions 
(Figure 4.18 A and B). Simple coverage calculations at AS/DS aligned at 
one border will answer this question. Thereby, one important feature has to 
be taken into account: Petryk et al. found AS often to be flanked by actively 
transcribed genes. This and the fact the Orc1 sites were often found at AS 
borders led to the hypothesis, that ORC loads Mcm2-7 helicases at the 
FIGURE 4.18: PRE-RC COMPONENT COVERAGE ANALYSIS REVEALED ACCUMULATION AT AS (LEFT) AND 
DEPLETION AROUND DS (RIGHT). A) MEAN ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN 
MCM3 COVERAGE. D) MEAN MCM7 COVERAGE. Coverage was calculated as number of reads/base 
within a 200 kb window around either AS or DS center.  
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borders. Delimitation by active transcription possibly directs Mcm2-7 
spreading towards AS. When calculating coverage at AS borders, flanking 
genes need to be taken into account (possibly sorting AS into different 
classes according to their association with transcription). Two results can 
be expected: i) indeed, ORC is enriched at AS borders, ii) Mcm3 and Mcm7 
are also enriched at the borders but migrate smoothly in the AS direction. 
Performing the analysis will reveal whether this hypothesis holds true.   
CONCLUSION 
Biologically, pre-RCs are a prerequisite for active replication. Notably, these 
results validate my pre-RC ChIP-seq approach and undoubtedly prove that 
I successfully chipped pre-RC components. While they were nicely 
associated with AS, the evident depletion at DS was unexpected. Petryk et 
al. did not observe or discuss any similar observations. DS are generally 
larger than AS (Figure 4.17 C) arguing for replication initiation being more 
precise than replication termination, which appears to be more random. 
This observation also indicates that replication fork speeds fluctuate, 
generating more disperse replication termination sites when forks collide. 
Pre-RC depletion in DS indicate little origin licensing within sites of 
replication termination. Termination zones often consist in actively 
transcribed gene bodies, but have not been further characterized so far. 
Consequently, several questions arise: Which features define replication 
termination zones? Is there also a link to heterochromatin? Why are pre-
RCs specifically absent from these zones? Is it actually simply the absence 
of pre-RCs that defines a termination zone as termination zone? And how is 
active transcription linked to replication termination zones? The last 
question will be also discussed in the next chapter. 
Detection of active replication by any method (OK-seq or SNS-seq) often 
links DNA replication to active transcription. Conserved AS that are shared 
between different cell types, are often flanked by actively transcribed genes 
(Petryk et al. 2016). Also SNS are often enriched in genes or promoters 
(Cayrou et al. 2011; Besnard et al. 2012; Picard et al. 2014; Cayrou et al. 
2015).  Consequently, after correlating pre-RC positions with sites of active 
replication, I was wondering, whether pre-RC ChIP-seq data also associate 
with active transcription.  
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 STABLE ORIGIN LICENSING IS ASSOCIATED TO REGULATION 
OF ACTIVE TRANSCRIPTION 
To be able to correlate pre-RC positions with active transcription, I first 
needed information about gene expression in Raji cells. Alexander Buschle 
and Prof. Dr. Wolfgang Hammerschmidt (Research Group EBV Genetics and 
Vectors, Research Unit Gene Vectors, HelmholtzZentrum München) kindly 
shared their RNA-seq data obtained from identical Raji cells.  
4.3.1 PRE-RC COVERAGE WAS INCREASED AT ACTIVE TRANSCRIPTION START 
SITES 
RNA-seq data reflects gene expression within a cell population. The 
obtained reads from sequencing are mapped against genes and quantified. 
The experiments were performed in triplicates and the mean quantification 
was considered to estimate gene expression. With the support of Tobias 
Straub (head of the Bioinformatics Core Unit, Ludwig-Maximilians-
Universität München), actively transcribed genes were arbitrarily defined as 
more than e2 = 7.39; (ln(mean) > 2), meaning that more than 7.39 
sequencing reads per gene define a gene as actively transcribed. This 
resulted in 10642 active and 12731 inactive genes. The transcription start 
sites of these genes were extracted and the coverage of the different pre-
RC target proteins was computed within a 4000 bp window around active 
or inactive TSSs.  
As observed in Figure 4.19 (left panel), all targeted members of the pre-RC 
were clearly enriched at active TSSs. Coverage of Mcm3 (Figure 4.19 C, left 
panel) was less prominent than for the other target proteins (Figure 4.20: 
Orc2: A, Orc3: B, and Mcm7: D, left panel), which might originate from the 
antibody. Pre-RC association was clearly dependent on transcriptional 
activity, as inactive TSSs were not enriched in any pre-RC component 
(Figure 4.19, right panel).       
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4.3.2 STRONG HOMER-DEFINED ORC, MCM2-7 AND PRE-RC ASSOCIATED 
WITH ACTIVE TRANSCRIPTION START SITES 
To examine the relation of HOMER- or T-PIC-defined ORC, Mcm2-7 and pre-
RC to active and inactive TSSs, I calculated the distance of each complex 
position to the next TSS. This resulted in an estimation of the frequency, in 
which complexes are found in vicinity or in distance of TSSs. The distances 
to active TSSs (colored) and inactive TSSs (grey) are represented in the 
graphs (Figure 4.20: HOMER-defined complexes (left panel); T-PIC-defined 
complexes (right panel)). As for inactive TSSs, all HOMER- and T-PIC-
defined complexes peaked at 100 kb distance. Considering roughly 13000 
inactive TSS and a human genome size of 3.1 Mb (hg19), a random 
distribution would result in an average distance of 238 kb. However, as the 
genomic organization is not random, but grouped in gene dense 
euchromatic and gene devoid heterochromatic regions, I propose that ORC, 
Mcm2-7 and pre-RC distributions around 100 kb from the next inactive TSS 
originate from TSS-independent distributions. When looking at the T-PIC-
defined complexes, their distribution in relation to active TSSs approximate 
the one of inactive TSSs (Figure 4.20 (right panel)), suggesting that T-PIC-
defined pre-RC depend only little on transcriptional activity. Moreover, 
Mcm2-7 are even more depleted from active TSS, compared to inactive TSS 
(mean distance from active TSS: 430 kb, mean distance from inactive TSS: 
186 kb, p-value = 2.2x10-16). 
By contrast, HOMER-defined complex distribution in respect to active TSSs 
is bipartite (Figure 4.20 (left panel)). A subpopulation of strong HOMER-
defined complexes, is located in close proximity (100 – 1000 bp) to active 
TSSs. This is true for ORC, Mcm2-7 and pre-RC, but also for the single 
replicates of each ChIP (data not shown). HOMER-defined complexes 
represent a population of very strong binding sites (Chapter 4.2.1, p. 60). 
Consequently, the proximity to active TSSs defines at least in part strong 
pre-RC binding.   
Dedicated programs take peak position information and calculate the peak 
proportions in specific genome features, as e.g. promoters, exons, and 
introns. Analysis of the genomic distribution of HOMER- and T-PIC-defined 
pre-RC with the CEAS program (cis-regulatory element annotation system 
(Shin et al. 2009)) confirmed the close association of pre-RCs to proximal 
promoter regions (see Appendix Figure 11). Thereby, HOMER-defined pre-
RCs again showed an increased association to close promoter regions and 
was also more depleted from intronic and distal intergenic regions compared 
to T-PIC-defined pre-RCs.  
FIGURE 4.19: PRE-RC COMPONENT COVERAGE ANALYSIS REVEALED INCREASED COVERAGE AT 
ACTIVE TSS (LEFT PANEL) AND UNCHANGED COVERAGE AT INACTIVE TSS (RIGHT PANEL). A) MEAN 
ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE.  
Coverage was calculated as number of reads/base within a 4000 bp window around TSS. Input was 
plotted as control (grey). 
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FIGURE 4.20: A SUBPOPULATION OF HOMER-DEFINED ORC, MCM2-7, AND PRE-RC WERE CLOSELY 
RELATED TO ACTIVE TSS. Left: HOMER-defined complexes, right: T-PIC-defined complexes. The 
distance of each position was calculated towards the next TSS and is plotted in log10 on the x-axis.  
Y-axis represents the frequency of complexes within a specific distance. 
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Nevertheless, T-PIC-defined pre-RCs were also slightly enriched in proximal 
promoter regions, indicating that active transcription indeed favors pre-RC 
positions, independent of the peak-calling algorithm.  
Promoter activity is amongst others regulated by specific histone 
modifications. In particular, H3K4me3 is known to recruit chromatin 
remodeling factors that create open chromatin which leads to transcription 
factor binding (Kimura 2013). Consequently, most active TSSs are marked 
by H3K4me3.  
4.3.3 PRE-RC COVERAGE WAS ENHANCED AT H3K4ME3 PEAKS 
With active TSS being marked by H3K4me3, pre-RC components are also 
expected to be enriched at H3K4me3 sites. The group of Dr. Jean-
Christophe Andrau (Transcription and Epigenomics in Developing T-Cells, 
IGMM, Montpellier) kindly shared their data of H3K4me3 and H3K36me3 
peak positions obtained from ChIP-seq in Raji cells. Indeed, direct 
comparison of active TSS and H3K4me3 positions revealed that 81% of 
active TSS coincide with H3K4me3 (Figure 4.21). Still, 52.8% of all 
H3K4me3 peaks do not directly overlap with TSS. However, further analysis 
of the  
 
FIGURE 4.21: MOST ACTIVE TSS DIRECTLY OVERLAPPED WITH H3K4ME3. Venn diagram of overlap 
between TSS and H3K4me3. Overall counts are indicated. The percentage of overlapping proportions 
are specified below in brackets.     
genomic distribution of H3K4me3 peaks revealed a close association to all 
regulatory regions upstream of the TSS (promoter, 5’UTR), as well as 
presumably first introns and exons (Appendix Figure 12).  Computational 
analysis of the mean coverage of the single pre-RC proteins (Figure 4.22) 
indicated an enrichment at H3K4me3 peak centers (except for Mcm3 
(Figure 4.22 C)). The calculated coverage is more irregular than at TSSs 
because H3K4me3 peaks of different sizes were centered and read coverage 
was calculated in a large 20 kb window (mean size = 2.2 kb, range from 
250 bp to 98.1 kb, see also Appendix Figure 13).  
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In contrast to pre-RC enrichments at H3K4me3 peaks, no enhanced 
coverage was observed at H3K36me3 regions (Appendix Figure 15). 
H3K36me3 is also a histone modification associated to active transcription, 
but is rather found in actively transcribed gene bodies (Kimura 2013), more 
precisely in intronic regions (Appendix Figure 14).  This finding specifically 
links replication licensing to the regulation of active transcription, but not 
to transcriptional activity itself. 
 
 
 
FIGURE 4.22: INCREASED COVERAGE OF TARGET PRE-RC PROTEINS AT H3K4ME3 PEAKS. A) MEAN 
ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE.  
Coverage was calculated as number of reads/base within a 20 kb window around H3K4me3 peak 
center. Input was plotted as control (grey).  
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4.3.4 STRONG HOMER-DEFINED MCM2-7 AND PRE-RC ENTIRELY 
ASSOCIATE WITH H3K4ME3 
Already coverage analyses implied a strong association of pre-RC with 
H3K4me3. However, it remained to be tested whether this association is 
confirmed by a co-localization of H3K4me3 and HOMER- and T-PIC-defined 
ORC, Mcm2-7 and pre-RC positions. Indeed, HOMER-defined Mcm2-7 
complexes and pre-RCs nearly completely overlapped with H3K4me3 
positions (88%) and ORC at least to 56,3% (Figure 4.23, left panel). In 
contrast, for T-PIC-defined peaks, ORC positions correlated to a higher 
degree with H3K4me3 peaks (14.4% of all ORC overlaps with nearly 50% 
of all H3K4me3 peaks, Figure 4.23, right panel). Mcm2-7 complexes and 
pre-RCs remained less associated. This result was also confirmed by 
analyzing the distance to H3K4me3 peak center (Appendix Figure 16, left 
panel). HOMER-defined Mcm2-7 and pre-RC completely resided in close 
proximity to the peak centers (100-1000 bp), while a subpopulation of ORC 
remained distant. The distance of all HOMER- or T-PIC-defined complexes 
to H3K36me3 remained randomly distributed. 
 
CONCORDANCE WITH PREVIOUS STUDIES AND FURTHER ANALYSES 
The regulation of transcriptional activity clearly impacts on origin licensing 
efficiencies. The comparison of HOMER- and T-PIC-defined complexes 
argues for the variability of favorable origin licensing features. Strong 
licensing depends entirely on active transcriptional regulation (association 
to TSS and H3K4me3) and thus affects the entire HOMER-defined pre-RC 
population. Regarding T-PIC-defined ORC, Mcm2-7 and pre-RC, licensing 
positions regulated by active transcription only built a sub-population of all 
T-PIC peaks and further features account for the other T-PIC-defined 
complexes. However, these features confer less localized binding of pre-RC 
components. 
Interestingly, ORC is the only HOMER-defined complex that did not entirely 
overlap with H3K4me3 peaks. This hypothesis is consistent with the fact 
that ORC also has other functions than regulating pre-RC formation, for 
instance in heterochromatin regulation (Giri et al. 2015; Giri and Prasanth 
2015). This can be tested by extracting the ORC subpopulation not 
associating with H3K4me3 and comparing these ORC positions with known 
heterochromatin regions.   
The association of active DNA replication and transcription is already widely 
proven (Martin et al. 2011; Besnard et al. 2012; Cayrou et al. 2015; Smith 
et al. 2016; Kylie et al. 2016). Furthermore, also both ChIP-seq studies 
targeting a component of ORC (Orc1: Dellino et al. 2013, Orc2: Miotto, Ji, 
and Struhl 2016), stated a close connection to transcriptional activity. 
Dellino et al. found 71% of all detected Orc1 sites at active TSS.  
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FIGURE 4.23: HOMER-DEFINED COMPLEXES NEARLY COMPLETELY OVERLAP WITH H3K4ME3 PEAKS. 
Left panel: HOMER-defined complexes, right panel: T-PIC-defined complexes. Venn diagram of the 
overlap between ORC, Mcm2-7, and pre-RC with H3K4me3 peaks. Overall counts are indicated. The 
percentages of overlapping proportions are specified below in brackets. 
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Additionally, the authors linked Orc1 sites with high transcription levels to 
early replication, while Orc1 sites with low or undetectable expression levels 
replicated late in S-phase. Thus, their study connects Orc1 sites and 
transcription with replication timing.   
Miotto et al. claim only a moderate association of Orc2 sites and active 
transcription (Pearson correlation 0.33, Miotto, Ji, and Struhl 2016). 
Considering ~52000 detected Orc2 sites and roughly 20000 human genes, 
of which maybe half are transcriptionally active, only 0
1
 of all Orc2 peaks 
could actually correlate with active transcription and a correlation coefficient 
of 0.33 should be judged as good. Re-analyzing their data and sorting Orc2 
peaks for strong and weak enrichments might also connect strong Orc2 
binding to active TSS. I intend to directly correlate their Orc2 peak positions 
with my HOMER- and T-PIC defined ORC, Mcm2-7, and pre-RC, to get an 
idea of concordance of the experiments. The authors claim that DNA 
accessibility is the main determinant of Orc2 positions. Consequently, they 
found Orc2 in promoters and regions enriched for active chromatin marks 
(H3K27ac, H3K4me1/2/3), consistent with my own results.  
Very recently, Smith et al. compared active replication in different human 
cell types and differentiation states and found mostly conserved replication 
origins associated with H3K4me3 (Smith et al. 2016). Also Cayrou et al. 
linked active replication to histone modifications favoring open chromatin 
(H3K4me, H3K9Ac, Cayrou et al. 2015). These findings suggest H3K4me3 
being a histone modification that contributes to an accessible chromatin 
environment for strong pre-RC binding and thus efficient replication 
initiation.   
The general question remains whether transcriptional activity positively or 
negatively influences origin licensing and activation. While it is evident that 
active transcription creates a chromatin environment also accessible for 
replication factors, multiple studies mutually exclude high transcription 
rates and efficient replication (Nieduszynski, Blow, and Donaldson 2005; 
Mori and Shirahige 2007; Lõoke et al. 2010; Martin et al. 2011). My results 
imply, that actively transcribed genes are indeed devoid of pre-RC 
components (absent pre-RC coverage at H3K36me3 peaks, Appendix Figure 
15), while pre-RCs are mostly found at active TSS (Figure 4.19) and 
promoter regions harboring active histone modification marks (H3K4me3, 
Figure 4.22). It has been reported that replication initiation events 
themselves are absent from TSS, but enriched in adjacent sequences 
(Martin et al. 2011). Petryk et al. found early replicating initiation zones 
predominantly flanked by actively transcribed genes, while many 
termination zones overlap active genes. Assuming that ORC is mostly found 
at initiation zone borders (as shown for Orc1, Dellino et al. 2013; Petryk et 
al. 2016), and Mcm2-7 helicases move from their initial loading site, one 
could hypothesize that transcription and RNA polymerase II action promote 
Mcm2-7 removal from actively transcribed genes.    
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RNA polymerase dependent Mcm2-7 double-hexamer sliding has indeed 
been shown by Gros et al. 2015 in budding yeast. The authors found that 
RNA polymerase II can push Mcm2-7 double-hexamers along the DNA, 
without them losing initiation potential. Also in Leishmania major, it has 
recently been demonstrated that most replication initiation sites are found 
at sites of RNA polymerase II stalling or transcriptional termination, arguing 
for co-migration of Mcm2-7 helicases and the transcriptional machinery 
(Lombraña et al. 2016). Furthermore, Powell et al. demonstrated by ChIP-
seq studies in Drosophila melanogaster, that Mcm2-7 helicases are evenly 
distributed throughout the genome in G1/S transition, but absent in actively 
transcribed genes (Powell et al. 2015). Thereby, an active transcription 
process is required for Mcm2-7 displacement from gene bodies. The authors 
propose Mcm2-7 residing in transcribed genes being displaced by the 
passage of RNA polymerase II.  
Absence of Mcm2-7 helicases at actively transcribed genes would 
explain active genes being favored zones of replication termination (Petryk 
et al. 2016). This model would situate ORC localizing at accessible regions, 
like TSS, and thus initiation zone boundaries. ORC loads Mcm2-7 helicases, 
which are subsequently translocated by active transcription into gene-
adjacent regions, defining replication initiation zones detected by Okazaki-
fragment sequencing. This RNA polymerase II-dependent translocation 
mechanism would also avoid head-to-head collisions of replication fork and 
the transcriptional machinery, preventing sources of replication fork stalling 
or DNA damage. Moreover, G4 structures might block Mcm2-7 helicase 
sliding, possibly explaining why G4 structures are found enriched at active 
replication origins (Besnard et al. 2012). The mechanism of Mcm2-7 
dislocation would include displacement or reassembly of nucleosomes and 
other DNA-binding proteins, which seems laborious for the cell and needs 
further investigation.  
CONCLUSION 
Pre-RC or replication origin association to the regulation of active 
transcription is generally accompanied by early replication timing. My 
results showing strong pre-RC binding at active TSS provoke the speculation 
whether active TSS are early replicated because of strong pre-RC binding. 
Miotto et al. used mathematical modeling to correctly predict replication 
timing dependent on ORC densities (Miotto, Ji, and Struhl 2016). As higher 
ORC densities presumably also result in more Mcm2-7 helicases, the 
probability of origin firing events increases, resulting in early replication. 
Replication timing domains are concordant with topologically associating 
domains (TADs), whose borders also might limit the Mcm2-7 helicase sliding 
to restricted domains.  
Consequently, active chromatin environment positively influences 
ORC binding probabilities, which leads to more Mcm2-7 helicase loading. 
These helicases are translocated from their original binding sites by 
transcription machineries, which is the reason for replication initiation not 
taking place within genes, but adjacent to them. The more accessible 
chromatin is, the higher ORC/Mcm2-7 densities may become, the higher 
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the probability for licensed origins to fire, the earlier replication origins are 
activated.  
 MCM2-7 HELICASES APPROXIMATE ORC IN S/G2 
Origin licensing can only happen in late mitosis/ early G1, when CDK and 
DDK activities are low. After ORC binding to DNA, Cdc6 and Cdt1 are 
required for further Mcm2-7 double-hexamer loading. Once a replication 
origin is activated, the helicases move as part of the replication forks, until 
replication termination and helicase dissociation. 
I chose the S/G2 time-point during the cell cycle as a control for my ChIP 
experiments, assuming that replication complexes either dissociate because 
of their replication activity, or passively, when replication forks move 
through inactive licensing complexes, thereby removing them from DNA 
(Kuipers et al. 2011). As a consequence, and as observed at oriP, I expected 
less Mcm2-7 binding to chromatin sites, resulting in less peak-algorithm 
defined complexes.  
4.4.1 COMPLEX NUMBER AND SIZES DO NOT CHANGE IN S/G2 
S/G2 pre-RC-ChIPs were performed in parallel to the G1 ChIPs and 
sequenced comparably. I analyzed the data as described previously and 
performed HOMER and T-PIC peak-calling, starting with comparing the 
number and positions of detected HOMER- or T-PIC-defined complexes in 
G1 and S/G2.  
For both HOMER-defined complexes, as well as T-PIC-defined complexes, 
neither the peak number nor the peak sizes changed considerably (Figure 
4.24, for EBV genome, see Appendix Figure 17 A and B). Opposing to what 
was expected, there were even more HOMER-defined strong Mcm2-7 
complexes detected in S/G2, which consequently resulted in slightly more 
defined pre-RCs (Figure 4.24 A). As for T-PIC-defined complexes, there was 
a minor reduction in the number of defined complexes observed (Figure 
4.24 B). Comparing the positions of the defined-complexes between G1 and 
S/G2 on the EBV genome revealed a strong conservation (Appendix Figure 
17 C). Also for the human genome, the majority of the HOMER-defined 
complexes in G1 are conserved in S/G2 (> 60%, Figure 4.25, left panel). 
Because more HOMER-defined Mcm2-7 positions were detected in S/G2, 
many new pre-RC sites were also determined.  
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FIGURE 4.24: DEFINED COMPLEXES DO NOT DIFFER IN NUMBER OR SIZE WHEN COMPARING G1 VS. 
S/G2. A) HOMER-DEFINED COMPLEXES. B) T-PIC-DEFINED COMPLEXES. Left: Number of defined ORC, 
Mcm2-7 and pre-RC was plotted as indicated in a bar chart in G1 vs. S/G2. Right: Complex sizes 
were potted as boxplot in G1 vs. S/G2. Thick line shows the median, the box is the distribution from 
the first to the third quartile, the whiskers indicate the smallest and largest value without being an 
outlier. Outliers represented by dots.    
A) 
B) 
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FIGURE 4.25: COMPARISON OF HOMER- AND T-PIC-DEFINED COMPLEX POSITIONS IN G1 VS. S/G2. Left: 
HOMER-defined complexes, right: T-PIC-defined complexes. Venn diagram of overlap between G1-
defined ORC, Mcm2-7, and pre-RC with the same complexes defined in S/G2. Overall counts are 
indicated. The percentage of overlapping proportions are specified below in brackets. 
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Concerning T-PIC-defined complexes, the situation was less pronounced. 
While there was a considerable conservation of ORC and pre-RC positions 
observed (>55% of S/G2 complexes overlap with G1 positions, Figure 4.25, 
right panel), this was not the case for Mcm2-7 (< 30% overlap of S/G2 
positions with G1). The reduction of the number T-PIC-defined complexes 
in S/G2 can be explained by a decrease in global protein binding. This 
reduced binding resulted in a more dispersed signal that did not meet the 
criteria for significant peak detection. However, observed reduction of 
defined T-PIC complexes was relatively unimportant, as a significant 
number of ORC, Mcm2-7, and pre-RCs were still detected in S/G2, indicating 
that a considerable amount of pre-RC proteins were still bound to DNA at 
this cell cycle stage. Moreover, I detected an increased amount of HOMER-
defined Mcm2-7 complexes and pre-RCs, arguing for an increased strong 
binding of Mcm2-7 proteins at defined positions in S/G2. 
I further analyzed the association of S/G2 ORC, Mcm2-7 and pre-RC with 
replication, transcription and active histone marks. In G1, pre-RC coverage 
was detected at replication initiation zones and specifically depleted from 
replication termination zones. In S/G2, after passage of the replication 
forks, I would expect a flat signal for both replication zones.  
4.4.2 MCM2-7 COVERAGE AT AS AND DEPLETION FROM DS ARE LESS 
PRONOUNCED 
Coverage analysis is a measure of global changes in binding of the single 
pre-RC components to certain features. A direct comparison of the 
maximum read coverage at AS is shown in Table 4.2, p. 89. While pre-RC 
coverage at AS decreased in S/G2, especially for Mcm2-7 components (for 
Mcm3: from 0.8 reads/base in G1 to 0.3 reads/base in S/G2, for Mcm7: 
from 0.5 reads/base in G1 to 0.3 reads/base in S/G2), coverage at DS 
seems less depleted (Figure 4.26). Also the quantification of T-PIC-defined 
ORC, Mcm2-7 and pre-RC densities revealed no major change of ORC 
densities at AS or DS, but a decrease in the remaining genomic regions 
(Appendix Figure 18 B). Mcm2-7 densities however showed an increase at 
DS, while AS and the remaining genome remain unchanged (Appendix 
Figure 18 C). These density shifts of ORC and Mcm2-7 resulted in pre-RC 
density reductions mostly at the remaining genome (Appendix Figure 18 A). 
These observations indicate T-PIC-defined ORC positions to only marginally 
change within AS or DS, but that the reduction of ORC numbers in S/G2 
essentially concerned the remaining genome. T-PIC-defined Mcm2-7 
complex densities and Mcm2-7 coverage rather indicate that Mcm2-7 
proteins were less present at AS and less absent from DS in S/G2. 
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It has already been shown in chromatin binding experiments based on cell 
cycle fractionation by centrifugal elutriation, that ORC still binds chromatin 
in S/G2, while Mcm3 and Mcm7 binding generally decreases (Ritzi et al. 
2003). Indeed, while Orc2 and Orc3 coverage profiles are very similar in G1 
and S/G2 (compare Figure 4.18 and Figure 4.26), Mcm3 and Mcm7 profiles 
assimilate Orc2/3 profiles, which involves decreased coverage at AS and 
less depletion from DS.  
Pre-RC ChIP-seq experiments in Drosophila cells showed that minimal 
Mcm2-7 double-hexamer loading can occur in absence of cyclin E (main 
regulator of S-phase entry), while maximal loading coincides with G1/S 
transition. Minimal loading strictly depends on ORC, while maximal Mcm2-
7 helicase loading during G1/S coincides less with ORC positions (Powell et 
al. 2015). It is possible that my pre-RC coverage profiles in S/G2 reflect 
minimal Mcm2-7 loading, strictly dependent on ORC, which might be the 
reason for both ORC and Mcm2-7 profiles becoming similar. 
ORC generally binds in accessible regions, the reason for ORC being mostly 
detected at TSS or H3K4me3 enriched regions (chapter 4.3, p. 72ff). If 
minimal Mcm2-7 double-hexamer loading in S/G2 strictly depends on ORC, 
I expect an increased Mcm2-7 coverage at these accessible regions. 
4.4.3 PRE-RC COVERAGE AT TSS AND H3K4ME3 WAS INCREASED IN S/G2 
When calculating the coverage of pre-RC subcomponents at active TSS, 
their association was generally increased (Table 4.2, Orc2 coverage from 
2.9 reads/base in G1 to 3.5 reads/base in S/G2, Orc3 coverage from 4.2 
reads/base in G1 to 5.1 reads/base in S/G2, Mcm3 coverage from 1.5 
reads/base in G1 to 2.8 reads/base in G2, Mcm7 from 3.3 reads/base in G1 
to 4.4 reads/base in G2; compare Figure 4.19 (G1) with Figure 4.27 
(S/G2)). This enhancement was more prominent for Mcm3 and Mcm7 (> 1 
read/base). Enhanced Mcm2-7 binding was also detected by HOMER peak-
calling. Strong HOMER peaks were shown to preferentially locate close to 
active transcription sites (Figure 4.20, left panel; Figure 4.23, left panel; 
Appendix Figure 11 A; Appendix Figure 16, left panel) consistent with these 
results.  
H3K4me3 peaks were also more covered by pre-RC components in S/G2 
(Table 4.2, Orc2 coverage from 2.8 reads/base in G1 to 3.8 reads/base in 
S/G2, Orc3 coverage from 3.3 reads/base in G1 to 4.3 reads/base in S/G2, 
Mcm3 coverage from 1.5 reads/base in G1 to 2.5 reads/base in S/G2, Mcm7 
from 2.5 reads/base in G1 to 3.2 reads/base in S/G2; compare Figure 4.22 
(G1) with Appendix Figure 19 (S/G2)).  
 
 
FIGURE 4.26: PRE-RC COMPONENT COVERAGE (S/G2) AT AS (LEFT PANEL) AND DS (RIGHT PANEL). A) 
MEAN ORC2 S/G2 COVERAGE. B) MEAN ORC3 S/G2 COVERAGE. C) MEAN MCM3 S/G2 COVERAGE. D) 
MEAN MCM7 S/G2 COVERAGE.  Coverage was calculated as number of reads/base within a 200 kb 
window around AS/ DS region center. Input was plotted as control (grey). 
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TABLE 4.2: DIRECT COMPARISON OF MAXIMUM MEAN READ COVERAGE AT REGIONS OF INTEREST IN 
G1 VS. S/G2. Mean read coverage is specified in reads/base.   
 G1 S/G2 Difference 
Initiation 
zones 
(AS) 
Orc2 0.5 0.4 - 0.1 
Orc3 0.5 0.5 0 
Mcm3 0.8 0.3 - 0.5 
Mcm7 0.5 0.3 - 0.2 
TSS 
Orc2 2.9 3.5 + 0.6 
Orc3 4.2 5.6 + 1.4 
Mcm3 1.5 2.8 + 1.3 
Mcm7 3.3 4.4 + 1.1 
H3K4me3 
Orc2 2.8 3.8 + 1.0 
Orc3 3.3 4.3 + 1.0 
Mcm3 1.5 2.5 + 1.0 
Mcm7 2.5 3.2 + 0.7 
 
When directly comparing HOMER- and T-PIC-defined pre-RC positions 
overlapping with H3K4me3 peaks, it became evident that the S/G2 HOMER-
defined pre-RCs still mainly overlap with H3K4me3 (Appendix Figure 20, 
left panel; for ORC and Mcm2-7, see Appendix Figure 21). Thereby, also a 
higher proportion of T-PIC-defined pre-RCs associated with H3K4me3 in 
S/G2 (Appendix Figure 20, right panel). 
These observations lead to the conclusion that, while HOMER-defined 
complexes are still related to active transcription in S/G2, T-PIC-defined 
complexes seem also to locate more towards actively transcribed regions in 
S/G2. This hypothesis was also confirmed by analyzing the genomic 
distribution of HOMER- and T-PIC defined pre-RCs (Appendix Figure 22).   
These results indicate that the distribution of Mcm2-7 complexes changed 
in S/G2. The enrichment in active replication sites decreased as well as the 
specific depletion from replication termination sites was less detectable. 
Moreover, the association of Mcm2-7 to active transcription notably 
increased. One possible explanation for these observations is Mcm2-7 being 
loaded on DNA without sliding away from their loading site. This possibly 
reflects an early time point of Mcm2-7 loading and would result a higher 
similarity between ORC and Mcm2-7 helicases in S/G2. 
 
FIGURE 4.27: PRE-RC PROTEIN COVERAGE INCREASED AT ACTIVE TSS IN S/G2. A) MEAN ORC2 S/G2 
COVERAGE. B) MEAN ORC3 S/G2 COVERAGE. C) MEAN MCM3 S/G2 COVERAGE. D) MEAN MCM7 S/G2 
COVERAGE. Coverage was calculated as number of reads/base within a 4000 bp window around TSS. 
Input was plotted as control (grey). Active TSS (left) inactive TSS (right). 
  4. RESULTS AND DISCUSSION 
90 | 
 
4.4.4 MCM2-7 HELICASES APPROXIMATE ORC POSITIONS IN S/G2 
To evaluate the relation between ORC and Mcm2-7 peak positions, I 
calculated the Jaccard index as explained in Figure 4.9 A and represented 
similarities in a heatmap (Figure 4.28). For both HOMER- and T-PIC-defined 
complexes, highest similarities were obtained when comparing each 
complex between G1 and S/G2 (highlighted as red boxes in Figure 4.28), 
consistent with complex positions being conserved for up to 80% (as shown 
in Figure 4.25). Only T-PIC defined Mcm2-7 showed little similarity between 
G1 and S/G2, as expected from previous results. However, similarities 
between ORC (S/G2) and Mcm2-7 (S/G2) increased (green boxes in Figure 
4.28) compared to ORC (G1) and Mcm2-7 (G1). These results confirm 
Mcm2-7 positions approximating ORC positions in S/G2.      
 
FIGURE 4.28: MCM2-7 APPROXIMATED ORC IN S/G2. T-PIC- and HOMER-defined ORC and Mcm2-7 
complex similarities represented as heatmap of Jaccard indices (G1 vs. S/G2). Dark red indicates 
high similarities while lighter red marks differences. Each complex generally tends to cluster together 
when comparing G1 vs. S/G2 (marked by red boxes). Mcm2-7 similarity to ORC increases in S/G2 
(green boxes).  
POSSIBLE REASONS FOR PREMATURE MCM2-7 BINDING AND ANTICIPATED 
VALIDATION 
During my analyses it became evident, that Mcm2-7 peak-calling does not 
necessarily lead to meaningful biologically relevant results. Due to the 
discussed Mcm2-7 sliding process, Mcm2-7 complexes may become 
undetectable by peak-calling algorithms. HOMER detects only 
accumulations of Mcm2-7, probably reflecting their initial loading sites. 
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Apparently, Mcm2-7 helicases are more dynamic in G1 (very low number 
(322) of strong HOMER-defined Mcm2-7), while they seem to be more 
localized in S/G2 (3x more HOMER-defined Mcm2-7 (1002), Figure 4.24 A).  
Thereby, most HOMER-defined Mcm2-7 from G1 are conserved in S/G2 
(88.5%, Figure 4.25, left panel). In contrast, T-PIC is more sensible for 
detecting protein enrichments. It obviously detects HOMER-defined peaks 
(Figure 4.13, Appendix Figure 6), but also identifies regions of lower 
intensities, presumably sites of Mcm2-7 helicase spreading. However, this 
sensible detection can explain low reproducibility of detected peak positions, 
as stochastic Mcm2-7 helicase sliding is not necessarily always detected at 
similar sites.  
Originally, I planned to use ChIP-seq data from the S/G2 cell cycle phase 
as negative control for my experiments. Interestingly, my analyses in S/G2 
provided insights in previously unknown Mcm2-7 DNA binding processes 
happening after origin firing, and it seems that pre-RC proteins are not 
completely dissociated from DNA in post-replicative cell cycle stages. While 
association of Mcm2-7 to replication units were reduced, ORC and Mcm2-7 
were preferentially found at regions of active transcription. Thereby, Mcm2-
7 showed a higher similarity to ORC positions in S/G2, than in G1. 
Consequently, these results suggest an early origin licensing state, with 
licensing first taking place at accessible regions and Mcm2-7 helicases still 
localizing at their loading sites. 
Origin licensing is generally prevented in G2. Major licensing block is the 
inhibition of the Mcm2-7 chaperone Cdt1 (Ballabeni et al. 2004). Cdk2 
(highest expression in G2) phosphorylates Cdt1, thereby targeting it for 
degradation (Blow and Dutta 2005). Furthermore, Geminin inactivates Cdt1 
during G2 and mitosis. Consequently, Mcm2-7 loading can only take place 
in late mitosis/early G1.  
The observation of Mcm2-7 loading in S/G2 might be explained by an 
elevated contaminating mitotic cell population. Thus, I need to more 
precisely define the exact cell cycle stage of my S/G2 population. Although 
centrifugal elutriation is routinely used in my laboratory and has been 
extensively characterized (Ritzi et al. 2003; Papior 2010), FACS analysis 
(Figure 4.2) is not sufficient to confirm the precise cell cycle stage. 
Expression of Cdt1 itself, as well as cell cycle markers cyclin E (S-phase), 
cyclin B (mitosis) and Histone 3 Serine 10 phosphorylation (additional 
mitotic marker) has to be determined by immunoblot, to deduce the portion 
of mitotic cells. Depending on the result, two scenarios are conceivable: i) 
in my S/G2 population, a considerable number of cells already progressed 
to mitosis, thus allowing origin licensing, and ii) my S/G2 population reflects 
indeed a time-point after DNA replication, indicating that residual origin 
licensing could occur earlier than expected.    
In Drosophila melanogaster, minimal Mcm2-7 loading can occur in absence 
of cyclin E/Cdk2 activity, while the full complement of Mcm2-7 requires 
cyclin E/Cdk2 kinase activity during G1/S transition (Powell et al. 2015). 
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The authors propose loading of the full Mcm2-7 complement being 
dependent on a second wave of Cdc6 expression during G1/S transition 
(Clijsters and Wolthuis 2014), which is stabilized by cyclin E/Cdk2 kinase 
activity. Alternatively, minimal loading of Mcm2-7 helicases themselves 
might promote full Mcm2-7 loading, by a direct Mcm2-7-cyclin E-Cdt1 
interaction (Geng et al. 2007; Powell et al. 2015). These experiments were 
performed in Drosophila Kc and S2 cell lines, treated with several RNAi and 
chemicals to induce cell cycle arrests at precise stages (early G1, G1 phase, 
and at G1/S transition). These treatments resulted in an unambiguous 
phenotype, with minimal Mcm2-7 loading in mitosis/early G1 and full Mcm2-
7 complement in G1/S. Subsequent ORC and Mcm2-7 ChIP-seq also clearly 
revealed ORC and Mcm2-7 co-localization in late mitosis/early G1, whereas 
little overlap was detected in G1/S. Cell cycle fractionation has the 
advantage of performing similar experiments without any chemical 
manipulation that might induce various biases. However, the cell cycle 
fractions I worked with were not as well defined as specifically arrested 
cells. Still, I observe similar phenomena: although I did not detect less 
loaded Mcm2-7 in S/G2 compared to G1, Mcm2-7 positions were more 
precisely associated to transcriptional regulation and approximated ORC. 
The fact that the amount of detected Mcm2-7 was not reduced in my 
experiments in S/G2 can be explained by diluted cell populations, with 
contaminating G1 and mitotic cell stages. However, closer association of 
Mcm2-7 to transcriptional regulation and ORC argues for an early stage of 
Mcm2-7 loading, before spreading occurs. 
Taken together, pre-RC ChIP-seq results in S/G2 populations suggest that 
full pre-RC formation is necessary for Mcm2-7 helicase loading, 
preferentially occurring at sites of transcriptional regulation. The exact cell 
cycle stage needs to be further characterized by assessing cyclin 
expression, but a combination of cyclins already allowing origin licensing is 
expected. Mcm2-7 positions differ between G1 and S/G2, arguing for Mcm2-
7 spreading with onset of G1 phase.    
CONCLUSION 
Pre-RC ChIP-seq experiments in G1 and S/G2 cell cycle stages and their 
analyses at replication initiation/termination zones and regions of active 
transcription regulation allowed to obtain a genome-wide representation of 
origin licensing dynamics. Interestingly, Mcm2-7 helicases emerge to be the 
sole determinant of replication origins (as proposed first in Xenopus (Lucas 
et al. 2000; Hyrien, Marheineke, and Goldar 2003; Woodward et al. 2006) 
and recently also claimed in yeast (Das et al. 2015) and Drosophila (Powell 
et al. 2015)). While pre-RC formation is mandatory for Mcm2-7 double-
hexamer loading, further Mcm2-7 spreading prior to S phase argues for 
replication initiation being independent of complete pre-RC. This scenario 
would explain low redundancies between ORC positions and active 
replication data (Miotto, Ji, and Struhl 2016; Petryk et al. 2016).  
This study describes the first genome-wide ChIP-seq analysis of ORC and 
Mcm2-7 components in humans. Thereby, these components correlated 
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with zones of active replication initiation, while being specifically depleted 
from replication termination zones. Actively transcribed genes often 
constitute termination zones, leading to the hypothesis that active 
transcription relegates Mcm2-7 helicases to gene-adjacent regions. In 
S/G2, the specific depletion from termination zones was less pronounced, 
while association to ORC and active transcription increased. Assuming that 
S/G2 populations represent a cell stage allowing early replication licensing, 
these results possibly reflect the initial loading of Mcm2-7 helicases, before 
spreading occurs. Mcm2-7 spreading might only occur with sufficient Mcm2-
7 helicases loaded, and possibly in presence of cyclin E/Cdk2 activity. Also, 
chromatin anchorage after mitosis might account for Mcm2-7 positions. In 
eukaryotes, replication timing is established prior to origin selection 
(Rivera-Mulia and Gilbert 2016b). The timing decision point coincides with 
re-organization of chromatin into TADs/replication domains after mitosis. If 
Mcm2-7 helicases were loaded at ORC sites prior to timing decision point 
and spreading took place after chromatin anchorage, Mcm2-7 density would 
be higher in gene dense TADs, while it would be lower in gene poor TADs. 
Assuming that Mcm2-7 dense regions stochastically replicate earlier that 
Mcm2-7 poor regions, this model would link replication timing to regulation 
of transcriptions and chromatin environment. 
Compartmentalization also localizes heterochromatin TADs towards the 
nuclear lamina. Heterochromatin is generally replicated late in S phase, 
indicating that despite a gene-poor environment, efficient origin licensing 
occurs. In these compartments, chromatin accessibility is most likely not 
the main determinant of ORC binding and origin licensing, implicating other 
mechanisms.  
One possible candidate is H4K20 methylation, as two methylation stages, 
H4K20me1 and H4K20me3, have already been shown be relevant for 
replication regulation. However, the exact mechanism of H4K20 
methylation action is elusive.   
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 ORC ASSOCIATES WITH H4K20ME3 IN HETEROCHROMATIN 
Cell cycle-dependent regulation of histone 4 lysine 20 
monomethyltransferase PR-Set7 renders H4K20 methylation a promising 
histone modification to affect DNA replication. Furthermore, stabilization of 
PR-Set7 (by expressing non-degradable PR-Set7PIPmutant in cells) leads to 
DNA re-replication, suggesting that origins are re-licensed and re-activated 
within one cell cycle, if correct regulation of PR-Set7 activity is hampered 
(Tardat et al. 2010; Beck et al. 2012). Consequently, H4K20 methylation 
seems to directly link chromatin regulation and replication licensing and/or 
activation. For this reason, I performed H4K20me1 and H4K20me3 ChIPs 
in parallel to pre-RC component ChIPs, to anticipate the role of H4K20 
methylation in origin licensing. 
4.5.1 H4K20ME1 IS PRESENT IN ACTIVE CHROMATIN WHILE H4K20ME3 
LOCALIZES TO HETEROCHROMATIN REGIONS 
In collaboration with Eric Julien (Chromatin and Cancer, IRCM, Montpellier) 
and Jean-Charles Cadoret (Pathology of DNA Replication, Institut Jaques 
Monod, Paris), H4K20me1 and –me3 were recently assessed genome-wide 
in U2OS cells. This study revealed H4K20me1 being a histone modification 
present in active chromatin regions, while H4K20me3 was rather associated 
with heterochromatin domains (Figure 4.29). These analyses were 
performed by calculating H3K36me3 (active chromatin) or H3K9me3 
(heterochromatin) ChIP-seq read coverage at H4K20me1 or –me3 peaks. 
Thereby, H4K20me1 sites were increasingly covered by H3K36me3 while 
H3K9me3 was enriched at H4K20me3 sites (analysis performed by Jean-
Charles Cadoret).   
H4K20me1 and –me3 ChIPs were performed in parallel to pre-RC 
component ChIPs in both G1 and S/G2 Raji cells in triplicates (qPCR 
validation Figure 4.4). Subsequent peak-calling was performed using the 
HOMER algorithm and the specific “histone” setting. This setting takes the 
possibility into account that histone modification ChIPs can result in broader 
peaks. Only peak positions present in all three triplicates were retained. The 
resulting peaks were around 2000 bp wide for both histone modifications, 
with both H4K20me1 and –me3 ranging from 200 bp to 88000 bp (Appendix 
Figure 23 A).  
H4K20me1 and –me3 positions in either euchromatic or heterochromatic 
regions already suggest mutual exclusivity of both histone modifications. 
When calculating the overlap of H4K20me1 and –me3 peaks, this 
assumption was confirmed by only ~ 1% of overlapping peaks (Appendix 
Figure 23 B). This result clearly situated both H4K20me1 and –me3 
individually in their respective chromatin environment, without any 
redundancies. 
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FIGURE 4.29: H4K20ME1 IS PRESENT IN ACTIVE CHROMATIN, WHILE H4K20ME3 CORRESPONDS TO 
HETEROCHROMATIN. Coverage of either H3K36me3 (active chromatin) or H3K9me3 (silent 
chromatin) ChIP-seq reads was calculated at H4K20me1/ -me3 peak sites and plotted as boxplot.  
* indicates statistical significance with p-value < 0.05 (Brustel et al., in preparation).  
4.5.2 ORC PREFERENTIALLY ASSOCIATES WITH H4K20ME3 
Coverage of pre-RC components was calculated at either H4K20me1 or –
me3 sites, to get a first impression of a direct association of either histone 
modification with pre-RC. All pre-RC components Orc2, Orc3, Mcm3, and 
Mcm7 were not particularly enriched at H4K20me1 sites (Figure 4.30). 
Accordingly, also HOMER- and T-PIC-defined ORC, Mcm2-7 and pre-RCs 
hardly overlapped with H4K20me1 (Appendix Figure 24).     
H4K20me3 sites however, were significantly enriched in pre-RC coverage, 
especially by Orc2 and Orc3, and to a substantial lesser extend by Mcm3 
and Mcm7 (Figure 4.31). Also when analyzing the overlaps of ORC, Mcm2-
7 and pre-RC with H4K20me3, especially ORC partially overlapped with 
H4K20me3, while Mcm2-7 and pre-RC showed little association (Figure 
4.32). An IGB profile of such an ORC co-localization with H4K20me3 is 
shown in Appendix Figure 25. 
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FIGURE 4.30: COVERAGE OF PRE-RC COMPONENTS (G1) AT H4K20ME1 PEAKS. A) MEAN ORC2 
COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE. 
Coverage was calculated as number of reads/base within a 6 kb window around H4K20me1 peak 
center. Input was plotted as control (grey). 
  
A) B) 
D) C) 
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FIGURE 4.31: ORC SHOWED INCREASED COVERAGE AT H4K20ME3 PEAKS. A) MEAN ORC2 COVERAGE. 
B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE. Coverage was 
calculated as number of reads/base within a 6 kb window around H4K20me3 peak center. Input was 
plotted as control (grey). 
 
A) B) 
D) C) 
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FIGURE 4.32: MOSTLY HOMER- (LEFT) AND T-PIC- (RIGHT) DEFINED ORC OVERLAPPED WITH H4K20ME3. 
Left: HOMER-defined complexes, right: T-PIC-defined complexes. Venn diagram of overlap between 
HOMER- and T-PIC-defined ORC, Mcm2-7 and pre-RCs with H4K20me3 peaks. Overall counts are 
indicated. The percentage of overlapping proportions are specified below in brackets. 
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4.5.3 NO DISTRIBUTIONAL CHANGE WAS OBSERVED IN S/G2  
H4K20 methylation ChIPs analyzed so far were performed in G1 cell cycle 
stage. As PR-Set7 is cell cycle dependently regulated, with degradation 
during S phase and a subsequent decrease of H4K20me1, I was wondering 
how H4K20 methylation peaks and the observed associations were 
modulated in S/G2.   
In general, detected number of H4K20me1 and –me3 peaks decreased in 
S/G2 compared to G1. This observation was more prominent for H4K20me1 
(from 7820 peaks in G1 to 1700 peaks in S/G2), than for H4K20me3 (from 
11709 peaks in G1 to 5560 peaks in S/G2). Thereby, most of the peaks 
detected in S/G2 overlapped with G1 peaks (> 84%, Appendix Figure 26), 
arguing for a dilution of H4K20 methylation during replication, which led to 
weaker ChIP signals, presumably below the threshold for peak-calling. This 
was also reflected by a decrease of H4K20 methylation coverage at their 
own respective G1 peaks (Appendix Figure 27). Again, H4K20me1 seemed 
to be more affected than H4K20me3, where no obvious coverage change 
was detected.     
Neither coverage of any pre-RC component, nor peak positions relative to 
either H4K20 methylation changed considerably in S/G2 (data not shown), 
indicating that no major licensing mechanism relies on the cell-cycle 
distribution of H4K20me1/ -me3. 
POSSIBLE MECHANISMS UNDERLYING ORIGIN LICENSING IN HETEROCHROMATIN 
Previous reports suggest that PR-Set7 and subsequent induction of 
H4K20me1 undoubtedly affects origin licensing and activation. An extensive 
genome-wide SNS-seq study correlating active replication with histone 
modifications claimed H4K20me1 associating with 50% of initiation sites, 
being one of the potential key regulators of replication (Picard et al. 2014). 
However, pre-RC coverage at H4K20me1 sites was not majorly enriched. 
This is in line with other genome-wide studies that did not find any 
associations between H4K20me1 and replication (Fu et al. 2013; Cayrou et 
al. 2015; Smith et al. 2016; Miotto, Ji, and Struhl 2016). By contrast, ORC 
coverage was clearly enriched at H4K20me3 sites, Mcm3 and Mcm7 
coverage to a lesser extent. This is in accordance with ORC directly 
interacting with H4K20me2/3, most probably through the BAH domain of 
Orc1 (Kuo et al. 2012; Beck et al. 2012). ORC interaction with 
heterochromatin has already been reported repeatedly in yeast and 
Drosophila (Micklem et al. 1993; Pak et al. 1997; Shareef, Badugu, and 
Kellum 2003; Leatherwood and Vas 2003; Shen et al. 2010). Thereby, ORC 
was attributed a chromatin silencing function independent of origin licensing 
(Dillin and Rine 1997; Leatherwood and Vas 2003). Regarding the low 
Mcm2-7 coverage enrichment, this might be an explanation for ORC – but 
not Mcm2-7 – associating with H4K20me3. However, dynamics of Mcm2-7 
loading might also be different in heterochromatin and little Mcm2-7 is still 
sufficient for efficient replication initiation. Consequently, I examined 
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whether ORC association to heterochromatin H4K20me3 was indeed linked 
to origin replication licensing and activation. 
 H4K20ME3 IS NECESSARY FOR ORIGIN LICENSING AND 
ACTIVATION IN HETEROCHROMATIN 
The association of ORC with H4K20me3 is not necessarily linked to 
replication licensing function of ORC. Mcm2-7 helicases seemed to be less 
present at H4K20me3 sites, than ORC (Figure 4.31), eventually arguing for 
a heterochromatin organization function of ORC.  I used the replication of 
the well-characterized autosomal plasmid system of the Epstein-Barr virus 
latent origin oriP (herein after called FR-DS, Hammerschmidt and Sugden 
2013) to functionally validate the role of ORC and H4K20me3 association. 
Contrarily to genome-wide analysis or genomic integration sites, this model 
system with defined genetic background allows the analysis of single 
aspects in the replication initiation process. The strategy was to specifically 
induce H4K20me3 at a distinct targeting site on the plasmid and to assess 
the effect on licensing and replication activity by ChIP-qPCR and plasmid 
abundance. For autonomous replication and segregation of FR-DS plasmids, 
the EBV viral protein EBNA1 needs to be expressed by the cells (Figure 
4.33 A). By binding of EBNA1 to the FR element, plasmids are tethered to 
the host chromatin conferring mitotic stability. EBNA1 binding to the DS 
element recruits ORC, which leads to the formation of an efficient internal 
origin of replication. Different reporter plasmids were generated: 
Introducing an upstream activation sequence (UAS) of the Gal4-UAS 
targeting system downstream of FR allows the specific targeting of 
Gal4(-fusion) proteins. DS can be removed or replaced by a 300 bp 
fragment of the human endogenous origin oriRDH, proven to also support 
autonomous plasmid replication, however less efficiently than DS (Gerhardt 
et al. 2006, described as ori6).  
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B) 
FIGURE 4.33: SCHEMATIC REPRESENTATION OF EXPERIMENTAL SETUP. A) EBV-DERIVED AUTOSOMAL 
REPORTER PLASMID SYSTEM. Five EBV-derived reporter plasmids are segregated throughout cell 
division by EBNA1-mediated tethering to host chromatin. Introduction of UAS sequence allows 
specific targeting of Gal4(-fusion) proteins. The internal replicator DS was removed or replaced by 
the human endogenous origin oriRDH. DNA fragments amplified by qPCR are indicated in red. B) 
PLASMID ABUNDANCE EXPERIMENTS. Experiments were conducted in HEK293 cells stably expressing 
EBNA1 and the indicated Gal4(-fusion) proteins. 1µg of reporter plasmids were transfected in the 
cells, kept replicating for 6 days and isolated from the cells by the HIRT protocol, specifically enriching 
for low molecular weight DNA. DpnI digest removes bacterial-derived input plasmids and DpnI-
resistant plasmids were electroporated in E.coli DH10B. Bacterial colony quantification is a direct 
measure of plasmid numbers. 
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FIGURE 4.34: GENERATION OF HEK293 EBNA1+ GAL4 (-FUSION) CELL LINES. pcDNA3_Zeo expression 
plasmids carrying the Gal4(-fusion) protein cassettes (obtained from E. Julien, IRMB, Montpellier) 
were linearized and transfected into HEK293 EBNA1+ cells. After selection and clonal expansion, 
depicted clones were chosen for further experiments. Ponceau stain is shown as loading control, 
immunoblot was performed using an anti-Gal4 antibody.    
4.6.1 SUV4-20H1 TARGETING UNSPECIFICALLY INDUCES H4K20ME3 
The first and very easy reasoning to define H4K20me3 action in replication 
processes was to simply target the H4K20me2/3 generating histone 
methyltransferase Suv4-20h1 to the FR-UAS-oriRDH reporter plasmid. 
Consequently, either Gal4 or Gal4-Suv4-20h1 expression cassettes were 
integrated into HEK293 EBNA1+ cells and their expression was tested by 
immunoblot (Figure 4.34, first two lanes). Interestingly, integration of Gal4-
Suv4-20h1 resulted in a doublet signal around 120 kDa, suggesting a post-
translational modification of this fusion protein (expected size ~ 100 kDa). 
Induction of Suv4-20h1-mediated H4K20me3 was verified by H4K20me3 
ChIP experiments for the FR-oriRDH and FR-UAS-oriRDH plasmids, followed by 
qPCR. While Gal4 and Gal4-Suv4-20h1 were specifically targeted to UAS 
(Gal4, Figure 4.35, left panel), Gal4-Suv4-20h1 induced H4K20me3 spread 
over the plasmid, even when no targeting site is present (Figure 4.35, right 
panel, FR-oriRDH vs. FR-UAS-oriRDH). Consequently, plasmid abundance 
experiments did not result in any effect of Gal4-Suv4-20h1 targeting 
(Appendix Figure 28), possibly due to heterochromatinization of both 
reporter plasmids.   
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FIGURE 4.35: SUV4-20H1 TARGETING TO FR-ORIRDH AND FR-UAS ORIRDH UNSPECIFICALLY INDUCES 
H4K20ME3 ALL OVER THE PLASMIDS. ChIP-qPCR analyses at FR, UAS and oriRDH sequences of FR-
oriRDH or FR-UAS-oriRDH plasmids transfected in the indicated cell lines. Fold enrichments relative to 
IgG. Data are means ± SEM (n=3).  
Reason for the observed unspecific induction of H4K20me3 can be the 
heavy overexpression of Gal4-Suv4-20h1. Assuming that also the modified, 
higher migrating form of Suv4-20h1 is functional, expression is doubled 
compared to Gal4 or Gal4-PR-Set7 proteins (Figure 4.34). Although the cell 
line itself did not exhibit any abnormalities concerning cell growth or 
morphology, it seems that Gal4-Suv4-20h1 is inducing H4K20me3 
completely independent from targeting to UAS. This renders the approach 
of Gal4-Suv4-20h1 targeting not suitable for our purposes.  
I refrained from producing a lower expressing cell line and decided to 
instead target H4K20 monomethyltransferase PR-Set7 to the plasmids. 
Induction of H4K20me1 will be converted in H4K20me2/3 by endogenous 
Suv4-20h1/2. 
4.6.2 PR-SET7 TARGETING LEADS TO INDUCTION OF H4K20ME1, 
CONVERSION INTO H4K20ME3 AND PRE-RC FORMATION 
Either FR-oriRDH/ FR-UAS-oriRDH or FR-DS/ FR-UAS-DS reporter plasmids 
were transfected in cell lines expressing Gal4, Gal4-PR-Set7 or a 
methylation-deficient N469A/H470A SET mutant of PR-Set7, Gal4-PR-
Set7SETmut (for integrated protein expression, see Figure 4.34, lanes 2-4).  
Efficient induction of H4K20me1 by PR-Set7 and conversion to H4K20me3 
was assessed by ChIP-qPCR. Furthermore, pre-RC formation was followed 
by the same technique, analyzing the specific pre-RC sub-component 
Mcm3. Indeed, Gal4-PR-Set7 targeting to FR-UAS-oriRDH plasmid induced 
H4K20me1, which was subsequently converted in H4K20me3 (Figure 4.36).  
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FIGURE 4.36: PR-SET7 TARGETING TO FR-UAS-ORIRDH LED TO H4K20ME1 INDUCTION, CONVERSION 
INTO H4K20ME3 AND PRE-RC FORMATION. ChIP-qPCR analyses at FR, UAS and oriRDH sequences of 
FR-oriRDH or FR-UAS-oriRDH plasmids transfected in the indicated cell lines. Fold enrichments relative 
to IgG and FR locus. Data are means ± SEM (n=4).  
This was not observed when Gal4 or the methylation-deficient PR-Set7SETmut 
were targeted to the reporter plasmids. Interestingly, both H4K20me1 and 
–me3 were also detected at oriRDH when PR-Set7 was targeted, presumably 
due to the close proximity of UAS and oriRDH primer positions (154 bp ~ 1 
nucleosome). More importantly, endogenous Mcm3 as member of the pre-
RC was detected at UAS in the Gal4-PR-Set7 cell line only, demonstrating 
pre-RC formation after H4K20me1/3 induction (Figure 4.36). Similar results 
were obtained when the respective Gal4, Gal4-PR-Set7 and 
Gal4-PR-Set7SETmut cell lines were transfected with oriP reporter plasmids 
FR-DS and FR-UAS-DS (Figure 4.37).  
It has already been shown that PR-Set7 targeting to a UAS integrated in 
the human genome leads to pre-RC formation (Tardat et al. 2010). I 
validated the autonomous plasmid system by reproducing these results. 
However, recruitment of pre-RC components is not necessarily sufficient for 
initiation of DNA replication (Blow, Ge, and Jackson 2011). Consequently, I 
assessed origin activity of the plasmids by measuring plasmid abundance.  
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FIGURE 4.37: PR-SET7 TARGETING TO FR-UAS-DS LED TO H4K20ME1 INDUCTION, CONVERSION INTO 
H4K20ME3 AND PRE-RC FORMATION. ChIP-qPCR analyses at FR, UAS and DS sequences of FR-DS or 
FR-UAS-DS reporter plasmids transfected in the indicated cell lines. Fold enrichments relative to IgG 
and FR locus. Data are means ± SEM (n=4).  
4.6.3 PR-SET7 TARGETING ENHANCES PLASMID REPLICATION EFFICIENCIES 
Principal of the plasmid abundance assay is the measurement of reporter 
plasmid replication efficiencies within a fixed time frame (procedure 
described in Figure 4.33 B). Shortly, I transfected reporter plasmids (either 
FR-oriRDH/ FR-UAS-oriRDH or FR-DS/ FR-UAS-DS) in Gal4, Gal4-PR-Set7 or 
Gal4-PR-Set7SETmut cell lines. Cells with transfection efficiencies greater 
70% were grown for 6d before low molecular weight DNA was harvested, 
DpnI digested and transformed into E.coli. DpnI digest removes bacterial-
derived input plasmids. The appearance of bacterial colonies from DpnI-
resistant plasmids is a direct measure of plasmid replication in mammalian 
cells. Because reporter plasmid replication efficiencies varied between cell 
lines, replication efficiencies of the control reporter plasmid without UAS 
targeting site were arbitrarily defined as 1. Replication efficiencies of the 
UAS-containing plasmids were calculated compared to control in each cell 
line and the result is depicted in Figure 4.38.      
For the FR-oriRDH/ FR-UAS-oriRDH plasmid pair, FR-UAS-oriRDH replicated 
about 3.5-times more than control when Gal4-PR-Set7 was targeted to the 
plasmid (Figure 4.38 A). This effect was solely attributable to PR-Set7 
methylation activity, as no effects were observed when either Gal4 or 
Gal4-PR-Set7SETmut were targeted. Plasmid abundance experiments with the 
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FR-DS/ FR-UAS-DS plasmid pair resulted in 2-fold enhanced replication 
efficiencies when Gal4-PR-Set7 was targeted (Figure 4.38 B). Replication 
increase of only 2-fold (compared to 3.5-fold in oriRDH context) might be 
due to the high intrinsic replication competence of DS.  
These results suggest that induction of H4K20me1 by PR-Set7 targeting, 
subsequent conversion into H4K20me3 and pre-RC formation led to 
replication initiation, in addition to intrinsic plasmid replication 
competences. Indeed, origin competence likely involves combination of 
different features ranging from sequence composition to higher-order 
chromatin structure (Méchali 2010). Thus, these results do not allow to 
distinguish between H4K20me1/3 increased origin activation as an 
enhancement of intrinsic origin activity or of additional origin formation. To 
pursue this question, the same experiments were performed with a reporter 
plasmid devoid of any replication competence. 
 
 
FIGURE 4.38: PR-SET7 TARGETING ENHANCED INTRINSIC PLASMID REPLICATION ACTIVITY. A) 
QUANTIFICATION OF FR-ORIRDH AND FR-UAS-ORIRDH PLASMIDS. B) QUANTIFICATION OF FR-DS AND FR-
UAS-DS PLASMIDS. Plasmid abundance assays in HEK293 EBNA1+ Gal4/ Gal4-PR-Set7/ 
Gal4-PR-Set7SETmut cell lines as indicated: Control plasmid (without UAS) replication efficiencies were 
arbitrarily defined as 1. Data are means ± SEM (n=4).  
4.6.4 PR-SET7 TARGETING INDUCES PLASMID REPLICATION 
To test whether PR-Set7 targeting can also lead to the induction of DNA 
replication, I removed the DS element from FR-UAS-DS plasmid and 
assessed the resulting replication efficiency compared to the strong 
replicating FR-DS reporter (Figure 4.39). While FR-UAS reporters were 
hardly detectable in Gal4 and Gal4-PR-Set7SETmut cell lines, FR-UAS plasmids 
clearly replicated in Gal4-PR-Set7 cell lines. The induced replication 
efficiency was about 1/3 as strong as the intrinsic DS activity and 4-fold 
increased to FR-UAS plasmid replication in Gal4 or Gal4-PR-Set7SETmut cell 
lines. A direct comparison of all reporter plasmid replication efficiencies is 
depicted in Appendix Figure 29. 
A) B) 
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ChIP experiments equally revealed H4K20me1/me3 being present at UAS, 
but due to the low plasmid abundance, it was challenging to conclusively 
perform Mcm3 ChIPs (Appendix Figure 30). Still, pre-RC formation is a 
prerequisite for replication activity.   
 
FIGURE 4.39: PR-SET7 TARGETING INDUCED PLASMID REPLICATION. QUANTIFICATION OF FR-DS AND 
FR-UAS PLASMIDS. Plasmid abundance assays in HEK293 EBNA1+ Gal4/ Gal4-PR-Set7/ 
Gal4-PR-Set7SETmut cell lines as indicated: FR-DS replication efficiency was arbitrarily defined as 1. 
Data are means ± SEM (n=3). 
In conclusion, induction of H4K20me1/3 leads to origin licensing and 
activation. However, no conclusion can be drawn whether conversion into 
H4K20me3 is needed for these processes.  
4.6.5 REPLICATION LICENSING AND ACTIVATION DEPEND ON H4K20ME3  
There is a lot of evidence that conversion from H4K20me1 to H4K20me3 is 
indeed needed for origin licensing and activation (Beck et al. 2012). Also 
my pre-RC ChIP-seq experiments imply the necessity for H4K20me3, as 
H4K20me1 is only marginally covered by pre-RC sub-components (Figure 
4.30), while especially ORC seems to have a preference for H4K20me3 
(Figure 4.31).  
Eric Julien (Chromatin and Cancer, IRCM, Montpellier), a close collaboration 
partner, also investigated the interplay of H4K20me3 and replication origins 
and showed that H4K20me3 is necessary for proper origin licensing. They 
performed replication timing experiments in MEF cells derived from Suv4-
20h2 -/-, Suv4-20h1 -/flox, Cre-ER embryos. The remaining Suv4-20h1 floxed 
allele can be deleted by adding 4-Hydroxytamoxifen (4-OHT), leading to 
absence of H4K20me2/3 and an increase in H4K20me1 (immunoblot 4d 
after 4-OHT treatment, Figure 4.40, (Schotta et al. 2008)). Comparing 
replication timing in wild type MEF and Suv4-20h knock-out MEF revealed 
a delay of 29% of late replication timing regions while some early replicating 
regions were even slightly advanced (red vs. blue arrows, Figure 4.40 A). 
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FIGURE 4.40: ABSENCE OF H4K20ME2/3 IMPAIRS ORIGIN LICENSING AND ACTIVATION IN DEFINED 
DOMAINS IN MEF CELLS. A) REPLICATION TIMING PROFILES ON CHROMOSOME 11 IN SUV4-20H1 FLOX/-
, SUV4-20H1 -/- MEFS, TREATED OR NOT WITH 4-OHT. Lower left panel: immunoblot confirmation of 
H4K20me2/3 absence. Lower right panel: replication timing in region [87560863-96672625]. Red 
arrows indicate delayed late replicating domains, blue arrows point to advanced early replicating 
domains. B) RELATIVE SNS ENRICHMENT of four H4K20me3 late-firing origins compared to control 
early-firing origin. H4K20me3-associated origins from chromosome 11 were quantified in relation to 
an early-firing origin in untreated and 4-OHT treated MEF cells. Data are means ± SEM (n=3). 
C) CHIP-QPCR ANALYSIS at the control early-firing origin and at four H4K20me3-associated origins 
from chromosome 11 in untreated and 4-OHT treated MEFs expressing FLAG-tagged Mcm2. Y-axis 
represents the ration of immunoprecipitate to input. (Figure adapted from Brustel et al. in 
preparation) 
A) 
B) 
C) 
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H4K20me3 is mostly present in heterochromatin, which is known to be late 
replicating. Specific measurement of origin activity in some of these late 
replicating domains delayed by Suv4-20h1/2 knock-out (H4K20me3-
associated origins) revealed severe reduction of origin efficiency upon 
Suv4-20h1/2 knock-out (Figure 4.40 B). Following ChIP-qPCR analysis at 
the same H4K20me3-associated origins showed a prominent decrease in 
pre-RC formation (assessed by Mcm2-FLAG ChIP), when H4K20me2/3 was 
absent (Figure 4.40 C). Consequently, delay of replication timing upon 
Suv4-20h1/2 knock-out results from the inability to properly license origins 
in regions that depend on H4K20me3. These regions might instead be 
replicated passively. These results already indicate the necessity of 
H4K20me3 for origin licensing and activity. To confirm these observation 
using the plasmid system with defined genetic background, I need the 
possibility to precisely block conversion of H4K20me1 to –me3 by inhibiting 
Suv4-20h1/2.  
The inhibitor compound A-196 specifically inhibits Suv4-20h1/2 methylation 
activity and results in a complete loss of H4K20me2/3, with a concomitant 
increase of H4K20me1, while other trimethylated histone states remained 
unaffected (examined by immunoblot, Figure 4.41). To directly evaluate A-
196 effect on H4K20me1/3 induced plasmid replication, I transfected 
HEK293 EBNA1+ Gal4-PR-Set7 cells with FR-oriRDH/ FR-UAS-oriRDH reporter 
plasmids and directly compared A-196 treated with untreated cells. ChIP-
qPCR analysis revealed induction of H4K20me1 and conversion to 
H4K20me3 in the untreated cell population, as expected, while A-196 
treated cells were reduced in H4K20me3 (Figure 4.42). Analyzing the 
presence of endogenous Mcm3 revealed failure of pre-RC formation at the 
UAS in A-196 treated cells (Figure 4.42). The incapacity to properly form 
pre-RCs at the UAS also led to reduction of plasmid replication efficiency to 
the level of the intrinsic origin oriRDH (Figure 4.43). In conclusion, 
experiments using the autonomous plasmid system showed that H4K20me3 
is definitely needed for proper origin licensing and consequently also for 
replication activity. Furthermore, genome-wide replication timing 
experiments revealed specific heterochromatic regions that depend on 
H4K20me3, while replication in other regions is presumably regulated 
through different mechanisms.   
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FIGURE 4.41: IMMUNOBLOT CONFIRMATION OF A-196 COMPOUND INHIBITING H4K20ME2/3. HEK293 
EBNA1+ Gal4-PR-Set7 cells were treated or not with 5µM A-196 for 6d. Indicated antibodies were 
used for detection of the respective histone modification. Ponceau stain of histones served as loading 
control. 
 
 
FIGURE 4.42: PR-SET7 TARGETING IN PRESENCE OF A-196 LED TO REDUCED H4K20ME3 LEVELS AND 
PRE-RC FORMATION COMPARED TO UNTREATED CELLS. ChIP-qPCR analysis at FR, UAS and oriRDH 
sequences of FR-oriRDH or FR-UAS-oriRDH reporter plasmids transfected in HEK293 EBNA1+ Gal4-
PR-Set7 cells treated or not with 5µM A-196. Fold enrichment relative to IgG and FR locus. Data are 
means ± SEM (n=3). 
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FIGURE 4.43: ENHANCED REPLICATION DURING PR-SET7 DEPENDS ON H4K20ME3. QUANTIFICATION OF 
FR-ORIRDH AND FR-UAS-ORIRDH PLASMIDS. Plasmid abundance assays in HEK293 EBNA1+ Gal4-PR-Set7 
cells treated or not with 5µM A-196 as indicated: FR-oriRDH replication efficiency was arbitrarily 
defined as 1. Data are means ± SEM (n=3).  
H4K20ME1 IS LIKELY NOT DIRECTLY LINKED TO REPLICATION ORIGIN LICENSING 
Cell cycle regulation of the H4K20 monomethyltransferase PR-Set7 and 
resulting catalyzation of H4K20me1 during late G2/M led to the hypothesis 
of this histone modification being involved in DNA replication regulation. My 
ChIP-seq experiments of H4K20me1 and –me3 revealed both methylation 
marks being mutually exclusive. H4K20me2 was not assessed, as the 
abundance of this mark argues against a possible role in DNA replication 
regulation (Pesavento et al. 2008). Together with Eric Julien (Chromatin 
and Cancer, IRCM, Montpellier), we identified the conversion from 
H4K20me1 to H4K20me3 to influence origin licensing, origin activation 
efficiency and replication timing, thus representing the first histone 
modification identified so far, that impacts on all levels of DNA replication 
regulation. Thereby, H4K20me3 affects origin licensing, consequently 
impairing origin formation at the very first step. This holds true for artificial 
induction of H4K20 methylation states on plasmids with defined genetic 
background, as well as for specific genomic loci with less defined chromatin 
context. Nevertheless, in both cases, origin licensing and activation entirely 
depend on the presence of H4K20me3.    
While knock-out of PR-Set7 is lethal in mammalians, absence of both Suv4-
20h1 and -h2 displays only minor cell cycle defects (Oda et al. 2010; S. Wu 
and Rice 2011; Beck et al. 2012; Schotta et al. 2008). Indeed, genome-
wide timing experiments only revealed a delay of some late replicating 
domains when Suv4-20h1/2 were missing. This indicates that while 
replication origin licensing and activation is perturbed in absence of 
H4K20me2/3, the concerned regions are still replicated, most likely 
passively. These results imply that the severe phenotype of PR-Set7 knock-
out presumably depend on other functions than replication regulation. It 
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has recently been reported, that unmethylated H4K20 (H4K20me0) marks 
post-replicative chromatin in G2 and is read by the H3-H4 histone 
chaperone TONSL-MMS22L, which is implicated in DNA repair (Saredi et al. 
2016). Taken together, this would situate H4K20me0/1 and PR-Set7 as cell 
cycle sensor mechanism, with H4K20me0 marking post-replicative 
chromatin and H4K20me1 identifying G1 chromatin, primed for replication. 
This scenario would explain both the re-replication phenotype when PR-Set7 
is stabilized – aberrant H4K20me1 in G2 mimics G1 cell cycle stage prone 
for replication – and cell cycle arrest in absence of PR-Set7 – as the cell 
cannot distinguish between pre- and post-replicative chromatin. 
Consequently, H4K20me1 might serve as cell cycle stage marker, but is not 
necessarily directly linked to origin licensing and replication initiation. 
HETEROCHROMATIN REPLICATION IS IN PART REGULATED THROUGH H4K20ME3 
In contrast, ORC binding to H4K20me3 convincingly connects 
heterochromatin with replication licensing and activation. In genome-wide 
ChIP experiments, especially ORC was detected at H4K20me3 sites, while 
Mcm2-7 was present to a lesser extent (Figure 4.31). Still, functional 
plasmid abundance experiments proved H4K20me3 being necessary for 
successful Mcm2-7 loading and origin activity. This result also implies the 
amount of Mcm2-7 detected by coverage analysis being sufficient for origin 
licensing. It is possible that an excess of ORC is needed to provide sufficient 
Mcm2-7 loading at inaccessible chromatin sites. Alternatively, the direct 
binding capacity of ORC (through the Orc1 BAH domain, Kuo et al. 2012; 
Beck et al. 2012) might reduce ORC on-and-off rates and stabilize ORC 
enough for Mcm2-7 recruitment. Furthermore, ORC might still execute 
heterochromatin organization functions besides origin licensing. Indeed, 
ORC has been shown bind heterochromatic structures in yeast, Xenopus, 
Drosophila, and mammals. ORC is directly interacting with heterochromatic 
protein 1 (HP1) and depletion of either protein reduces chromatin binding 
capacity of the other. In mammals, ORC also interacts with ORC-associated 
ORCA/LRWD1, which likely facilitates HP1 recruitment to heterochromatin 
(Chakraborty, Shen, and Prasanth 2011). Furthermore, experiments 
combining ChIP-seq and mass spectrometry have shown ORCA/ORC 
complex to directly bind the most prominent repressive histone 
modifications H3K9me3, H3K27me3 and H4K20me3 (Vermeulen et al. 
2010). Thereby, it has been proposed that ORC/ORCA specifically recruits 
lysine methyltransferases and are thus necessary for heterochromatin 
establishment and maintenance (Giri et al. 2015). Furthermore, 
ORC/ORCA/HP1 was suggested to facilitate origin licensing in 
heterochromatin (Leatherwood and Vas 2003; Shen et al. 2012), however 
ORC-heterochromatin interaction has already been shown to be separated 
from licensing functions of ORC (Dillin and Rine 1997; Leatherwood and Vas 
2003). My results clearly attribute an origin licensing function to ORC 
binding to heterochromatic H4K20me3. Genome-wide replication timing 
experiments thereby revealed that defined late-replicating domains – 
characterized by the presence of H4K20me3 in unperturbed cells – depend 
on H4K20me3, while other late-replicating regions did not. These regions 
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might represent heterochromatin where replication is regulated through 
different mechanisms. In conclusion, H4K20me3-mediated origin licensing 
and subsequent activation is one mechanism of replication regulation in 
heterochromatin. 
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5. CONCLUSION 
With this study, I intended to close the gap between extensive analyses of 
active replication initiation and pre-RC positions. Furthermore, I aimed to 
elaborate the relation between H4K20 methylation and regulation of DNA 
replication.  
 CHROMATIN ACCESSIBILITY IS THE MAIN DETERMINANT OF 
PRE-RC POSITIONING IN ACTIVE CHROMATIN 
I performed ChIP-seq of the two major pre-RC subcomponents ORC and 
Mcm2-7, targeting two subunits of each complex (Orc2, Orc3, Mcm3, and 
Mcm7) to increase validity of the results. Pre-RC ChIP-seq analysis on the 
EBV genome allowed the determination of the most appropriate peak-calling 
algorithm, by comparing already published pre-RC positions on the EBV 
genome with detected pre-RC positions from ChIP-seq. Despite differences 
in techniques and bioinformatical analyses, the majority of T-PIC-defined 
pre-RCs detected by ChIP-seq coincided with previously determined pre-RC 
positions (Papior et al. 2012). Comparing replicates of the same ChIP 
between each other and the different target pre-RC proteins, relatively little 
variances were observed. ORC, Mcm2-7 and pre-RC positions were 
concordant and even changed only marginally when ChIP-seq was 
performed in S/G2 cell cycle stage. This suggests little dynamics of the 
chromatinized EBV genome, resulting in delimited ORC, Mcm2-7, and pre-
RC positions.  
Applying the peak-calling settings determined on the EBV genome on the 
human genome, variances between replicates and between the two pre-RC 
subcomponents ORC and Mcm2-7 increased. This presumably relies on the 
definition of a peak as a specific accumulation of reads at a defined position, 
while neighboring regions decrease in read numbers. However, ORC and 
Mcm2-7 ChIPs do not meet these requirements. ORC binding has been 
shown to depend mostly on chromatin accessibility, which renders ORC 
positions extremely flexible and variable from cell to cell. Consequently, 
although the region of ORC binding might accord, the precise ORC position 
fluctuates, which appears as a broad profile from bulk cell ChIP-seq. This 
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impedes the definite detection by a peak calling program, resulting in either 
non-concordant peaks, or in undetected enrichments due to high read 
densities, also in neighboring regions. For Mcm2-7, this observation is even 
more prominent, as Mcm2-7 translocate after loading, rendering peak-
detection impossible. To avoid this bias introduced by peak-calling, I 
additionally relied on the mean sequencing read coverage of each pre-RC 
component within a specific region of interest. Analyzing the mean read 
coverage is independent of any peak-calling algorithm and allows a global 
impression of the average situation at all regions of interest, 
simultaneously.  
Evaluating pre-RC component coverage at active initiation zones revealed 
pre-RC enrichment within initiation zones, additionally confirming 
successful pre-RC ChIP-seq. For further analyses, it will be interesting to 
distinguish between initiation zones flanked or not by actively transcribed 
genes. As especially Mcm2-7 positioning might depend on transcriptional 
activity, fundamental differences are expected. Interestingly, pre-RC 
components, notably Mcm2-7, were specifically depleted from replication 
termination zones in G1 phase. This observation was cell cycle dependent, 
as depletion was less prominent in S/G2. Replication termination zones are 
to a large extent comprised of active genes, consistent with the idea of 
Mcm2-7 helicase translocation by active transcription machineries.   
Generally, pre-RC component coverages were enriched at sites of active 
transcriptional regulation, like TSS or H3K4me3 sites, in accordance with 
previous studies. This enrichment was enhanced at an early stage of pre-
RC loading (corresponding to S/G2 phase in this study, probably 
representing a later stage of the cell cycle; needs to be confirmed), implying 
that within active chromatin, ORC/ pre-RC is first bound to accessible 
chromatin sites, while Mcm2-7 helicases relocate from their initial loading 
site prior to S phase (G1 cell cycle stage). Consequently, this study also 
touches genome-wide pre-RC cell cycle dynamics. The excess of Mcm2-7 
compared to ORC situates Mcm2-7 as major determinant of replication 
initiation.    
Employing both HOMER and T-PIC peak-calling, observations from coverage 
analysis were actually confirmed. Very strong coverage enrichments, as 
observed at active TSSs or H3K4me3, coincide with strong, HOMER-defined 
peaks. Active initiation zones were moderately enriched in coverage, 
however, also sensitive T-PIC-defined peaks were preferably detected in 
replication initiation zones, when compared to replication termination 
zones.  Consequently, although peak-calling might be misleading for ORC 
and Mcm2-7 ChIPs, final conclusions are not significantly altered. 
My original intention was to unite discrepancies in genome-wide studies of 
active replication initiation by providing a comprehensive picture of the 
regulation of pre-RC positioning. In Raji cells, there are no SNS-seq data 
available, rendering a direct comparison of pre-RC ChIP-seq, SNS-seq and 
OK-seq impossible. Furthermore, the pre-RC ChIP-seq analysis in hES cells 
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is too preliminary to draw any final conclusions from direct comparisons 
with SNS-seq. Still, several conclusions emerge from this study:  
The major difference between SNS-seq and OK-seq is SNS-seq detecting 
single replication initiation events, while OK-seq detects zones of 
preferential initiation, encompassing multiple inefficient initiation sites. This 
technique disregards single replication origins and correlates with pre-RC 
coverage analyses, which also do not consider single pre-RC positions. 
Enrichment of ORC and Mcm2-7 within initiation zones and depletion of 
these proteins from replication termination zones provide an explanation 
for the occurrence of preferential replication initiation or termination, 
depending solely on the density of pre-RC proteins, especially Mcm2-7, on 
DNA. Only 20% of SNS overlap with initiation zones and vice versa (Petryk 
et al. 2016). However, replication initiation events also occur outside of 
initiation zones and amount in total to 30000-50000 initiation events per 
cell. Mapping of more than 200000 replication initiation sites by SNS-seq 
(Besnard et al. 2012) presumably originates from the large distribution of 
Mcm2-7, resulting in many different initiation sites in a bulk cell population. 
It might be possible, that the 200000 detected origins are the detection 
limit of the SNS-seq technique, by employing a limited number of cells and 
a certain size selection of nascent DNA. It might be discussable whether 
many more replication initiation sites could possibly be detected 
encompassing all sites of all cells. 
Single-cell replication initiation experiments might provide answers for that 
question. Combination of various single-cell experiments would reveal 
whether the final number of detected initiation events evens out around 
200000 events or continues to grow exponentially. Also single-cell pre-RC 
ChIPs would help to better understand the context. However, although 
single-cell experiments are advancing, both single-cell SNS-seq or pre-RC 
ChIP-seq are not feasible to date. Currently broad pre-RC profiles 
originating from bulk ChIP-seq experiments complicate conclusions about 
precise ORC or Mcm2-7 positions. Knowing the positions in a single cell and 
extrapolating the results would indeed complete the idea of variable ORC 
and Mcm2-7 positioning.     
In conclusion, this study provided new insights in the regulation of pre-RC 
positioning and implies Mcm2-7 being the main determinant of DNA 
replication in accessible chromatin regions characterized by transcriptional 
activity.  
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 DIRECT ORC-CHROMATIN INTERACTIONS REGULATE PRE-RC 
POSITIONING IN HETEROCHROMATIN 
H4K20 methylation was also assessed in this study, to decipher the role of 
this histone modification in replication regulation. Altering the expression of 
the Histone 4 Lysine 20 monomethyltransferase PR-Set7 has severe DNA 
replication phenotypes. Consequently, H4K20me1 was expected to be 
involved in the regulation of replication licensing and/or activation. 
However, pre-RC displayed no striking association to H4K20me1 in 
euchromatin in ChIP-seq experiments. This result situates PR-Set7 being a 
major regulator of the cell cycle rather than DNA replication mechanisms 
themselves. Interestingly, especially ORC associated with H4K20me3 in 
heterochromatin, while binding of Mcm2-7 was less prominent. Because of 
reported roles of ORC in heterochromatin organization, I functionally tested 
implication of H4K20me3 in origin licensing and confirmed that H4K20me3 
is necessary for Mcm2-7 recruitment and subsequent replication activation, 
in specific heterochromatin domains.   
Consequently, euchromatin and heterochromatin differ in ORC loading 
mechanisms. While in euchromatin, ORC randomly binds accessible 
chromatin sites and loads multiple Mcm2-7 complexes, in heterochromatin 
ORC-binding is stabilized by specific histone modifications. In my study, 
H4K20me3 regulates replication in specific heterochromatin regions. 
H4K20me3 is necessary for pre-RC formation within these regions and also 
controls pre-RC activation. Combining my observations and current 
literature led to the proposition of the following model (Figure 5.1): 
FIGURE 5.1: MODEL FOR REPLICATION LICENSING MECHANISMS IN EUCHROMATIN AND 
HETEROCHROMATIN. A) OPEN CHROMATIN STRUCTURES AND ACTIVE TRANSCRIPTION MEDIATE 
MCM2-7 LOADING AND TRANSLOCATION. High ORC on- and off-rates lead to excessive Mcm2-7 
loading. Active transcription machineries translocate Mcm2-7 helicases to gene-adjacent regions. B) 
IN HETEROCHROMATIN, H4K20ME3 STABILIZES ORC BINDING. Lower on- and off-rates lead to less 
Mcm2-7 recruitment. 
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A. Euchromatin locates interior of the nucleus, is marked by active 
chromatin marks (like H3K4me3) and is actively transcribed. ORC favors 
accessible chromatin regions (like TSS) and binds these regions. High 
on- and off-rates of ORC or chromatin conformation lead to multiple 
Mcm2-7 hexamer loading, which are translocated by the transcriptional 
machinery to gene-adjacent regions. Elevated Mcm2-7 densities 
increase activation probability in S phase and lead to early origin firing. 
 
B. Heterochromatin locates closer to the nuclear lamina. ORC binding is 
impaired through less accessible chromatin structure. Consequently, 
direct interactions of histone modifications (like H4K20me3) and ORC 
mediate ORC association to DNA. Stabilization of ORC leads to lower on- 
and off-rates and less Mcm2-7 recruitment. However, one Mcm2-7 
double-hexamer is theoretically enough for replication initiation although 
reduced firing probabilities situate heterochromatin replication in late S 
phase.   
Taken together, this work constitutes the first genome-wide ChIP-seq 
analysis of a full set of pre-RC components, as especially Mcm2-7 has not 
been analyzed so far. It situates Mcm2-7 as major determinant of 
replication initiation in euchromatin, while ORC displays the major regulator 
in heterochromatin. Furthermore, it provided direct evidence of replication 
origin licensing in heterochromatin depending on H4K20me3. These results 
added a piece to the puzzle of human replication regulation. Some already 
existing pieces might require re-evaluation, while future investigations will 
certainly provide other missing elements to complete the picture.   
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APPENDIX FIGURE 1: DIFFERENT REPRESENTATIONS OF INPUT (GREY) AND ORC2 (RED) CHIP-SEQ 
SAMPLES IN IGB AT THE MCM4/PRKDC LOCUS. A) SEQUENCING ALIGNMENT AFTER MAPPING AGAINST 
THE HUMAN GENOME. UTRs of divergent Mcm4 and PRKDC genes are visible as black bars, the first 
PRKDC exon as thicker black bar. [chr8: 48.872.624-48.872.814]. B) DIRECT COMPARISON OF 
SEQUENCING ALIGNMENT AND PROFILE REPRESENTATION. Upper two panels: Zoom-out of 
sequencing alignment from A); Lower two panels: profile representation of the same samples. introns 
= thin lines, arrowheads point to direction of transcription. Thicker black bars = exons, thin black 
bars = UTR. [chr8: 48.862.188-48.883.250]. 
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APPENDIX FIGURE 2: HEATMAP REPRESENTATION OF THE JACCARD SIMILARITY INDEX OF T-PIC-
DEFINED COMPLEXES AND PRE-RC (PAPIOR ET AL. 2012) AND SNS (PAPIOR ET AL. 2012). From little 
similarity (light red) to high similarity (dark red).  
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APPENDIX FIGURE 3: VALIDATION OF ES CELL PLURIPOTENCY. A) CELL MORPHOLOGY. Red bar 
represents 100µm. B) FACS STAIN OF PLURIPOTENCY MARKERS OCT4 AND SSEA4. Staining was 
performed according to BD Stemflow Human and Mouse Pluripotent Stem Cell Analysis Kit.  FACS 
was calibrated using the corresponding isotype negative control.  
A) 
B) 
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APPENDIX FIGURE 4: IGB VISUALIZATION OF THE MCM4/PRKDC LOCUS FOR PRIMER DEFINITION. Primer positions are indicated as black bars on top. 
Positive primer marked by Mcm4+, negative primer marked Mcm4-. Input: grey, Orc2: red, Orc3: orange, Mcm3: blue, Mcm7: turquois. [chr8: 
48870064-48875373]. 
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APPENDIX FIGURE 5: IGB VISUALIZATION OF THE BANF LOCUS FOR PRIMER DEFINITION. Primer positions are indicated as black bars on top. Positive 
primer marked by BANF+, negative primer marked BANF-. Input: grey, Orc2: red, Orc3: orange, Mcm3: blue, Mcm7: lightblue. [chr11: 65767460-
65771961] 
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A) B) 
APPENDIX FIGURE 6: MOST HOMER PEAKS RESIDE WITHIN THE TOP 10% OF T-PIC PEAKS. 
REPRESENTATIVE EXAMPLE ANALYSIS FOR A) ORC3 AND B) MCM7 IN ONE REPLICATE. Venn diagram 
of overlap between all HOMER-detected peaks with the top 10% of T-PIC-detected peaks. Overall 
counts are indicated. The percentage of overlapping HOMER-detected peaks are specified in brackets. 
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APPENDIX FIGURE 7: PRE-RC BINDING AT LAMINB2 ORIGIN IS DETECTED BY T-PIC BUT NOT BY HOMER.  Input: grey, Orc2: red, Orc3: orange, Mcm3: blue, 
Mcm7: turquois. T-PIC-detected peaks are visualized as bars; HOMER-detected peaks are additionally highlighted by lightblue background. Position of 
LaminB2 origin is marked by green horizontal line. [chr19: 2416622-2440010].  
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APPENDIX FIGURE 8: PRE-RC BINDING AT JUNB ORIGIN IS DETECTED BY T-PIC BUT NOT BY HOMER.  Input: grey, Orc2: red, Orc3: orange, Mcm3: blue, 
Mcm7: turquois. T-PIC-detected peaks are visualized as bars; HOMER-detected peaks are additionally highlighted by lightblue background. Position of 
JunB origin is marked by green horizontal line. [chr19: 12882387-12904261]. 
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APPENDIX FIGURE 9: ORC AND MCM2-7 COMPLEX SIZES (HOMER VS. T-PIC). A) ORC. B) MCM2-7. 
Represented in boxplot: thick line shows the median, the box is the distribution from the first to the 
third quartile, the whiskers indicate the smallest and largest value without being an outlier. Outliers 
represented by dots.  
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A) B) 
APPENDIX FIGURE 10: OVERLAPS OF HOMER- AND T-PIC DEFINED COMPLEXES. A) ORC B) MCM2-7. 
Venn diagram of overlap between HOMER- and T-PIC-defined complexes. Overall counts are 
indicated. The percentage of HOMER-defined complexes common with T-PIC-defined pre-RCs is 
specified in brackets.   
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A) 
B) 
APPENDIX FIGURE 11: GENOMIC DISTRIBUTION OF A) HOMER-DEFINED PRE-RC AND B) T-PIC DEFINED 
PRE-RC REVEALED ASSOCIATION TO PROXIMAL PROMOTER REGIONS. The genomic distribution was 
calculated using the CEAS program and normalized against the “default” genomic distribution of the 
single criteria (position 0 on the y-axis). Distribution was then represented with upwards orienting 
bars showing % enrichments and downwards oriented bars showing % depletion compared to 
“default” genomic distribution.  
APPENDIX 
130 | 
 
  
APPENDIX FIGURE 12: GENOMIC DISTRIBUTION OF H3K4ME3 PEAKS SHOWED CLOSE ASSOCIATION TO 
REGULATORY 5‘ GENIC REGIONS. The genomic distribution was calculated using the CEAS program 
and normalized against the “default” genomic distribution of the single criteria (position 0 on the y-
axis). Distribution was then represented with upwards orienting bars showing % enrichments and 
downwards oriented bars showing % depletion compared to “default” genomic distribution.   
Genomic distribution of H3K4me3 peaks 
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APPENDIX FIGURE 13: H3K4ME3 POSITIONS WERE MORE LOCALIZED THAN H3K36ME3. Peak sizes in 
[kb] are represented in boxplots: thick line shows the median, the box is the distribution from the 
first to the third quartile, the whiskers indicate the smallest and largest value without being an outlier. 
Outliers represented by dots.  
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APPENDIX FIGURE 14: GENOMIC DISTRIBUTION OF H3K36ME3 PEAKS SHOWED ENRICHMENT IN 
INTRONS. The genomic distribution was calculated using the CEAS program and normalized against 
the “default” genomic distribution of the single criteria (position 0 on the y-axis). Distribution was 
then represented with upwards orienting bars showing % enrichments and downwards oriented bars 
showing % depletion compared to “default” genomic distribution.   
Genomic distribution of H3K36me3 peaks 
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APPENDIX FIGURE 15: NO ENRICHED COVERAGE OF PRE-RC PROTEINS AT H3K36ME3 PEAKS. A) MEAN 
ORC2 COVERAGE. B) MEAN ORC3 COVERAGE. C) MEAN MCM3 COVERAGE. D) MEAN MCM7 COVERAGE.  
Coverage was calculated as number of reads/base within a 20 kb window around H3K36me3 peak 
center. Input was plotted as control (grey). 
A) B) 
D) C) 
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APPENDIX FIGURE 16: HOMER-DEFINED ORC, MCM2-7, AND PRE-RC WERE CLOSELY ASSOCIATED TO 
H3K4ME3 AND NOT H3K36ME3. Left: HOMER-defined complexes, right: T-PIC-defined complexes. The 
distance of each position was calculated towards the next H3K4me3 or H3K36me3 peak center and 
is plotted in log10 on the x-axis. The frequency of complexes within a specific distance is plotted on 
the y-axis. 
APPENDIX 
135 | 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) 
B) 
C) 
APPENDIX FIGURE 17: T-PIC-DEFINED ORC, MCM2-7, AND PRE-RC ARE VERY SIMILAR IN G1 AND S/G2 
ON EBV. A) COMPLEX NUMBERS. Number of T-PIC-defined ORC, Mcm2-7 and pre-RC was plotted as 
indicated in a bar chart in G1 vs. S/G2. B) COMPLEX SIZES. Complex sizes were potted as boxplot in 
G1 vs. S/G2. Thick line shows the median, the box is the distribution from the first to the third 
quartile, the whiskers indicate the smallest and largest value without being an outlier. Outliers 
represented by dots. C) COMPLEX POSITION OVERLAPS. Venn diagram of overlap between G1-defined 
ORC, Mcm2-7, or pre-RC and the same complexes defined in S/G2. Overall counts are indicated. 
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APPENDIX FIGURE 18: COMPARISON OF T-PIC-DEFINED PRE-RC, ORC AND MCM2-7 DENSITIES AT AS, 
DS, AND THE REMAINING GENOME IN G1 AND S/G2. A) T-PIC-DEFINED PRE-RC DENSITIES. B) T-PIC-
DEFINED ORC DENSITIES. C) T-PIC-DEFINED MCM2-7 DENSITIES. The cell cycle stage is represented 
above/beneath each line, S/G2 densities are represented in darker colors. 
A) 
B) C) 
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APPENDIX FIGURE 19: PRE-RC PROTEIN COVERAGE IN S/G2 AT H3K4ME3 PEAKS IS MORE PROMINENT 
THAN IN G1. A) MEAN ORC2 S/G2 COVERAGE. B) MEAN ORC3 S/G2 COVERAGE. C) MEAN MCM3 S/G2 
COVERAGE. D) MEAN MCM7 S/G2 COVERAGE. Coverage was calculated as number of reads/base 
within a 20 kb window around H3K4me3 peak center. Input was plotted as control (grey). 
A) B) 
D) C) 
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APPENDIX FIGURE 20: OVERLAPS OF HOMER- (LEFT PANEL) OR T-PIC- (RIGHT PANEL) DEFINED PRE-RC 
WITH H3K4ME3 PEAKS IN G1 VS. S/G2.  Left: HOMER-defined complexes, right: T-PIC-defined 
complexes. Venn diagram of overlap between G1- and S/G2-defined pre-RCs with H3K4me3 peaks. 
Overall counts are indicated. The percentage of defined pre-RC overlapping with H3K4me3 are 
specified in brackets.  
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APPENDIX FIGURE 21: OVERLAPS OF HOMER- (LEFT PANEL) OR T-PIC- (RIGHT PANEL) DEFINED ORC 
AND MCM2-7 WITH H3K4ME3 PEAKS IN G1 VS. S/G2. Left: HOMER-defined complexes, right: T-PIC-
defined complexes. Venn diagram of overlap between G1- and S/G2-defined complexes with 
H3K4me3 peaks. Overall counts are indicated. The percentage of defined complexes overlapping with 
H3K4me3 is specified in brackets. 
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APPENDIX FIGURE 22: GENOMIC PRE-RC DISTRIBUTION IN G1 VS. S/G2. A) HOMER-DEFINED PRE-RCS. 
B) T-PIC-DEFINED PRE-RCS. The distribution in G1 is plotted in rainbow color. The S/G2 distribution 
is overlaid by gray bars.   
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APPENDIX FIGURE 23: H4K20ME1 AND –ME3 POSITIONS ARE MUTUALLY EXCLUSIVE. A) H4K20ME1 AND 
–ME3 PEAK SIZES REPRESENTED IN A BOXLOT. Thick line shows the median, the box is the distribution 
from the first to the third quartile, the whiskers indicate the smallest and largest value without being 
an outlier. Outliers represented by dots. B) OVERLAP OF H4K20ME1 AND –ME3 PEAK POSITIONS. Venn 
diagram of overlapping H4K20me1 and H4K20me3 peaks. Overall counts are indicated. The 
percentage of overlapping proportions are specified below in brackets. 
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APPENDIX FIGURE 24: HOMER- (LEFT PANEL) AND T-PIC- (RIGHT PANEL) DEFINED COMPLEXES HARDLY 
OVERLAP WITH H4K20ME1. Left: HOMER-defined complexes, right: T-PIC-defined complexes. Venn 
diagram of overlap between HOMER- and T-PIC-defined ORC, Mcm2-7 and pre-RC with H4K20me1 
peaks. Overall counts are indicated. The percentages of overlapping proportions are specified below 
in brackets. 
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APPENDIX FIGURE 25: IGB VISUALIZATION OF ORC AND H4K20ME3 COLOCALIZATION. Input: grey, Orc2: red, Orc3: orange, Mcm3: blue, Mcm7: turquois, 
H4K20me3: violet; [chr1: 18071736-18101785]. 
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APPENDIX FIGURE 26: COMPARISON OF H4K20ME1 AND –ME3 POSITIONS IN G1 AND S/G2. A) H4K20ME1. 
B) H4K20ME3. Venn diagram of overlap between G1 and S/G2 determined H4K20me peaks. Overall 
counts are indicated. The percentage of overlapping proportions are specified below in brackets. 
A) B) 
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APPENDIX FIGURE 27: H4K20ME1 AND –ME3 COVERAGE AT H4K20ME1 AND –ME 3 PEAKS (G1 VS. S/G2). 
Coverage was calculated as number of reads/base within a 6 kb window around H4K20me1/-me3 
peak center. H4K20me1 coverage in green, H4K20me3 coverage in violet, S/G2 coverages colored 
lighter.  
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APPENDIX FIGURE 28: SUV4-20H1 TARGETING HAS NO EFFECT ON PLASMID REPLICATION. 
QUANTIFICATION OF FR-ORIRDH AND FR-UAS-ORIRDH PLASMIDS. Plasmid abundance assays in HEK293 
EBNA1+ Gal4/ Gal4-Suv4-20h1 cell lines as indicated: FR-oriRDH replication efficiency was arbitrarily 
defined as 1. Data are means ± SEM (n=3). 
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APPENDIX FIGURE 29: DIRECT COMPARISON OF ALL REPORTER PLASMID REPLICATION EFFICIENCIES 
RELATIVE TO FR-DS. Plasmid abundance assays in HEK293 EBNA1+ Gal4/ Gal4-PR-Set7/ 
Gal4-PR-Set7SETmut cell lines as indicated: FR-DS replication efficiency was arbitrarily defined as 1. 
Data are means ± SEM (n=4). 
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APPENDIX FIGURE 30: PR-SET7 TARGETING TO FR-UAS LED TO H4K20ME1 INDUCTION AND 
CONVERSION INTO H4K20ME3. ChIP-qPCR analysis at FR and UAS sequences of FR-UAS reporter 
plasmids transfected in the indicated cell lines. Fold enrichment relative to IgG. Data are means ± 
SEM (n=3). 
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RESUME SUBSTANTIEL  
INTRODUCTION 
La réplication d’ADN réfère au processus de duplication précise de 
l’information génétique afin d’assurer la transmission fidèle du génome 
pendant chaque division cellulaire. De ce fait, la réplication d’ADN est initiée 
une seule fois par cycle cellulaire. Une dérégulation de ce processus 
provoque de l’instabilité génétique, ce qui peut aboutir à des pathologies 
diverses, comme le cancer ou d’autres troubles génétiques. Les sites de 
l’initiation de la réplication d’ADN s’appellent « origines de réplication ». Sur 
le génome humain, entre 30000 et 50000 origines de réplication sont 
activées pendant chaque cycle cellulaire afin d’assurer la duplication 
complète du génome. Il y a un excès d’origines de réplication possible, de 
ce fait, uniquement une partie d’entre elles sont utilisées à chaque cycle 
réplicatif. Pour activer une origine, le chargement correct du complexe de 
pré-réplication (pre-RC) est requis. Le pre-RC consiste en deux sous-
complexes majeurs : l’ « origin recognition complex » (ORC) qui interagit 
directement avec l'ADN et est nécessaire pour recruter le second sous-
complexe, les hélicases Mcm2-7, qui sont responsables de l'initiation de la 
réplication. Le pre-RC est uniquement formé pendant la phase G1 du cycle 
cellulaire, tant que l’activité de la kinase cycline dépendante (CDK) est 
basse. Avec l’activation de la CDK et de la DDK (kinase dépendante de 
DBF4) pendant la transition de G1/S, plusieurs protéines additionnelles se 
lient au pre-RC afin d’activer les hélicases Mcm2-7. En conséquence, le 
double hexamère Mcm2-7 se dissocie en deux hexamères actifs qui 
génèrent deux réplisomes constitués de plus de 150 protéines chacun qui 
assurent la réplication bidirectionnelle du génome.  
Le choix de l’activation d’une origine est principalement stochastique. Le 
fait que seulement une partie des pre-RCs formés est activée au début de 
la phase S et que chaque cellule utilise une cohorte différente d’origines, a 
abouti à la définition du terme « efficacité de l’origine de réplication » qui 
représente la fréquence à laquelle une origine spécifique est activée dans 
une cellule donnée pendant un cycle cellulaire donné. 
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Recemment, plusieurs caractéristiques influencant l’efficacité de la 
formation et de l’activation d’une origine ont été identifié. Entre autre, la 
chromatine joue un rôle important dans le choix des origines de réplication. 
Il a été démontré que non seulement le positionnement des nucléosomes 
mais aussi les modifications des histones influencent la position et 
l’efficacité des origines de réplication. 
La méthylation de l’histone H4 sur la lysine K20 (H4K20me) est notamment 
un candidat prometteur jouant un rôle dans la régulation de la réplication 
d’ADN pour des raisons multiples : i) l’expression de la transférase de 
monométhyle de H4K20, PR-Set7 (ou Set8, SetD8, KMT5A) est régulée au 
cours du cycle cellulaire, avec une concentration basse en G1, une absence 
complète en phase S, puis son expression augmente en G2 et atteint son 
maximum en mitose. ii) La stabilisation de l’expression de PR-Set7 pendant 
tout le cycle cellulaire induit la ré-réplication d’ADN, indiquant que la 
réplication a lieu plusieurs fois par cycle cellulaire. Une mutation 
additionnelle dans le domaine de méthylation de la protéine réverse ce 
phénotype, indiquant que la méthylation de H4K20 est un facteur régulateur 
de la réplication. iii) L’absence complète de PR-Set7 perturbe la progression 
cellulaire et est létale aux stages précoces du développement d’embryons 
de souris. PR-Set7 est la seule enzyme connue capable de catalyser la 
monométhylation de H4K20. Les méthylations additionnelles (di- et tri-
méthylation) de H4K20 sont catalysées par les enzymes Suv4-20h1/h2. 
L’absence de Suv4-20h1/h2 provoque cependant un phénotype moins 
sévère que l’absence de PR-Set7. En conséquence, le rôle exact de PR-Set7 
et H4K20me1 ou H4K20me3 dans la formation du pre-RC et son activation 
reste à découvrir.       
Il est techniquement possible de cartographier (« mapping ») les 
évènements d’initiation de la réplication sur le génome humain par des 
approches différentes. A part le peignage d’ADN qui permet d’identifier des 
origines de réplication sur des molécules uniques, les méthodes les plus 
connues sont le séquençage des brins naissants (SNS-seq) et le séquençage 
des fragments d’Okazaki (OK-seq). La méthode du SNS-seq est basée sur 
l’isolation et le séquençage des brins précoces naissants des fourches de 
réplication actives. L’application d’une profondeur de séquençage élevée a 
révélé plus de 200000 origines de réplication actives dans une population 
de cellules asynchrones, représentantes des cohortes différentes d’origines 
potentielles utilisées par cellule. La technique de SNS-seq a été utilisée avec 
des cellules de variétés différentes, incluant les cellules souches 
embryonnaires humaines. Contrairement à cette méthode qui révèle une 
position précise de toutes les origines de réplication possible, le OK-seq sert 
à l’identification des larges zones de préférence d’activation et de 
terminaison de la réplication. En conséquence, une large zone d’initiation 
représente une zone préférentielle d’initiation de réplication, avec des sites 
d’initiation multiples mais seulement une origine de réplication active par 
cellule. OK-seq est une méthode plus récente et a été appliquée aux cellules 
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cancéreuses HeLa et la lignée cellulaire de lymphome de Burkitt Raji 
infectée par le virus d’Epstein-Barr (EBV).  
Les deux techniques de SNS-seq et OK-seq servent à identifier les origines 
activées dans une population de cellules. Pour identifier les positions 
potentielles d’activation de la réplication, il faut définir les positions du 
pre-RC dans les cellules. Les études génomiques par immuno-précipitation 
de la chromatine et le séquençage à haut débit (ChIP-seq) des pre-RCs 
peuvent être utilisé pour répondre à cette question. Aujourd’hui, les études 
de ChIP-seq des pre-RCs sont rares et jusqu’à maintenant seulement 
disponibles pour ORC. Etant donné que Mcm2-7 migre potentiellement de 
son site de chargement initial, il est crucial d'obtenir des informations sur 
le positionnement des Mcm2-7 pour la compréhension complète de la 
régulation de la réplication. 
Des ChIP-seq de ORC et Mcm2-7 ont été réalisés sur le génome de EBV 
dans mon laboratoire hôte. L’EBV infecte les cellules B humaines et établit 
une infection latente persistante. Pendant l’infection latente, le génome de 
l’EBV est répliqué par la machinerie de réplication de l’hôte. La réalisation 
de ChIP ciblant les composants du pre-RC Orc2 et Mcm3, l’isolation parallèle 
de SNS et la digestion de la chromatine par la nucléase micrococcal (MNase) 
dans les cellules Raji, suivie par l’hybridation de l’ADN isolé sur une puce 
d’ADN désignée, a permis une analyse extensive de la relation entre la 
formation des pre-RCs, leur activation et le rôle du positionnement des 
nucléosomes dans ce contexte. Ces expériences fournissent un aperçu pour 
notre compréhension de l’organisation des origines de réplication dans des 
cellules humaines. Elles ont également montré que la technique du ChIP 
des composants du pre-RC est réalisable dans des cellules humaines et ont 
sensibilisé à la nécessité de contrôles adaptés. La prochaine étape sera la 
réalisation d’analyses similaires sur le génome humain entier afin de 
répondre à la question de la régulation des pre-RCs sur le génome humain.   
BUT DE LA THESE  
La régulation de l’initiation de la réplication a déjà été étudiée 
extensivement et cela a abouti à l’identification de plusieurs facteurs 
impliqués. Cependant, pour une compréhension complète de la régulation 
de la réplication, il nous faut connaitre la combinaison des informations sur 
l’initiation de la réplication et celles du positionnement du pre-RC. 
Notamment, le positionnement des Mcm2-7 – n’étant pas encore analysé 
jusqu’à présent – pourrait permettre de comprendre les divergences entre 
le ChIP-seq des ORC actuels et les données sur l’initiation de la réplication.   
Le but de ma thèse sera d’utiliser la technique du ChIP-seq du pre-RC sur 
les génomes des cellules Rajis en ciblant les deux sous-unités majeures, 
ORC et Mcm2-7. Contenant le génome de l’EBV comme référence interne, 
les cellules Raji présentent un contrôle parfait de la qualité des résultats 
ChIP-seq. Une fois établi, ChIP-seq sera aussi utilisé dans les cellules 
souches embryonnaires humaines (cellules hES), en collaboration avec mon 
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co-directeur de thèse Dr. Jean-Marc Lemaitre. La comparaison des 
informations sur le positionnement des pre-RCs avec l’initiation de la 
réplication, ainsi que l’identification des caractéristiques qui déterminent ce 
positionnement vont contribuer à la compréhension fondamentale de la 
relation entre la formation des pre-RCs et leur activation. De plus, la 
position des pre-RCs sera comparé avec certaines des caractéristiques de 
la chromatine, comme les modifications des histones. Il y a des preuves 
fonctionnelles que la méthylation de H4K20 est impliquée dans la régulation 
de la réplication de l’ADN, mais il nous manque la compréhension au niveau 
moléculaire. En conséquence, le ChIP-seq de H4K20me1 et –me3 sera aussi 
effectué, afin de conclure directement sur leurs implications possibles dans 
la régulation de la réplication d’ADN. Ces candidats seront validés en 
utilisant un système de plasmide basé sur l’EBV, afin de confirmer 
fonctionnellement la relation entre le méthylation de H4K20 et la 
réplication.  
RESULTATS 
OPTIMISATION, REALISATION ET VALIDATION DES CHIP-SEQ DU PRE-RC DANS LES 
CELLULES RAJI 
Afin de répondre aux questions mentionnées auparavant, j’ai commencé 
par établir les expériences de ChIP-seq en cellules Raji. Pour l’optimisation 
du protocole du ChIP, afin d’assurer un maximum de rigueur et de 
spécificité, plusieurs considérations ont été pris en compte : i) une 
synchronisation des cellules en G1 permet d’effectuer le ChIP sur une 
population de cellules où le pre-RC est formé. Dans les cellules Raji, il est 
possible de fractionner les cellules à différents stades du cycle cellulaire 
selon leur taille. Ceci n’étant pas possible pour les cellules hES, ce ChIP fût 
conduit sur une population de cellules non-synchrone. ii) Une optimisation 
du temps de fixation des cellules (« cross-link ») ainsi qu’une sonication 
douce permet la préservation du complexe. iii) L’utilisation de différents 
anticorps pour cibler le même complexe consolide les résultats obtenus. J’ai 
décidé de cibler deux protéines de l’ORC : Orc2 et Orc3, ainsi que deux 
protéines de Mcm2-7 : Mcm3 et Mcm7. iv) L’augmentation de la spécificité 
des anticorps par l’optimisation des conditions des tampons est cruciale 
pour un résultat optimal.        
L’utilisation des cellules Raji présente l’avantage de permettre le contrôle 
de la qualité des ChIPs ciblant les composants différents du pre-RC sur les 
régions connues pour être enrichies avec ces protéines par de la PCR 
quantitative en temps réelle (qPCR). Le locus choisi sur le génome de l’EBV 
est le « dyad symmetry element » (DS). La protéine virale, EBNA1, guide 
ORC à cette position, suivi par un recrutement des Mcm2-7, dépendant du 
cycle cellulaire. En effectuant ces contrôles par qPCR, ORC était présent 
dans les deux stades du cycle cellulaire choisis : G1 et S/G2. En revanche, 
Mcm3 et Mcm7 étaient plus enrichis en G1, ce qui valide d’une part la qualité 
des ChIPs et d’autre part le fractionnement des stades du cycle cellulaire. 
Des duplicates des ChIPs de Orc2 et Orc3, et trois exemplaires de Mcm3 et 
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Mcm7 en G1 et S/G2 ont été séquencés avec environ 70 millions de 
« reads » de profondeur. En parallèle, des duplicates des ChIPs de 
H4K20me1 et -me3 aux mêmes stades du cycle cellulaire ont été séquencés 
avec une profondeur de 45 millions de « reads ».   
Afin de valider le ChIP et de choisir un programme de détection de pics, les 
« reads » du séquençage ont tout d’abord été alignés avec le génome de 
l’EBV. En comparant le résultat de trois différents programmes de détection 
de pics (MACS2, HOMER et T-PIC), avec des positions du pre-RC 
déterminées auparavant, j’ai établi que le programme T-PIC permettait de 
trouver les pics pertinents d’une manière sensible et fiable. 
REALISATION CHIP-SEQ DE PRE-RC DANS DES CELLULES HES 
L’analyse génomique des positions des composants du pre-RC dans les 
cellules Raji a également permis de déterminer des positions dans le 
génome qui permettent la validation des ChIPs du pre-RC par qPCR dans 
d’autres types cellulaires. Les ChIPs du pre-RC dans les cellules hES ont été 
validés sur l’origine de réplication connue Mcm4 et sur un locus identifié 
pour être enrichi dans les cellules Raji, BANF1. Après le séquençage, un 
premier aperçu des données a été obtenu. En collaboration avec Anissa 
Zouaoui, bioinformaticienne dans le laboratoire du Dr. Jean-Marc Lemaitre, 
l’identification de pics a été effectuée avec MACS2 et son paramètre pour 
déterminer des larges pics. Cette analyse nous a permis de déterminer que 
les composants de Mcm2-7 étaient beaucoup plus distribués que ceux de 
ORC. Par contre, ORC co-localisait plus avec les positions de la réplication 
active (obtenu par le SNS-seq), alors que les Mcm2-7 co-localisait à peine. 
Finalement, pour obtenir une meilleure idée des relations entre pre-RC et 
initiation de la réplication, il nous fallait une analyse plus précise et 
extensive. Dans ce but, nous avons utilisé le programme de détection de 
pics T-PIC (précédemment validé sur le génome de l’EBV) et analysé 
comment la couverture des « reads » est en corrélation avec les SNS, des 
positions des modifications de histones et d’autres éléments de la 
chromatine.  
LES COMPOSANTS DU PRE-RC SONT ENRICHIS DANS LES ZONES DE LA REPLICATION 
ACTIVE 
Afin de valider les données du ChIP-seq des composants du pre-RC dans 
les cellules Raji, nous les avons corrélés avec les zones d’activation et de 
terminaison de la réplication. Ces zones ont été déterminé par la méthode 
du OK-seq. Le séquençage des fragments d’Okazaki permet la 
différentiation en brins Watson et Crick. Grâce à cette différentiation, il est 
possible de calculer une « directionalité de la fourche de réplication », ce 
qui résulte en un profil de séries de segments ascendants (AS) et 
descendants (DS) de différentes tailles et pentes. Les AS représentent des 
zones préférentielles d’initiation de la réplication, alors que les DS sont des 
zones préférentielles de terminaison de réplication. L’amplitude y reflète 
l’efficacité de l’initiation ou de la terminaison.  
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En calculant la densité des pics de ORC ou Mcm2-7 dans les AS ou DS, j’ai 
montré que la densité des protéines du pre-RC dans des zones d’initiation 
de réplication est 2,5 fois plus élevée que dans les zones de terminaison.  
Une autre façon d’analyser les données de séquençage est de calculer la 
couverture des « reads » sur une superposition soit d’AS, soit de DS. Cette 
méthode a l’avantage d’être indépendante de tout algorithme de détection 
de pics et permet l’obtention d’une tendance globale de la situation 
moyenne de tous les sites simultanément. La couverture moyenne de 
chaque membre du pre-RC était enrichie dans les zones d’initiation de 
réplication, et défavorisée dans les zones de terminaison de réplication. Ces 
résultats valident mon approche de ChIP-seq des protéines du pre-RC. De 
plus, la déplétion évidente des membres du pre-RC dans les zones de 
terminaison était inattendue et nécessite plus d’études afin de comprendre 
exactement les mécanismes impliqués.  
LA POSITION DES MEMBRES DU PRE-RC EST PLUS STABLE DANS LES REGIONS DE 
REGULATION ACTIVE DE LA TRANSCRIPTION 
Quelque ce soit la méthode d’analyse des origines de réplication, la 
réplication active est souvent liée à la transcription active. En conséquence, 
j’ai analysé la corrélation entre les membres du pre-RC et de la transcription 
active.  
J’ai calculé la couverture moyenne des « reads » sur les sites d’initiation de 
la transcription (TSSs) actives déterminées dans les cellules Raji. La 
couverture était élevée sur les TSSs actives et non sur les TSSs inactives 
pour toutes les protéines du pre-RC, alors que ORC était légèrement plus 
élevé que Mcm2-7. Une analyse de détermination de pics montrait que les 
pics trouvés en proximité des TSSs actives sont plutôt forts et bien définis.  
Une étude de la corrélation des membres du pre-RC avec des modifications 
des histones associées à la transcription active, H3K4me3 et H3K36me3, 
montrait que le pre-RC est localisé de façon préférentielle en association 
avec H3K4me3, une modification connue pour déterminer les promoteurs 
actifs. H3K36me3 est plutôt retrouvé dans le corps de gènes activement 
transcrits et ces positions ne sont pas enrichies du tout par les protéines du 
pre-RC.  
LES HELICASES DU MCM2-7 SE RAPPROCHENT DE ORC EN S/G2 
La liaison du pre-RC à l’ADN est limitée à la phase G1 du cycle cellulaire. En 
conséquence, pour un contrôle négatif de mes ChIP-seq, j’ai effectué les 
mêmes ChIPs dans la phase S/G2 du cycle cellulaire. Présumant que le 
pre-RC se dissocie de l’ADN soit à cause de leur activité de réplication, soit 
passivement, je me suis attendu à une diminution des membres du pre-RC 
aux positions identifiées auparavant.  
Contrairement aux attentes, le nombre de positions des protéines du 
pre-RC, défini par les programmes de détection de pics n’ont pas changé 
notablement. De plus, la majorité des positions détectées coïncide avec les 
positions identifiées en G1. Par contre, l’analyse de couverture moyenne 
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autour des zones d’initiation de la réplication (AS) et les zones de 
terminaison de la réplication (DS) ont montré une diminution de Mcm3 et 
Mcm7 autour des AS par rapport à G1 ainsi qu’une égalisation de la 
couverture autour des DS. Contrairement à cette observation, la couverture 
moyenne des membres du pre-RC autour des TSSs est encore plus élevée 
en S/G2 qu’en G1, identiquement à la couverture sur les positions de 
H3K4me3. De plus, l’analyse de détection de pics a montré que plus de pics 
pour Mcm2-7 étaient identifiés par le programme, ce qui indique un profil 
propagé de Mcm2-7 en G1 et un profil plus défini en S/G2. Ces observations 
indiquaient surtout que le positionnement de Mcm2-7 changeait en S/G2. 
Une analyse de la similarité des positions de ORC et Mcm2-7 en G1 et S/G2 
montrait que les positions de Mcm2-7 se sont rapprochées de ORC en S/G2. 
L’explication possible de ce phénomène est que les hélicases Mcm2-7 sont 
initialement chargées sur des sites précis, déterminés par ORC, suivi par 
une migration de Mcm2-7 et éventuellement propagé par la transcription 
active.   
ORC S’ASSOCIE A H4K20ME3 DANS L’HETEROCHROMATINE 
Une question initiale de ma thèse était le rôle de la méthylation de H4K20 
dans la régulation de la réplication. Dans ce but, des ChIPs additionnels 
ciblant soit H4K20me1 ou H4K20me3 ont été réalisés dans les mêmes 
conditions. Alors que H4K20me1 est une modification d’histone 
euchromatique, H4K20me3 fait partie des modifications des histones 
définissant l’hétérochromatine. Une analyse de la couverture moyenne des 
protéines du pre-RC aux positions soit de H4K20me1, soit de H4K20me3 a 
montré que le pre-RC n’est pas lié à H4K20me1, mais surtout que ORC est 
majoritairement enrichi à des positions proches de H4K20me3. Etant donné 
que ORC a aussi potentiellement un rôle dans la régulation de 
l’hétérochromatine, il fallait fonctionnellement tester le rôle de l’association 
de ORC avec H4K20me3.  
H4K20ME3 EST NECESSAIRE POUR LA FORMATION DU PRE-RC ET SON ACTIVATION 
DANS L’HETEROCHROMATINE 
En appliquant un test fonctionnel utilisant des plasmides autonomes basés 
sur l’EBV, il est possible de valider fonctionnellement le rôle d’ORC et 
H4K20me3. La stratégie étant de spécifiquement induire la tri-méthylation 
de H4K20 sur un locus du plasmide et de vérifier si cette induction est suivie 
par la formation du pre-RC sur ce locus et par une activation de la réplication 
du plasmide. En effet, l’induction de H4K20me1 sur le plasmide en guidant 
PR-Set7 sur le locus spécifique est suivie par une conversion en H4K20me3 
par les enzymes Suv4-20h1/h2, le recrutement du pre-RC et l’activation de 
la réplication du plasmide. Pour déterminer si la conversion en H4K20me3 
est nécessaire pour la réplication, l’utilisation d’un inhibiteur spécifique des 
enzymes Suv4-20h1/h2 empêchait la conversion de H4K20me1 en 
H4K20me3. En utilisant cet inhibiteur, la formation du pre-RC sur le 
plasmide est inhibée ainsi que sa réplication. Ces résultats montrent que 
H4K20me3 est en effet nécessaire pour la régulation de la réplication dans 
l’hétérochromatine. De plus, des expériences génomiques sur le timing de 
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la réplication ont révélé des régions spécifiques dans l’hétérochromatine, 
qui dépendent de H4K20me3, alors que la réplication dans d’autres régions 
est potentiellement régulé différemment.   
CONCLUSION  
En conclusion, cette étude propose deux mécanismes différents de la 
régulation de l'assemblage du pre-RC dépendants de l’environnement de la 
chromatine. Dans la chromatine active, l’accessibilité de la chromatine joue 
un rôle très important pour le positionnement aléatoire d’ORC, en connexion 
avec la régulation de l’activité de la transcription. Le recrutement de 
multiples Mcm2-7 est possible et les Mcm2-7 sont probablement propagés 
par la machinerie de la transcription active dans les régions avoisinantes.  
Dans l’hétérochromatine, une liaison aléatoire d’ORC est impossible à cause 
du compactage de la chromatine. En conséquence, une stabilisation d’ORC 
est nécessaire afin d’assurer la réplication correcte dans les domaines 
hétérochromatiques. Cette stabilisation dans l’hétérochromatine est entre 
autre accompli par H4K20me3. Les analyses génomiques ont démontré une 
association spécifique des sous-unités d’ORC avec H4K20me3, restreint 
dans des domaines définis par H4K20me3. Les analyses fonctionnelles ont 
précisé que H4K20me3 est nécessaire pour la formation et activation 
correcte du pre-RC.  
L’ensemble de cette étude constitue la première analyse génomique par 
ChIP-seq de plusieurs composants du pre-RC, notamment car Mcm2-7 
n’avait pas encore été analysé jusqu’à maintenant. Cette étude situe 
Mcm2-7 comme étant le déterminant majeur de l’initiation de la réplication 
dans l’euchromatine, alors que ORC représente le régulateur majeur dans 
l’hétérochromatine. De plus, elle fournit des preuves directes que la 
régulation de la formation du pre-RC dans l’hétérochromatine est 
dépendant de H4K20me3. Ces résultats ajoutent une pièce au puzzle de la 
régulation de la réplication humaine. Alors que quelques pièces déjà 
existantes exigent éventuellement une réévaluation, des investigations 
futures révèleront certainement d’autres éléments manquants afin de 
compléter l’image.  
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